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ABSTRACT
Obesity, a recognized health problem, is associated with cardiovascular disease,
diabetes and hypertension. Removal o f adrenal steroids by adrenalectomy (ADX) slows
the development o f obesity. Leptin decreases food intake through effects initiated by
activation o f the JAK-STAT pathway. Defects in leptin signaling lead to obesity, which
is associated with hyperleptinemia and leptin resistance. In chapter 4, leptin induces
phosphoewo/pyruvate carboxykinase (PEPCK) mRNA expression and increases glucose
production in hepatocytes from lean but not obese Zucker rats. This suggests that
hyperleptinemia in obesity causes hyperglycemia. In chapter 5, ADX decreased the levels
o f PEPCK mRNA, and increased leptin receptor mRNA expression o f obese Zucker rats.
The decrease in PEPCK mRNA is presumed to correct the hyperglycemia in these rats.
ADX decreases leptin levels and increases leptin receptor (OBR) mRNA in obese Zucker
rats, suggesting that leptin downregulates OBR. ADX was reported to increase sensitivity
to leptin treatment. I hypothesized that high glucocorticoids in obesity impaired OBR
signaling, and removal thereof will activate this pathway. In chapter 6, ADX increased
the expression o f leptin receptor mRNA in Sprague Dawley rats. ADX increased STAT-3
mRNA and protein levels, and induced constitutive STAT-3 phosphorylation and DNA
binding activity. ADX also reduced SOCS-3 mRNA and protein levels. ADX and leptin
treatment increased STAT-3 phosphorylation, but with no concomitant increase in DNA
binding activity. We speculate that PIAS-3, a protein inhibitor o f activated STAT-3,
inhibited DNA binding o f the activated STAT-3 as a protective measure o f cytokine
hypersensitivity in the absence o f SOCS-3. Leptin and ADX decreased NPY mRNA
expression, but their combination did not further decrease NPY mRNA. In conclusion,

xvi
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ADX mimicked leptin in activating STAT-3, and ADX decreased SOCS-3 inhibitory
system. Leptin sensitivity could also result from the release o f anorexigenic and
orexigenic neuropeptides, but more research is warranted. In chapter 7, high-fat diet
induced leptin resistance could be due to downregulation o f the leptin receptor proteins in
the hypothalamus. Further research is required to define the leptin resistance in OM rats
induced by high fat diet, such as changes in leptin receptor signaling and SOCS-3
expression.

xvii
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CHAPTER OINE
INTRODUCTION
Obesity, the prevalence of which has been progressively increasing, has reached
epidemic proportions in the developed countries. This phenomenon is usually ascribed,
through epidemiological studies, to the combination o f excess consumption o f processed
foods and decreased physical activity (Ravussin & Tataranni, 1997). The pathogenesis of
obesity remains largely unknown, but obesity is closely associated with increased
morbidity and mortality caused by several o f the m ost common diseases in the western
world,

including

type

2

diabetes,

hypertension,

dyslipidemia,

atherosclerosis,

cardiovascular disease and cancer (Bjomtorp, 19'98). The increasing rates o f obesity
cannot be explained exclusively by the high availability of energy- and fat-dense foods
and increased food intake, or decreased energy expenditure due to the increasingly
sedentary lifestyle. The study of factors such as genetics and lifestyle implicated in
obesity is crucial for predictions of the impact o f th e obesity epidemic, and provides an
opportunity for the implementation o f preventive measures (Grundy, 1998).
Variations in obesity-related phenotypes

has been shown to be heritable

(Commuzzie and Allison, 1998), and environmemtal factors are becoming important
determinants in the development of obesity (Bray, 1998). A gene x environment effect
arises when the response o f a phenotype to environmental changes depends on the
genotype of the individual. It is well known that tfiere are individual differences in the
response to changes in energy balance. Therefore, gene x environment interactions are
shown to be ubiquitous, as monozygotic twins responded similarly to variations in energy
balance (Bouchard & Tremblay, 1997). The epidemic o f obesity is therefore attributed

1
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largely to environmental factors, namely, the abundance o f high energy foods and a
sedentary lifestyle. It is possible that, in the nearest future, candidate genes predisposing
individuals with susceptibility or resistance to the development of obesity in response to
changes in environmental factors will be identified. Since obesity rates are high, the
continuous efforts by scientists in genetic and molecular research are warranted in order
to identify the genes responsible for the susceptibility to obesity and to delineate further
the cause o f obesity, which involves neuroendocrine, genetic and dietary factors, in
addition to lifestyle (York, 1992b; York, 1996; Weinsier, et al., 1998; Williamson, 1996;
Bray and Bouchard, 1997). The role o f a genetic predisposition to obesity has long been
recognized (Bray and Bouchard, 1997), with evidence from human single gene mutations
(e.g.

leptin,

proopiomelanocortin,

peroxisome

proliferator-activated

receptor-y,

melanocortin-4 receptor), mendelian syndromes (e.g. Cushing’s, Prader-Willi), animal
models (genetically obese rodents, transgenic animals) and linkage and association
studies (twins and adoption, nuclear families).
In

animals,

obesity

phenotypes

have

been

categorized

into

dietary,

neuroendocrine and genetic, depending on the origin o f the obesity (York, 1992; York,
1996). Dietary obesity is produced by a variety o f dietary manipulations, which include
increasing the dietary fat or sugar and increasing palatability o f foods (Sclafani, 1992).
Little is known of the factors that predispose individual humans to become obese,
because obesity is a complex syndrome which appears to be polygenic rather than
monogenic, and may be affected by environmental influences. The myriad o f central
neurotransmitters and peptide systems involved in the regulation o f body weight in
humans remain to be assessed, because these may regulate or be regulated by susceptible

2
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genes which in turn may alter appetite or food preference and fiiel metabolism. Animal
models have become useful alternates for such studies. Single gene mutations producing
obesity in rodents provide insights into the genetically modulated development of
obesity. On the other hand, models o f dietary-induced obesity provide important insights
into defects that might predispose rats to become obese, and these models can be
identified prospectively before they express their respective phenotypes. These models
also allow manipulations of the environment so as to alter metabolic and neural functions
of rodents o f a known phenotype or genotype. These studies will therefore help decipher
whether diet-induced obesity in humans is an inherited polygenic trait or not.
Studies o f the interactions between heredity and physical activity have shown that
the genetic background may modify the effect of physical activity on weight change
(Heitman, et al., 1997; Samaras, et al., 1999), and that lifestyle may have an obesitypromoting effect, depending on a genetic predisposition (Hill, 1998; Hill and Peters,
1998). Genotype-environment interactions, which arise when a phenotype responds to
environmental changes based on the genotype o f an individual, may affect body weight
and energy expenditure induced by overeating or by high fat diet consumption.
Therefore, the examination of factors such as genetics and lifestyle, implicated in weight
gain and obesity, is crucial in our understanding o f obesity development. This will impact
on the integrated approach for the effectiveness o f prevention and management strategies
for obesity. The main challenge for the future is, therefore, to precisely define the
genotype-environment interactions that are fundamental to the development o f obesity,
and to show that this leads to the obesity phenotype observed due to changes in
susceptibility genes that remained silent until the conducive environment was attained.

3
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This dissertation describes studies on l)the effects o f leptin and glucocorticoids
on the liver phosphoewo/pyruvate carboxykinase, 2) the effects of glucocorticoids on the
leptin receptor gene expression in lean and obese Zucker rats, and 3) the increased
sensitivity to leptin treatment in adrenalectomized rats. These experiments tested the
hypotheses that PEPCK gene expression contributes to hyperglycemia observed in obese
Zucker rats, and that glucocorticoids also regulate the leptin receptor signaling system by
playing a part in the leptin resistance observed in obesity.
In the following chapters, each of the various effects of leptin and glucocorticoids
are described in detail. There are a total o f eight chapters. Chapter two gives a detailed
review o f the literature. Chapter three presents the general methods and techniques used
in studies in this dissertation. Chapter four discusses the effects of leptin on liver gene
expression and metabolism. Chapter five investigates the effects o f glucocorticoids on
PEPCK and leptin receptor gene expression in lean and obese Zucker rats. Chapter six
describes the effects o f adrenalectomy on the leptin receptor signaling system. Chapter
seven describes the modulation o f leptin receptor signaling system by high fat and low fat
diets in Osbome-Mendei and S5B/P1 rats. Chapter eight offers the author’s summary and
future research directions.
Final conclusions that can be drawn from the presented dissertation research are
1) that glucocorticoids cause significant changes in the leptin receptor signaling system in
the hypothalamus during obesity, and that these changes may account to some extent for
the establishment o f leptin resistance in obesity, and 2) that high fat diet induces leptin
resistance by downregulating the leptin receptors in the hypothalamus o f obesitysusceptible Osbome-Mendei rats.

4
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CHAPTER TWO
REVIEW OF THE LITERATURE
2.1 OBESITY
Obesity is the major nutritional problem affecting industrialized societies. The
- specific syndromes o f obesity both in animai models and in humans are associated with
identified dietary, endocrine and/or genetic causes (York,

1996). However, the

pathogenesis o f obesity in humans is still unknown, apart from unexplained chronic
excess in caloric intake relative to energy needs. Therefore, an understanding o f obesity
and its consequences requires the investigation o f the many factors that control energy
intake and

energy expenditure.

Such factors may

be

genetic,

environmental,

physiological, psychological, social or cultural, all o f which are known to influence the
presence o f obesity in modem societies.
2.2 ANIMAL MODELS OF OBESITY
Using

animal

models,

obesities

have

been

categorized

into

dietary,

neuroendocrine and genetic, depending on the origin o f obesity (York, 1992b; York,
1996). Dietary obesity can be produced in laboratory animals by a variety o f dietary
manipulations, which include increasing the dietary fat or sugar and increasing
palatability o f foods (Sclafani, 1992). Although the role o f dietary factors in human
obesity has not been precisely identified, this research with laboratory animals clearly
shows that certain diets promote hyperphagia and obesity in animals. Epidemiological
studies show that obesity is more prevalent in humans consuming high fat diets, a
characteristic o f westernized diets, accompanied by decreased physical activity (Ravussin
& Tataranni, 1997).
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The ventromedial hypothalamic (VMH) region is responsible for integrating
information about energy stores, and hypothalamic bilateral lesions o f the ventromedial
nuclei (VMN) produce obesity in laboratory animals (Bray, et al., 1990). The VMH
obesity was produced by lesions o f the VMN in rats by passing an electric current
through an electrode, whereas in mice the lesions were produced by intraperitoneal (ip)
injection o f gold thioglucose (GTG) (Brecher & Waxier, 1949). Obesity can also be
produced by destroying the paraventricular hypothalamic nuclei (PVN) (Leibowitz, et al.,
1981) or by damaging the arcuate nucleus (ARC) bilaterally using monosodium
glutamate (MSG) (Olney, 1969).
Apart from induction o f obesity by diet and hypothalamic lesions, a large number
o f genetically inherited forms o f obesity have been described (Trayhum, 1984; York,
1996). Genetically obese animals have been divided according to their mode of
inheritance into the single-gene dominant or single-gene recessive strains, and the
polygenic inbred or hybrid strains due to a number o f mutations in various genes (see
Table 2.1). While great interest has justifiably been focused on the single gene mutations
which result in obesity in rodents, and recently humans (Licinio, et al. 1998), it is likely
that most instances o f human or animal obesity reflect the interaction o f a number o f
genes with a permissive environment. Recently, gene linkage analysis o f animal models
o f obesity has identified over 80 linkages o f chromosomal locations with obesity and/or
body fat distribution in polygenic forms o f obesity (Chagnon, et al., 1999).
Classical parabiosis studies by Coleman (1978), in which blood circulation of
obese (ob/ob) mice was joined to that o f obese (db/db) mice, showed that the ob/ob mice
reduced food intake and lost weight, whereas db/db mice became more obese.
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Table 2.1 Animal models o f genetically inherited obesity

Animal model
Recessive inheritance
ob/ob

Chromosome Gene defect

Gene product

Mechanism

6

stop codon 105
Leptin
produces truncated leptin
(167 amino acids)

Leptin signal from fat to
brain and peripheral organs

db/db

4

splicing defect

Leptin receptor
(505 amino acids)

Impaired leptin receptor

M a

5

Gin to Pro mutation

Leptin receptor

Impaired leptin receptor

Fat

8

Insert

Carboxypeptidase E

Pro-peptides not cleaved

tub

7

Insert

Phosphatase

Phosphate not cleaved

2

Agouti signaling protein
ectopic expression

Asp

Competes with MSH
for receptors

Dominant inheritance
Yellow mouse (Ay)

Polygenic inheritance
NZO mouse
KK mouse

(133 amino acids)

7

?

?

?

7

7

7
7

When ob/ob mice were joined to lean mice, the ob/ob mice lost weight and the lean mice
remained normal. Upon joining the db/db mice to normal lean mice, the db/db mice
became more obese and the lean rats had decreased glucose and insulinemia. This
suggested either an absence o f a circulating factor or an inability to respond to a
circulating factor was fundamental to the development o f obesity in these animal models
(ob/ob, db/db and fa/fa). This factor was recently discovered to be leptin in ob/ob mice,
while mutations in the leptin receptor in db/db mice and fa /fa rats (Zhang, et al., 1994;
Tartaglia, et al., 1995; Chua, et al., 1996; Lee, et al., 1996; Iida, et al., 1996) explained
their inability to respond to leptin.

dfc!db

normal

I insulinemia
i blood glucose
Diabetes t body weight
fW AT mass
Lean

dbitfo

abiats

ed/tsfr

i body weight
I WAT mass
1 insulinemia
| blood glucose
Diabetes t body weight
tW A T mass
Obese

Lean
Obese

rwffiwi

No change
i food intake
j. insulinemia
I blood glucose

Figure 2.1. Model o f the parabiosis experiment o f Coleman (1978). When obese (ob/ob)
mice were joined to obese (db/db) mice, the ob/ob mice reduced food intake and lost
weight. These experiments led Coleman to hypothesize that ob/ob mice fail to produce a
circulating factor (OB protein from their fat cells), but their brain remains sensitive to it,
while db/db mice produced the circulating factor (functional OB proteins), but their brain
was unresponsive. Adapted from Coleman (1978).
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2.3 EFFECTS OF GLUCOCORTICOIDS ON OBESITY
Adrenal hormone secretion plays a major role in the control o f substrate supply to
tissues and in the partitioning o f dietary energy between storage compartments. In
general, glucocorticoids are catabolic toward protein, increasing muscle protein
breakdown and enhancing gluconeogenesis in stress and starvation to maintain the
glucose supply for the brain. They are also catabolic toward fat at high doses (Woodward
& Emery, 1989), but anabolic in fat metabolism at low doses (Diamant & Shafrir, 1975).
Glucocorticoids enhance the induction o f lipogenic enzymes by insulin, an effect
illustrated by the submaximal induction o f linogenic enzymes on refeeding o f
adrenalectomized rats (Wurdeman, et al., 1978).
Adrenalectomy (ADX) prevents all forms o f obesity (Bray, et al., 1990a; Bray, et
al., 1990b). The reduction in body weight in response to ADX is small in lean rats but
pronounced in obese rats (Bray, et al., 1990a; Bray, et al., 1990b; King, et al., 1983; Saito
& Bray, 1984; Tokuyama & Himms-Hagen, 1989). On the contrary, glucocorticoid
replacement o f adrenalectomized animals restores fat deposition irrespective of any
increase in food intake (Saito & Bray, 1984; Bruce, et al., 1982; Freedman, et al., 1985;
Freedman, et al., 1986). Glucocorticoid replacement in adrenalectomized obese rats
restores obesity, whereas no induction of obesity is observed in lean animals upon
replacement (Freedman, et al., 1985; Freedman, et al., 1986).
Glucocorticoids regulate the autonomic nervous system by suppressing the
sympathetic drive to brown adipose tissue (BAT) and enhancing the parasympathetic
drive to the pancreatic islets and thus promoting insulin secretion (Holt & York, 1989;
Stubbs & York, 1991). The effects are exaggerated in obese rats and mice compared to
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lean animals (Bray, et al., 1990a; Bray, et al., 1990b). The low thermogenic response of
BAT to diet contributes to the increased energy efficiency associated with obesity
(Marchington, et al., 1983; York, 1989). Adrenalectomy enhances BAT thermogenesis to
diet stimuli elevating the sympathetic drive to the tissue (Marchington, et al., 1983; York,
1989; York, et al., 1985). Conversely, corticosterone suppresses BAT activity in lean rats,
which is associated with the impairment in sympathetic drive to the tissue (York, 1989;
York, et al., 1985). This impairment is specific to diet-related BAT thermogenesis in fa /fa
rats and does not affect cold-responsive nonshivering thermogenesis (Bray, et al., 1990a;
Bray, et al., 1990b; Holt, et al., 1983), showing that the glucocorticoid site o f action is
prior to the efferent sympathetic pathway. Glucocorticoids also interfere with the central
responses to glucose metabolism through suppression of both the feeding and
sympathetic responses to 2-deoxyglucose (York, et al., 1985; Allars & York, 1986).
ADX reduces body weight gain in Zucker fa /fa rats concomitant with reduction in
food intake and marked attenuation o f fat accumulation (Yukimura, et al., 1978; Bray, et
al., 1992). In the obese (ob/ob) mouse, ADX increases energy expenditure (Vander Tuig,
et al., 1984), restores norepinephrine turnover to normal in BAT and heart (Vander Tuig,
et al., 1984), abolishes insulin resistance in muscle (Oshima, et al., 1984), lowers
circulating levels o f insulin and glucose (Yukimura & Bray, 1978a) and normalizes
glucose tolerance (Solomon, et al., 1977; Bailey, et al., 1986). Similar changes have been
reported for the diabetes (db/db) mouse (Bray, 1982) and the fatty rat (Marchington, et
al., 1983). It is, therefore, likely that changes in the hormonal milieu, which include the
effects o f glucocorticoids and insulin, contribute to the altered food intake, energy
expenditure and obesity.
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2.4 GLUCOCORTICOID RECEPTOR
Glucocorticoids are steroid hormones synthesized and released by the adrenal
cortex that influence a variety of physiological and developmental processes including
intermediary

metabolism,

differentiation,

response

to

stress

and

immunity.

Glucocorticoids, like all steroid hormones, exert their effects on responsive cells by
interacting with a specific cytosolic glucocorticoid receptors (GR), which in turn regulate
glucocorticoid-responsive genes through interactions with hormone-response elements on
the gene (Yamamoto, 1985). Moreover, studies using the GR antagonist, RU486, which
inhibits obesity, showed that the development o f obesity is due to the overactivity o f the
GR receptor (Langley & York, 1990; Okada, et al., 1990).
2.4.1 GLUCOCORTICOID RECEPTOR STRUCTURE
GR shares a similar structure to nuclear receptors, for retinoic acid, vitamin D,
estrogen, androgen, progesterone and thyroid hormone. This group collectively forms a
superfamily referred to as ligand-activated transcription factors (Evans, 1988). Members
o f this superfamily share a common domain structure composed o f three distinct regions,
each required for a specific function (Figure 2.2). The amino terminal end o f the
receptor, the transactivation domain, is responsible for its ability to activate transcription.
The precise function o f this domain is not known, but it appears to be involved in
interactions with other transcription factors. The deoxyribonucleic acid (DNA) binding
domain is located in the center of the receptor protein and comprises 70 amino acids. This
sequence is required for interaction with the glucocorticoid response element (GRE), a
short 15 base-pair regulatory DNA sequence located near the promoter, to which the
receptor binds to modulate transcription. This domain also contains sequences involved

11

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

in nuclear translocation o f GR and for dimerization o f the receptor. The carboxy terminal
region of the GR comprises the hormone-binding domain. This region also contains
residues important for transcription activation, nuclear translocation and dimerization
(Gehring, 1993).
2.4.2 GLUCOCORTICOID RECEPTOR FUNCTION
The effect o f steroid hormone results from the hormone passing through the cell
membrane by passive diffusion and binding to the receptor. Unbound GR is found
predominantly in the cytosol. Unlike other hormones, eg. insulin, which transduce the
hormonal signal as second messengers into the cell, glucocorticoids activate GR directly
and influence transcription o f glucocorticoid-responsive cells. The mechanism o f action
o f GR involves ligand binding to the receptor, which then results in dimerization and
activation o f GR (Figure 2.2). In the absence o f ligand, the GR is composed o f multiple
proteins in an aggregate with various components. The aggregates are formed by
noncovalent interactions o f a monomeric GR with a heat shock protein 90K (Hsp90)
dimer (Pratt, et al., 1992). In this state, the GR is unable to bind to DNA. Following
ligand binding to GR, the Hsp90 dissociates from the ligand-GR complex, the Iigand-GR
complex dimerizes and then translocates to the nucleus, where the GR binds to the GRE.
The consensus sequence for the GRE is 5’-GGTACAnnnTGTTCT-3’, where n is any
nucleotide (Beto, 1989).
2.4.3 GLUCOCORTICOID RECEPTOR REGULATION
Cellular responsiveness to glucocorticoids depends upon GR levels. Therefore,
mechanisms that modulate the concentration o f functional GR can be pivotal controllers
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Figure 2.2. A model for the mechanism of glucocorticoid receptor action. GR is folded
into three domains: hormone-binding domain at the C-terminus, DNA binding domain in
the middle, and the gene transcription activation domain at the N-terminus. See text for
description of the mechanism. Adapted from Boumpas, et al. (1991).
o f glucocorticoid action. All steroid hormone receptors are regulated by their specific
hormone, leading to autoregulation (Haddock and Malbon, 1991). This process involves
hormone-mediated transcriptional (mRNA synthesis),

post-transcriptional (mRNA

stability) and post-translational (protein turnover) mechanisms. Sequence analysis studies
o f human GR, by Burnstein and colleagues (1993), showed that the gene contains
sufficient sequence information to confer glucocorticoid-inducible GR down regulation,
which could involve either the rate o f transcription or the stability o f the GR mRNA.
Most steroid hormone receptors are phosphoproteins (Orti, et al., 1992). The GR
is phosphorylated predominantly in the amino terminal transactivation domain. All the
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phosphorylated amino acids are serines except for one threonine (Bodwell, et al., 1991).
So far, the function o f this phosphorylation o f GR is unknown. It is hypothesized that
phosphorylation-dephosphorylation mechanisms could be involved in the regulation o f
transcription.
2.4.4 GLUCOCORTICOIDS AND THE HYPOTHALAMIC-PITUITARYADRENAL AXIS
Cortisol, the major glucocorticoid secreted by the human adrenal cortex,
(corticosterone in the rat) mediates a number o f metabolic functions essential for life. The
secretion o f cortisol is narrowly regulated because both deficient and excess plasma
concentration o f cortisol are associated with disease and mortality. Hypothalamic
corticotropic

releasing

hormone

(CRH)

stimulates

the

pituitary

to

secrete

adrenocorticotropic hormone (ACTH) which in turn stimulates the secretion o f cortisol
from the adrenal cortex into the systemic circulation. Circulating cortisol exerts negative
feedback on the hypothalamus and pituitary by inhibiting the secretion o f CRH and
ACTH. These functionally linked units, composed o f the hypothalamus, pituitary and
adrenal cortex, form a regulatory system for plasma cortisol, termed the hypothalamicpituitary-adrenal (HPA) axis (Bjomtorp, 1995; Chalew, et al., 1995).
Glucocorticoids impair insulin action and increase circulating glucose levels.
They inhibit glucose uptake by peripheral tissues (Bowes, et al., 1991; Nosadini, et al.,
1993) and augment the effect o f glucagon and epinephrine to enhance gluconeogenesis in
the liver (DeFeo, et al., 1990). Therefore, the effects o f cortisol work to render insulin
action ineffective. Furthermore, glucocorticoids promote the differentiation o f human
adipocyte precursor cells into fat cells (Hauner, et al., 1987) and is associated with
increased adipocyte lipoprotein lipase activity and hyperlipidemia (Taskinen, et al.,
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1983). The pathological role of cortisol in the development o f glucose intolerance and
other complications o f obesity makes it imperative to study the HPA axis and its role in
obesity.
2.5 T H E ob G EN E AND LEPTIN
The ob (obese) gene was recently identified (Zhang, et al., 1994) and initially found to be
expressed and the protein secreted primarily in the adipose tissue, where it encodes a 4.04.5 kb mRNA with a 167-amino acid open-reading frame without any sim ilarities to other
proteins. The search o f a 3-dimensional structure database, to determine whether the ob
protein might adopt a fold similar to any known structure, revealed that the ob sequence
is comparable with structures from the family o f helical cytokines that includes
interleukin-2 and growth hormone (Madej, et al., 1995; Zhang, et al., 1994; Murakami &
Shima, 1995). Whether the gene is also expressed in the brown adipose tissue is
controversial (Frederich, et al., 1995; Moinat, et al., 1995; Deng, et al., 1997). The ob
mRNA encodes an 18 kDa protein which is secreted, after cleavage o f th e signal peptide,
from the adipocytes as a 16 kDa glycoprotein named leptin, from the Greek leptos,
meaning thin or small (Halaas, et al., 1995). Leptin is single-stranded w ith a disulfide
bridge at the C-terminus, which is pivotal for stability and bioactivity (Rock, et al., 1996).
Leptin mRNA and protein levels increase with adipose stores (Maffei, et al.,
1995a; Frederich, et al., 1995) and therefore, leptin is considered to signal the size o f the
white adipose tissue (WAT) depots. This provides a molecular basis for the lipostat
theory o f energy regulation (Kennedy, 1953), proposing that there is a feedback loop. The
existence of such a chemical feedback signal was supported by the classical parabiosis
experiments o f Coleman (Coleman, 1973; Coleman, 1978). Leptin may w ork as a satiety
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factor because administration o f the recombinant leptin to ob/ob mice decreased food
intake and body weight (Halaas, et al., 1995; Pelleymounter, et al., 1995; Campfield, et
al., 1995; Stephens, et al., 1995).

Food Intake
PITUITARY
LEPTIN

WAT
ADRENAL
WAT MASS
FOOD

Figure 2.3. Model o f the feedback loop proposed by Kennedy (1953). The hypothalamus
is depicted as the central controller of food intake, and leptin, which increases due to
increased white adipose tissue mass, sends a satiety signal to the hypothalamus, thus
causing the decrease in food intake.
There are site-specific variations in the expression o f the ob gene (Trayhum, et
al., 1995; Maffei, et al., 1995a; Masuzaki, et al., 1995; Frederich, et al., 1995), and the
highest level o f expression is evident in the epididymal and perirenal adipose tissue
(Trayhum, et al., 1995; Maffei, et al., 1995a; Masuzaki, et al., 1995). Leptin has also
been shown to be expressed in the stomach (Bado, et al., 1998), and placenta (Masuzaki,
et al., 1997; Hoggard, et al., 1997b). Increased levels o f ob mRNA have been reported for
ob/ob mouse, db/db mouse and the Zucker fa /fa rat (Zhang, et al., 1994; Trayhum, et al.,
1995; Maffei, et al., 1995; Frederich, et al., 1995; Funahashi, et al., 1995). Therefore,
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obesity seems to be associated with increased expression of the ob gene. Classic
parabiotic experiments between ob/ob and wild-type mice indicated that a factor
circulating in the bloodstream o f lean (ob/ob littermates) or db/db mice reverses the
effects o f the ob mutation (Coleman, 1973; Coleman, 1978). Thus, the elevated levels o f
ob mRNA may reflect the strength of the feedback signals to adipose tissue resulting
from the fact that a truncated, non-functional leptin is synthesized in this mutant (Zhang,
et al., 1994). This is true for the db/db mouse and the fa /fa rat because the mutants
produce defective receptor systems for leptin. Treatment o f ob/ob mice with leptin
reversed the obesity phenotype (Weigle, et al., 1995; Halaas, et al., 1995; Pelleymounter,
et al., 1995).
2.6 REGULATION OF LEPTIN PRODUCTION
Leptin biosynthesis

and

release

is governed

by

a complex

array

of

neuroendocrine, endocrine and paracrine signals that impinge on the adipocyte. Fasting
decreases the level o f ob mRNA expression, which is rapidly reversed on refeeding
(Trayhurn, et al., 1995; Frederich, et al., 1995; Hardie, et al., 1996; MacDougald, et al.,
1995; Saladin, et al., 1995). In contrast with normal rats and mice, fasting does not induce
the decrease in the ob mRNA in ob/ob mice (Trayhurn, et al., 1995; Frederich, et al.,
1995). The decrease in leptin appears to be central to the neuroendocrine adaptation to
starvation (Ahima, et al., 1996). Insulin increases the ob mRNA expression (Wabitsch, et
al., 1996) and circulating protein levels (Malmstrom, et al., 1996), and the idea that
insulin may be a controlling factor over leptin expression has been suggested. During
starvation, the decrease in insulin may be a key regulatory signal for the suppression o f
leptin expression (Boden, et al., 1996).
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Leptin is also regulated positively by glucocorticoids at high doses (De Vos, et al.,
1995; Slieker, et al., 1996; Wabitsch, et al., 1996; Considine et al., 1997) and cytokines
(Grunfeld, et al., 1996; Sarraf, et al., 1997), and negatively by B2- and 133-adrenergic
receptor agonists and cAMP (Slieker, et al., 1996; Mantzoros, et al., 1996; Trayhum,
1996b). Thyroid hormones also suppress leptin production from the adipose tissue (Fain,
et al., 1997; Escobar-Morreale, et al., 1997; Valvaci, et al., 1997; Yoshida, et al., 1997)
The ob gene promoter is positively regulated through a functional binding site for
CAAT/enhancer binding protein (C/EBP-a) (He, et al., 1995; Miller, et al. 1996; Hwang,
et al., 1996), whereas thiazolidinedione agonists for peroxisome proliferation activated
receptor (PPAR-y) transcription factor suppress leptin expression in rodents (Forman, et
al., 1995; De Vos, et al., 1996; Nolan, et al., 1996; Zhang, et al., 1996; Kallen & Lazar,
1996). This may involve a functional antagonism between C/EBPa and PPARy on the
leptin promoter (Hollenberg, et al., 1997). In summary, nutritional status, stress and
immune activation influence leptin expression and production.
2.7 LEPTIN RECEPTOR
The receptor for the leptin protein was recently identified by an expression
cloning strategy (Tartaglia, et al., 1995; Devos, et al., 1996). A cDNA library was
constructed from mouse choroid plexus to clone this leptin binding activity. From this
screen, cDNAs that encoded a cell surface leptin receptor (OB-R) were identified
(Tartaglia, et al., 1995). The majority o f the transcripts are those encoding the short forms
of the receptor (Ghilardi, et al., 1996). The transcript that encodes the long form is less
abundant even though it was detected in nearly all tissues in mice and humans by
ribonuclease protection analysis (RPA) and polymerase chain reaction (PCR) (Ghilardi,
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et al., 1996). Nevertheless, the long form is expressed mainly in the hypothalamus. This
long form transcript is found in regions that are thought to control body weight, namely,
the ARC, VMN and PVN (Mercer, et al., 1996a).
The murine cDNA clones identified above revealed a single membrane-spanning
receptor that is similar to the class I cytokine receptor family (Tartaglia, et al., 1995). The
closest relatives of OB-R were shown to be gpl30 (Taga, et al., 1989; Hirano, et al.,
1994), the granulocyte colony stimulating factor (G-CSF) receptor (Larsen, et al., 1990),
and leukemia inhibitory factor receptor (LIF-R) (Gearing, et al., 1991).

O B -R l

O B -R s

100 %

816 aa

transmembrane domain
303 aa

Expressed in
multiple tissu es

Expressed pred om inan tly
in h y p o t h a l a m u s

Figure 2.4. Short form (OB-Rs) and long form (OB-Rl) leptin receptors. The similarities
and differences between the extracellular, transmembrane, and intracellular domains of
OB-Rs and OB-Rl are shown schematically, aa; amino acids, 100% is similarity between
extracellular domains. 23 aa represents the transmembrane domain o f the OB-Rs and OBR l. OB-Rs has 34 aa and OB-RL has 303 aa in the intracellular domain. Adapted from
Tartaglia (1997).
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The extracellular domain o f OB-R is about 816 amino acids and the intracellular
domain o f the short form is composed o f 34 amino acids. The long form has an
intracellular domain made o f approximately 303 amino acids (Tartaglia, et al., 1995;
Chen, et al., 1996; Lee, et al., 1996). The extracellular domains o f the short and long
forms are identical throughout their entire length, except in the fa /fa rat where a mutation
has been described (Chua, et al., 1996; Iida, et al., 1996a; Iida, et al., 1996b). Differences
only arise from the alternative RNA splicing at the carboxy-terminal coding exon, which
results in the leptin receptor intracellular domains with differing length and sequence
composition (Chen, et al., 1996; Lee, et al., 1996; Tartaglia, 1997). Additional short
forms have been identified, all of which terminate shortly after the point o f divergence at
Lys889, i.e., after amino acid 29 o f the intracellular domain (Chen, et al., 1996; Chua, et
al., 1996). A transcript that potentially encodes a soluble form o f the receptor was also
described (Lee, et al., 1996). This protein lacks the transmembrane domain found in the
other OB-R proteins. Genetic mapping of the gene encoding OB-R localized its position
to mouse chromosome 4 (Tartaglia, et al., 1995). The position is within the genetic
interval to which the db locus has been mapped (Chen, et al., 1996).
2.8 LEPTIN RECEPTOR MUTATIONS
The gene encoding the leptin receptor was sequenced from the wild type and
db/db mice and revealed a mutation in db/db mice (Chen, et al., 1996; Lee, et al., 1996).
The mutation is a single nucleotide substitution, G—>T, within the exon containing the
carboxy terminus and 3’-UTR of the short form o f OB-R. The mutation consequently
resulted in the generation of a new splice donor site, creating an exon that is
inappropriately spliced into the transcript encoding the long form o f OB-R. This new
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exon is made up o f the last six codons and the first 88-bp o f the 3’-UTR o f the primary
short form and is inserted where the long form and short form domains diverge. As a
result of this insertion, the long form transcript in db/db mice encodes a protein in which
the majority of the intracellular domain is truncated and thus identical to the major short
form. The defect in db/db mice is in the OB-R gene providing evidence for the
importance o f this receptor in body weight control (Chen, et al., 1996).
In the fa /fa Zucker rat, the genetic mutation is a single nucleotide substitution,
A

—»C that leads to a single amino acid substitution, from Gin

to Pro

, in the

extracellular domain. This mutation causes the obesity phenotype as it affects cell surface
expression and binding affinity o f leptin at the cell surface (Chua, et al., 1996a; Chua, et
al., 1996b; Philips, et al., 1996, Iida, et al., 1996a; Iida, et al., 1996b). The expression
levels o f the OB-R mRNA in the brain of Zucker fa /fa rat was higher than for lean
littermates (Iida, et al., 1996). The fa mutation was mapped to rat chromosome 5, a region
syntenic with the db region on mouse chromosome 4 (Truett, et al., 1991).
Another mutation o f the leptin receptor was found in the inbred genetic model of
non-insulin-dependent diabetes mellitus (NEDDM), an NIH-corpulent rat (cp/cp),
(Koletsky, 1973; Lee, et al., 1997). This mutation is a f a allele (fa^/fa09) since crosses of
rats carrying the f a mutation with rats carrying the cp mutation yielded obese progeny
(Yen, et al., 1977). The mutation is a single base change o f T2289 to A2289 in the obese
corpulent rats resulting in the conversion of Tyr763 to a stop codon (Lee, et al., 1997).
This nonsense mutation results in the termination of translation at the amino terminal end
o f the transmembrane domain. As a result, none of the leptin receptor isoforms in cp/cp
rats are predicted to encode a transmembrane domain, nor any o f the motifs necessary for
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signal transduction. The mutation in the corpulent rat and the ffameshift mutation in 129
db3J/db3J mice confirm that defects in the leptin receptor lead to abnormalities in the
leptin-leptin receptor pathway and an obese phenotype.
2.9 LEPTIN R E C EPTO R FUNCTIONS
The functions o f the long and short intracellular domains o f the leptin receptor are
currently being defined. The high expression levels o f the short form have been
speculated to play a role in transporting leptin from the blood to the cerebrospinal fluid
(CSF), where leptin can then move by diffusion to the ARC, PVN or VMN to regulate
body weight. This is supported by the observation that leptin enters the brain by a specific
and saturable transport mechanism (Banks, et al., 1996). However, the role o f the leptin
receptors in this transport system has not been described. The short form o f OB-R may
also play a role in clearance due to their distinct tissue distribution (Cumin, et al., 1996).
The long form o f the receptor shows sequence homology to members o f the class
I cytokine receptor superfamily (Tartaglia, et al., 1995; Bazan, 1990). This provides
important information as to possible intracellular mediators o f leptin receptor activation
(Figure 2.5). The cytoplasmic domains o f the class I cytokine receptors lack enzymatic
activity and instead they associate with the cytoplasmic tyrosine kinase o f the Janus
kinase (JAK) family (Ihle, 1995). Ligand binding leads to activation o f receptor-bound
JAK kinases, which phosphorylate tyrosines in the cytoplasmic domain o f the receptor as
well as other cytoplasmic target proteins, including the signal transducers and activators
of

transcription

(ST AT),

ras/mitogen

activated

protein

(MAP)

kinase,

and

phosphoinositide-3-kinase pathways (Ihle, 1996; Darnell, et al., 1994). The activated
ST AT proteins then translocate to the nucleus and stimulate gene transcription.
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Figure 2.5. Schematic diagram o f the leptin receptor and its molecular signaling
pathways. Homodimerization of the OBR complex by leptin binding to leptin binding
domain (LBD) activates JAK kinase activity, which phosphorylates OBR on tyrosine
residues in the cytoplasmic domain. Phosphorylated tyrosine residues provide specific
docking sites for the SH2 domains o f STAT-3 proteins, causing receptor association and
subsequent phosphorylation of STAT-3. After activation, STAT3 translocates to the
nucleus to modulate transcription. Negative regulators o f JAK/STAT signaling, e.g.,
SOCS and PIAS, interfere at specific sites in the signaling cascade, with SOCS-3
inhibiting JAK association with the OBR and inhibit OBR activation and STAT-3
phosphorylation, and PIAS-3 inhibiting the DNA binding o f activated STAT-3. In
addition to activating the JAK/STAT cascade, leptin also stimulates the MAP kinase
pathway. This pattern o f JAK/STAT protein activation by leptin is predominantly in the
hypothalamus. Adapted from Auernhammer and Melmed (2000).
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Thus, the long form OB-R is likely to be the active signaling receptor because it has
features similar to that of the class I cytokine receptors that are essential for signaling.
Furthermore, it is preferentially expressed in the hypothalamus, the primary site o f leptin
action.
Co-transfection studies have shown that the long form o f OB-R is capable o f
activating the STAT proteins in response to ligand binding (Baumann, et al., 1996;
Ghilardi, et al., 1996). This effect is not observed in the presence o f the short form
receptor. The short form of the receptor was unable to bind to or activate JAK kinase
(Ghilardi & Skoda, 1997) which is consistent with the inability to activate STAT
proteins. In contrast to the inability o f the short form leptin receptor to bind and activate
JAK/STAT proteins, the short form does induces gene transcription o f c-fos and c-jun
(Murakami, et al., 1997; Yamashita, et al., 1997). This is similar to transcription induced
by the truncated G-CSF receptor, which contains a short cytoplasmic domain (Baumann,
et al., 1996). This suggests, therefore, that the leptin-induced mRNA expression in CHO
cells transformed with the short form OB-R was signaled through the short cytoplasmic
domain (Murakami, et al., 1997). The Zucker rat leptin receptor not only exhibits a
slightly reduced leptin binding affinity, it was also shown to perform reduced signal
transduction by stimulating the transcription o f c-fos, c-jun and jun-B (Yamashita, et al.,
1997).
2.10 PERIPHERAL METABOLIC ACTIONS OF LEPTIN
The presence of receptors for leptin not only in the hypothalamus, but also in the
peripheral tissues, including adipose tissue, liver, skeletal muscle and islet cells, suggests
that leptin has peripheral as well as central actions (Tartaglia, et al., 1995; Tartaglia,
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1997; Wang, et al., 1997a; Berti, et al., 1997; Muller, et al., 1997). Such peripheral
actions were confirmed by studies which showed that leptin can impair insulin signaling,
both in skeletal muscle and adipocytes. For example, leptin impairs insulin-mediated
glucose uptake in adipocytes (Muller, et al., 1997). Furthermore, in both HepG2 cells and
skeletal muscle myotubules, leptin was found to inhibit phosphorylation o f insulin
receptor substrate-1 (IRS-1) (Berti, et al., 1997; Muller, et al., 1997).
In addition to its effect on insulin-mediated glucose uptake, leptin inhibits insulinmediated lipogenesis, and stimulates lipolysis and protein kinase A (PKA) (Wang, et al.,
1997a). These studies suggest a role for leptin in peripheral metabolic regulation, and
have raised the possibility that the impaired insulin signaling in obese subjects might
result, in part, from increased circulating leptin levels.
2.11 LEPTIN AND THE HPA AXIS
Conflicting results have been obtained in studies looking at the relationship
between plasma leptin and cortisol levels (Licinio, et al., 1997; Haffner, et al., 1997;
Vettor, et al., 1997). The diurnal variation of leptin and cortisol is reciprocal, leptin levels
peak during the nadir of cortisol secretion. In cultured adrenocortical cells, leptin was
found to dose-dependently inhibit ACTH-stimulated cortisol production and P450 1 7 a hydroxylase mRNA expression (Bomstein, et al., 1997). In contrast, leptin increases
CRH expression in the PVN (Schwartz, et al., 1996). Despite the observation that
dexamethasone can stimulate leptin production in culture adipocytes, peripheral CRH
administration in humans does not influence leptin levels (Cizza, et al., 1997). It is
therefore apparent that leptin and HPA axis may be reciprocally related, but with
interactions at several levels.
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An intact HPA axis has been suggested to be necessary for the normal actions of
leptin on energy balance. Leptin feeds back to the HPA axis to inhibit release o f CRH.
Stress is the classic stimulus to the HPA axis (Dallman, M.F. 1993). Starvation and
immobilization stress markedly stimulate this endocrine axis (Chowers, et al., 1969;
Akana, et al., 1992). Administration o f leptin to fasting mice or to restraint-stressed rats
attenuates stimulation o f the HPA axis and both ACTH and corticosterone levels are
normalized to that o f the fed state (Ahima et al., 1996). Heiman and colleagues showed
that such inhibition may be exerted at the hypothalamic level, because leptin directly
inhibited CRH release in response to hypoglycemia, and because it did not directly
change the secretion o f ACTH, which is a counterregulatory response to prevent
hypoglycemia (Aizawa, et al., 1981; Widmaier, et al., 1988; Heiman, et al., 1997).
Injection o f leptin centrally to ADX rats showed that the hypophagic and weightreducing effects o f leptin were significantly amplified, and this effect was abolished by
treatment with dexamethasone (Zakrzewska, et al., 1997). These observations suggested
that glucocorticoids exert a counter-regulatory effect on leptin action, and that the activity
o f the HPA axis may set the level o f sensitivity to leptin. In humans, however, little is
known about the possible effects o f leptin on the HPA axis in human obesity. Vettor et al.
(1997) showed that no relationship exists between the activity o f the HPA axis and serum
leptin concentrations in women with different obesity phenotypes.
2.12 LEPTIN AND REPRODUCTION
Studies in rodents have shown that male and female homozygous ob/ob mice are
obese and infertile (Hoggard, et al., 1998) and these mice do not produce functional
leptin (Chehab, et al., 1996). Whereas male ob/ob mice can reproduce if maintained on a
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restricted diet, female ob/ob mice are always sterile (Lane and Dickie, 1964). Early
sexual development is normal in ob/ob females; however, ovulation never occurs and the
mice remain prepubertal indefinitely, with no occurrence o f estrus cycle. Reproductive
hormones are reduced in ob/ob female mice, showing a functional defect from the
hypothalamic-pituitary axis (Chehab, et al., 1996). When injected with leptin, female
ob/ob mice show an increase in serum luteinizing hormone (LH) levels and ovarian
weight, and they become fertile (Chehab, et al., 1996; Barash, et al., 1996). The leptininduced elevation in LH in ob/ob mice suggested that the primary regulatory effect of
leptin was on the reproductive neuroendocrine system, with the ovarian effects being
secondary to stimulation by LH. The detection of leptin receptor mRNA in human ovary
has suggested a direct action o f leptin in the ovary (Cioffi, et al., 1996). Zachow and
Magoffin (1997) showed that leptin can act directly on the ovarian granulosa cells to
selectively decrease estradiol (E 2 ) but not progesterone (P 4 ) production. Interestingly,
follicle-stimulating hormone (FSH)-dependent E2 production was not reduced by leptin,
whereas leptin impaired the sensitizing effect of insulin-like growth factor-l (IGF-1) on
FSH-dependent E 2 synthesis by granulosa cells.
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C H A PTER THREE
GENERAL M ETHODS AND TECHNIQUES
3.1

PR EPA RA TIO N OF HEPATOCYTES
Perfusion and preparation o f hepatocytes was carried out as illustrated in Figure

3.1 using the in situ collagenase perfusion method as described previously (Berry and
Friend, 1969; Seglen, 1976) with modifications o f Pertoft & Smedsrod (1987). Rats were
anesthetized by intraperitoneal injection o f ketamine (0.125 ml/100 g body weight) and
decontaminated with a 70% ethanol solution. The first cannula was placed in the hepatic

Hver

inflow c a n n u l a
(insK ja p o r ta l v am )

o
Figure 3.1. Diagrammatic representation o f liver perfusion.

portal vein, and a second was placed in the inferior vena cava. The liver was perfused, at
a rate o f 30 ml/min, with calcium-free perfusion buffer [Hank’s Balanced Salt Solution
(HBSS), pH 7.5; 10 mM glucose] that had been equilibrated at 37°C with 95% oxygen
and 5% CO 2 . This initial perfusate was allowed to drain to waste. The liver was then
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enzymatically digested for 10 min by recirculating 50 ml o f collagenase buffer [HBSS; 2
mM CaCI2; 0.05% (w/v) type 1 collagenase (Worthington Biochemical Corp., Lakewood,
NJ)]. The liver was carefully removed, placed in a beaker containing collagenase buffer
and minced. The liver lysate was further incubated at 37°C for 15 min with shaking to
release hepatocytes, and then placed on ice for 5 min. An equal volume o f ice-cold wash
buffer [HBSS; 2 mM CaCl2] was added to the cell suspension, which was then filtered
through a 250 pm nylon filter into a sterile centrifuge tube. The cell suspension was
centrifuged at 300 rpm for 2 min at 4°C. Cells were washed three times in the wash
buffer. The final pellet was resuspended in 20 ml o f wash buffer. For cell counting and
viability determination, cells were diluted 1:10 with William’s E (WE) medium (Sigma
Chemical Co., St Louis, MO) and counted on a hemacytometer using the inverted
microscope. Cell viability was determined by using the trypan blue dye exclusion
method. Hepatocytes (4 x 106/5ml) were plated onto collagen-coated 60 mm2 cell culture
dishes (Coming Glass Works, Coming, NY) in WE medium containing I nM insulin, 1
nM dexamethasone (DEX) and 5% (v/v) fetal bovine serum (FBS). The cultures were
incubated at 37°C in a humidified 5% C 0 2/95% air incubator for 4 hr to allow the cells to
attach to the substratum. After 4 hr, unattached cells were removed by aspiration o f
medium, and cells were incubated overnight in serum-free medium containing 1 nM
insulin and 1 nM DEX. The spent medium was replaced with either fresh WE medium or
fresh glucose-, L-glutamine and sodium pyruvate-free Dulbecco’s minimal essential
medium (DMEM) (Life Technologies, GIBCO BRL, Grand Island, NY) containing
different hormones as described in the respective experimental setups.
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3.2

TOTAL RNA EXTRACTION FROM HEPATOCYTES
Isolation o f total RNA was carried out by the standard procedure of Chomczynski

and Sacchi (1987, 1992) with modifications. After treatment with various hormones, the
culture medium was aspirated and cells were quickly washed with 2 ml o f ice-cold
phosphate-buffered saline (PBS, pH 7.2) and lysed in 1 ml o f ice-cold solution D (4 M
guanidinium isothiocyanate; 25 mM sodium citrate; 0.5 % Sarcosyl; 0.72% Pmercaptoethanol). The cell lysate was scraped to one end o f the plate using a sterile
disposable cell scraper (Fisher Scientific, Pittsburg, PA), passed up-and-down four times
through a 1-ml micropipette and transferred into heavy gel phase lock tubes (5 Prime —>
3 Prime, Inc., Boulder, CO, USA). The following solutions were sequentially added to
the lysate with mixing: 0.1 ml o f 2 M sodium acetate (pH 4.0), 1 ml water-saturated
phenol and 0.5 ml chloroform. The suspension was incubated on ice for 15 min, and then
centrifuged at 3,300 rpm for 15 min at 4°C. The aqueous phase was transferred into a
fresh polypropylene tube and total RNA was precipitated with an equal volume o f
isopropanol at -20°C for 1 hr. Total RNA was pelleted by centrifugation at 10,000 rpm
for 10 min at 4°. The pellet was resuspended in 0.3 ml solution D and transferred into an
1.5 ml Eppendorf tube. The RNA was re-precipitated overnight at -20°C with an equal
volume o f isopropanol. The precipitate was centrifuged at 14,000 rpm at 4°C in a
Eppendorf microcentrifuge. The pellet was washed with 75% ethanol, air-dried and
completely dissolved in 0.1 ml RNAse-free water at 60°C for 10 min. Total RNA was
quantified spectrophotometrically at 260 and 280 nm (1 A260 unit = 40 pg/mL RNA) and
the purity was determined by the 260/280 ratio. The quality o f the total RNA was further
analyzed by 1% agarose-2.2 M formaldehyde gel electrophoresis at 100 V for 2-3 hr.
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3.3 ISOLATION OF TOTAL RNA FROM TISSUES USING TRIZOL REAGENT
Isolation of total RNA was carried out using the TRIzoI reagent protocol as
described by the manufacturer (GD3CO BRL, Grand Island, NY, USA) and modified
recently (Nakajima, et al., 1998). This protocol follows the original method o f RNA
isolation described by Chomczynski and Sacchi (1987, 1992). Frozen liver tissue (0.1 g)
was homogenized in 1 ml TRIzol reagent using the Polytron (model MR3000,
Kinematica AG, Switzerland) at maximum speed for 15 sec. The homogenate was
transferred into a heavy gel phase lock tube (5 Prime —> 3 Prime, Inc., Boulder, CO,
USA) and incubated at room temperature for 5 min. After 5 min, 0.2 ml chloroform was
added per 1 ml of TRIzol. The suspension was mixed vigorously for 15 sec, incubated at
room temperature for 3 min, and then centrifuged at 3,300 rpm for 5 min at 4°C. After
centrifugation, the aqueous phase containing total RNA was transferred into a fresh
polypropylene tube. Total RNA was precipitated with 0.5 ml isopropanol per 1 ml o f
TRIzol at -20°C for 1 hr, and centrifuged at 10,000 rpm for 15 min at 4°C. The pellet was
resuspended in 0.3 ml Solution D [4 M guanidinium isothiocyanate; 25 mM sodium
citrate; 0.5 % sarcosyl; 0.72% P-mercaptoethanol], and transferred into an Eppendorf
tube. The RNA was precipitated with an equal volume of isopropanol overnight at -20°C.
Total RNA was recovered by centrifugation at 14,000 rpm at 4°C in a microcentrifuge
(Eppendorf centrifuge model 5402, Hamburg, Germany). The pellet was washed with
75% ethanol, air-dried and completely dissolved in 1 ml o f RNAse-free water at 60°C for
10 min. RNA was quantified and quality checked as described above.
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3.4 NORTHERN BLOT ANALYSIS
Agarose gel electrophoresis and Northern blotting were performed according to
standard procedure (Sambrook, et al., 1989). Total RNA (20 or 40 pg/lane) obtained from
tissues or hepatocytes was mixed (1:2 v/v) with RNA sample buffer [62.5% formamide;
9.25% formaldehyde; 1.25X formaldehyde gel running buffer; 50 fig/ml bromophenol
blue; 50 gg/ml xylene cyanole FF; 50 pg/ml ethidium bromide (5 Prime —> 3 Prime, Inc.,
Boulder, CO, USA)], denatured at 65°C for 10 min, and immediately chilled on ice for 5
min. Samples were loaded and size-fractionated in a 1% agarose-2.2 M formaldehyde gel
at 100 V for 2-3 hr. The quality of the RNA was determined by visualization under UV
light using either a UV transilluminator (Spectronics Corp., Westbury, NY) or
Chemilmager (Alpha Innotech Corp., San Leandro, CA). The gel was photographed
using Polaroid DS34 instant camera (Polaroid Corp., Cambridge, MA), placed in 10 mM
NaOH solution for 10 min and the RNA was transferred overnight onto a Hybond N+
nylon membrane (Amersham, Buckinghamshire, UK) by using the standard upward
transfer method with 10X SSC as transfer buffer (20X SSC = 3 M sodium chloride, 0.3
M sodium citrate, pH 7.0). The efficiency of transfer was determined by checking the gel
under UV light after transfer. The 18S and 28S ribosomal RNA positions were marked by
nicking the membrane. The membrane was briefly rinsed with 2X SSC, dab-dried and
baked in a vacuum-oven at 80°C for 30 min. The membrane was prehybridized for 3 hr
or overnight at 42°C (for cDNA probes) or 50°C (for oligonucleotide probes) in a
prehybridization solution [50% formamide; 0.12 M Na 2 HPC>4 ; 0.25 M NaCl, 7% (w/v)
SDS], After prehybridization, the membrane was hybridized for 18 hr with radiolabeled
probe in prehybridization buffer. The membrane was then stringently washed three times
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as follows: 2X SSC/0.1% SDS for 15 min at room temperature, 0.5X SSC/0.1%SDS for
20 min at room temperature, 0.1X SSC/0.1% SDS for 15 min at 60°C, placed in a sealed
plastic bag and exposed to phosphoscreen overnight. The signal was quantified using the
Phosphoimager and the ImageQuant software (Molecular Dynamics, Sunnyvale, C A).
♦ Labeling o f cDNA probes by random priming
cDNA inserts, obtained from various plasmids used in this study, were labeled by
random primer labeling method using the DECAprime II kit (Ambion Inc., Austin, TX).
Briefly, 25ng template DNA was mixed with 1 pL o f 10X decamers to a final volume o f
11 pL and heated for 5 min at 95°C. The solution was snap-frozen in liquid nitrogen
before placing on ice. Then, 14 pL o f labeling master mix [IX dCTP-minus buffer, [a32P]dCTP, Klenow large fragment E. coli polymerase] was added and incubated at 37°C
for 30 min. The reaction was stopped by adding 1 pi o f 0.5 M EDTA and the
unincorporated label was removed by centrifugation through a Micro Bio-Spin™-30
chromatography column (Bio-Rad Laboratories, Hercules, CA). The specific activity o f
the probe was determined by counting 1 pi in 10 ml o f EcoLite scintillation liquid in the
Beckman LS6000 scintillation counter (Beckman Instruments Inc., Fullerton, CA).
Before use, the radiolabeled probe (1-5 x 106 cpm/ml hybridization buffer) was linearized
by heating at 95°C for 5 min, chilled on ice, and added to prehybridization buffer.
3.5

CLONING THE LEPTIN RECEPTOR FRAGMENT

♦ cDNA synthesis
Total RNA was isolated from the hypothalamus o f a lean Zucker rat using the
TRIzol reagent method as described in section 3.3. Reverse transcription polymerasechain reaction (RT-PCR) was carried out according to the manufacturer’s instructions
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(Promega Corp., Madison, WI) and as described by Ghilardi and colleagues (1996). Five
pg o f hypothalamic RNA or yeast control RNA was mixed with oligo(dT)i2 -i8 primers
(Life Technologies, GIBCO BRL, Grand Island, NY, USA) in a sterile 0.5 ml PCR tube
and incubated at 70°C for 10 min to denature RNA secondary structure. A 12 pi reverse
transcriptase master mix [IX reverse transcriptase buffer, 2.5 mM MgCh, 0.5 mM
deoxyribonucleotides (dNTPs), 10 mM dithiothreitol (DTT), 1 pL Moloney-Murine
leukemia virus reverse transcriptase (M-MLV)] was prepared. After denaturation, the
tubes were chilled on ice for 1 min and the master mix was added. To ensure that the
primers did not prime o ff o f the contaminating genomic DNA, a negative control omitted
the reverse transcriptase. The tubes were incubated at 42°C for 55 min for synthesis, and
the enzyme was inactivated by heating at 70°C for 15 min. The tubes were chilled at 0°C
for 1 min. One pi o f RNAse H was added to each tube and further incubated at 37°C for
30 min. The reaction was thereafter chilled on ice or stored at —20°C until required for
PCR.
♦

Polymerase-chain reaction (PCR) amplification
The leptin receptor cDNA was amplified using the PCR amplification reagents

obtained from Promega (Madison, WI. USA). The following primers were used to
amplify the leptin receptor cDNA: forward, 5’-TTCCTATCGAGAAATATCAG-3’,
reverse, 5’-GGTACCATCTCATCTTTATT-3’, (named leptin I and H, respectively),
selected to amplify sequences corresponding to nucleotides from +2473 to +2875 o f the
rat leptin receptor cDNA (GenBank U52966) as described by Ghilardi, et al. (1996). Two
pL of the cDNA synthesis reactions were mixed with 48 pi o f the PCR master mix [IX
PCR buffer, 1.5 mM MgCl, 0.4 mM dNTP mix, 0.5 pi Taq polymerase, 200 nM each o f
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leptin I and II primers or control primers for yeast RNA] and amplified for 40 cycles
[PCR conditions: initial denaturation at 94°C for 90 sec; followed by 94°C for 45 sec;
45°C for 45 sec; 72°C for 2 min; final extension at 72°C for 10 min, and held at 4°C,
using the Programmable Thermal Controller (PTC-100™, MJ Research Inc., USA). PCR
products were electrophoresed on a 1% agarose gel in 0.5X TBE at 100 V for I hr. The
amplified products were visualized under UV light and photographed. Figure 3.2 shows
the PCR amplified leptin receptor cDNA, named ObR403 based on its expected size.
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Figure 3.2. RT-PCR product of the hypothalamic leptin receptor. Leptin receptor was
amplified from the cDNA obtained from total hypothalamus RNA. Reverse transcription
was performed using hexamers [lanes 2-5] and oligo(dT)i2 -i8 primers [lanes 6-9]. Lane I
is a control without reverse transcriptase. M = 100 base-pair DNA ladder. PCR products
were fractionated in a 1.5% agarose gel for 1.5 hr.

♦ Cloning o f ObR403 cDNA
The amplified ObR403 cDNA was cloned by T-A cloning method using pGEM^-T Easy
vector systems according to the manufacturer’s instructions (Promega Corp., Madison,
WI). Briefly, the ObR403 cDNA was mixed with 50 ng pGEM®-T Easy vector (3:1 and
1:3 ratios) in a ligation reaction containing IX T4 DNA ligase buffer and 0.3 Weiss
units/pl T4 DNA ligase. The reaction was carried out overnight at 10°C, and placed on
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ice. Escherichia coli (E. coli) JM 109 strain was transformed with 50 ng DNA according
to supplier’s instructions (Promega Corp., Madison, WI). Briefly, bacterial cells were
thawed on ice. Cells were mixed with the ligated DNA and incubated on ice for 30 min.
The cells were heat-shocked for 50 sec in a 42°C w ater bath and placed back on ice for 2
min. Sterile SOC medium, pH 7.0 [2% tryptone, 0.5% yeast extract, 0.05% NaCl, 2.5
mM KC1] at room temperature was added and the cells were allowed to recover for 1.5 hr
at 37°C with shaking at 225 rpm. Cells were diluted 1:10, spread-plated on Luria-Bertani
(LB) agar plates containing 50 pg/ml ampicilin and incubated at 37°C for 16 hours.
Individual isolated colonies were picked and cultured overnight in 5 ml LB medium
containing 100 pg/ml ampicilin. DNA minipreps were performed, as described below, to
identify the clones that were successfully transformed with the ObR403 cDNA.
3.6 PLASMID DNA EXTRACTION PROTOCOL
Plasmid DNA was extracted using the Wizard™ Plus DNA purification system
(Promega Corp., Madison, WI). Cells were pelleted by centrifugation at 10,000 xg for 10
min at 4°C using the Eppendorf microcentrifuge. The pellet was completely resuspended
in 300 pi o f cell resuspension solution [10 mM Tris-HCl, pH 8.0, 0.5 mM NaCl, 1 mM
EDTA, 10 pg/ml lysozyme]. To the suspension, 300 pL o f fresh lysis solution [0.2 N
NaOH, 1% SDS] was added and the contents were mixed by inversion. Then, 300 pi o f
the neutralization solution [1.32 M potassium acetate, pH 5.2] was added and mixed by
inversion. The lysate was centrifuged at 10,000 xg for 5 min at 4°C in a microcentrifuge.
The supernatant was carefully aspirated and mixed with 1 ml o f DNA purification resin.
The DNA/resin mix was then transferred into the barrel o f a mini-column/syringe
assembly and vacuum was applied to draw the solution through the mini-column. Then 2
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ml o f column wash solution was added to the mini-column and vacuum was applied as
above. The mini-column was dried under vacuum and transferred to an Eppendorf tube
for further drying by centrifugation at 10,000 xg for 2 min. The plasmid DNA was eluted
by adding 50 (il o f TE [10 mM Tris-HCl, pH 8.0; 1 mM EDTA] and centrifuged at
10,000 xg for 20 sec. The plasmid DNA was subjected to restriction enzyme analyses and
agarose gel electrophoresis, and aliquots were stored at -20°C until required for further
analysis. Figure 3.3 shows the gel electrophoresis profile o f ObR403 cDNA cloned into
pGEM-T Easy vector. The ObR403 DNA insert was then excised from the pGEM-T Easy
vector using EcoRl, and subcloned into the EcoRl site o f pBluescript II SK(+/-).
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Figure 3.3. Restriction endonuclease digestion of purified pZObR403 plasmid. The
amplified plasmid was undigested (lane 1), insert excised with EcoRl (lane 2) and
BamHl-HindlH (lane 3), and plasmid linearized with BamHl (lane 4) and HindlH (lane
5). Lanes M are 100-bp/l-kb DNA ladders. Fragments were fractionated on a 1% agarose
gel containing ethidium bromide at 80V for 1.5 hr. Arrow indicates the position o f the
403 bp fragment after EcoRl digestion.
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3.7 SEQUENCING O F CDNA CLONES
The cloned and purified plasmid DNAs for pZObR403, pSOCS-3 and pSTAT-3
were sequenced using T7 universal primers. The plasmid DNA inserts were PCR
amplified using T7 primers with conditions as follows: denaturation at 95°C for 4 min,
and 30 cycles o f denaturation at 95°C for 30 sec, synthesis at 56°C for 1 min and
extension at 70°C for 30 sec, and final extension at 70°C for 5 min. The inserts were
sequenced by using the Big Dye Terminator Cycle Sequencing Ready Reaction kit
(Perkin Elmer, Foster City, CA). Sequencing reaction products were purified using
96-well gel filtration kit for Big Dye Terminator clean-up, and loaded in a 6% FS
automated polyacrylamide sequencing gel in a 373 A automated DNA sequencer (Perkin
Elmer, Applied Biosystems, Foster City, CA). Figure 3.4 shows an electrophoretogram
o f the ObR403 sequence.
3.8 G EL PU RIFICA TIO N OF cDNA INSERTS
Purified plasmid DNA was digested overnight with specific restriction enzymes
as indicated by the restriction maps and on the legends to the figures. Restriction
fragments were fractionated by 1% agarose gel electrophoresis in 0.5X TBE (TrisBorate-EDTA) buffer at 100 V for 1.5 hr. The fragments were visualized under UV light
and photographed. The band of interest was excised from the gel, minced in 200 pi TE
buffer and transferred into the nebulizer and Microcon concentrating system (Amicon
Inc., Beverly, MA). The unit was centrifuged at 10,000 xg for 5 min. The cDNA was
recovered by centrifuging the Microcon in an inverted position as above for 30 s. The
DNA was quantified by 1% agarose gel electrophoresis using the high or low DNA Mass
ladder (GIBCO BRL, Grand Island, NY).
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Figure 3.4. An electrophoretogram of pZObR403 plasmid DNA sequence obtained by sequencing using the ABI PRISM®
BigDye1Mterminator cycle sequencing ready reaction kit after purification of the PCR products. Samples were loaded onto
a 36 cm gel containing 5% LongRanger gel, and run on an ABI PRISM® 373 automated DNA sequencer. A BLAST
search (v. u w .m. In nlmmli uh ./Moni) identified nucleotides 4-69 as pBluescript II vector sequence and nucleotides 72.-330
as rat longform leptin receptor gene sequence.

3.9 I N

VITRO

TRANSCRIPTION REACTION

FOR PREPARATION

OF

RIBOPROBES
♦

Preparation of Template
Template DNA (50 pg) was linearized by complete restriction enzyme digestion

with an enzyme that cleaves distally from the selected promoter site. An aliquot o f the
linearized product (0.5 pg) was analyzed by I% agarose gel electrophoresis in 0.5X TBE
at 100 V for 2 hr to determine complete digestion by restriction enzymes. The linearized
template DNA was then incubated with 100 pg/ml Proteinase K in 10 mM Tris-HCl (pH
8.0), 0.5% SDS and 2 mM CaCl2 at 50°C for 30 min. The mixture was extracted once
with phenol/chloroform (1:1) to remove any contaminating proteins. The aqueous phase
was carefully transferred to a new tube and the linearized DNA was precipitated with 0.1
volume of 5M ammonium acetate and 2 volumes o f ethanol at -20°C for 1 hr. The
template DNA was recovered by centrifugation at 14,000 rpm for 15 min at 4°C. The
pellet was washed with 70% ethanol, air-dried and resuspended in nuclease-free water to
0.5 pg/pl. The quality o f template DNA was assessed by 1% agarose gel electrophoresis
and the concentration was estimated by comparison to the DNA mass ladder.
♦ Assembly of the Transcription Reaction
The transcription reaction was carried out according to the manufacturer’s instructions
using the RPA III kit (Ambion Inc., Austin, TX). Reagents were added at room
temperature.

One

pg

o f the

linearized

DNA

template,

transcription

buffer,

ribonucleotides (NTPs), [a-32P]UTP and RNA polymerase (T3 or T7) were mixed in a
final volume o f 10 pi and incubated at 37°C for 1 hr. The template DNA was removed by
digestion with 0.5 pi o f RNase-free DNase I (2U/pL) at 37°C for 15 min. The reaction
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was terminated by adding 0.5 pL o f 0.5 M EDTA. An equal volume o f gel loading buffer
was added to the reaction, heated at 95°C for 5 min, and then chilled on ice for 5 min.
One

pi aliquot was removed and added to

10 ml o f EcoLite (Amersham,

Buckinghamshire, UK) scintillation liquid and radioactivity was counted using the
Beckman LS6000 scintillation counter (Beckman Instruments Inc., Fullerton, CA). The
remaining aliquot was heated at 95°C for 3 min, loaded onto a 5% acrylamide/8M urea
gel and electrophoresed at 300 V for 2.5 hr. After electrophoresis, the gel was exposed to
X-ray film (Eastman Kodak Co., Rochester, NY) for 1-5 min in the dark. The film was
developed using the Kodak X-OMAT automatic developer. The full-length labeled
transcript was precisely localized and excised with a razor blade. The gel piece was
transferred into an Eppendorf tube containing 350 pL o f Elution Buffer, vortexed and
centrifuged briefly. The elution was allowed to proceed overnight at 37°C. One pL
aliquot of the eluted probe was removed to count radioactivity as described above.
♦

Ribonuclease Protection Assay (RPA)

Ribonuclease protection assay (RPA) was carried out essentially as described by the
manufacturer (Ambion Inc., Austin, TX). Routinely, 20 or 40 pg total RNA was mixed
with antisense radiolabeled riboprobe (300,000 cpm), and the mixture was precipitated
with 0.1 volumes o f ammonium acetate and 2.5 volumes o f absolute ethanol at —20°C for
15 min. Tubes were centrifUged at 14,000 rpm for 15 min at 4°C, and the supernatant was
completely aspirated. The pellet was dissolved in hybridization solution and the tubes
were heated at 95°C for 4 min and vortexed vigorously. The tubes were incubated in a
45°C water bath for 18 hours to allow hybridization o f probe and complementary mRNA.
After hybridization, a diluted mixture of RNase A+Tl solution was added and the tubes
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were incubated at 37°C for 30 min to digest the unprotected single-stranded RNA.
RNases were inactivated by adding the RNAse inactivating solution, and the protected
RNA was precipitated at -20°C for 15 min. The tubes were centrifuged as before and the
supernatant was discarded. The pellets were resuspended in gel loading buffer and heated
at 95°C for 4 min to solubilize and denature the RNA. The protected fragments were
resolved on a 5% denaturing polyacrylamide gel at 250 V for 3 hr in IX TBE. The gels
were carefully transferred onto a Whatman 3M filter paper and dried at 80°C under
vacuum. The dried gels were exposed to a phosphoscreen overnight. Signals were
quantified using the Phosphoimager and the ImageQuant software (Molecular Dynamics,
Sunnyvale, CA). Figure 3.5 shows a typical RPA gel showing the hypothalamic and liver
leptin receptor protected fragments. The long form ObR, represented by the 403-bp
protected fragment, was evident only in the hypothalamus and none was seen in the liver.
The short isoform, 270-bp, of ObR was present in both tissues.
3.10 PREPARATION OF TOTAL PR O TEIN LYSATES
Total protein lysates were prepared according to O’Donnell, et al., (1995).
Briefly, frozen hypothalamic tissue was placed directly into a 2 ml Eppendorf tube
containing 5 volumes of ice-cold TEGMD buffer [TEGMD = 20 mM Tris-HCl, pH 7.4, 1
mM EDTA, 10% Glycerol, 10 mM Sodium Molybdate, 1 mM Dithiothreitol], and
homogenized on ice using a sonicator (Ultrasonic Homogenizer, 4710 series, ColeParmer) at output 6 for 2 sec to disrupt the tissue and cells. The sonication was repeated 5
more times on ice. The resulting homogenate was centrifuged at 105, 000 xg for 45 min
at 4°C in a Beckman L8-80 ultracentrifuge. The supernatant, containing the total protein
fraction, was collected and aliquoted into 1.5 ml Eppendorf tubes.
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40
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Figure 3.5. Leptin receptor ribonuclease protection assay o f total RNA from the
hypothalamus and liver. Increasing concentration o f total RNA from the hypothalamus
and liver were hybridized overnight with 32P-labeIed antisense ObR403 and P-actin RNA
riboprobes. Samples were processed as detailed in the preceding section and fractionated
on a 5% sequencing gel. M is the century RNA molecular marker. The protected
fragments, 403 and 270 bp, represent the long and short isoforms o f the leptin receptor.
The other bands could represent other ObR transcripts that we did not study very closely.
The P-actin protected fragment was used as an internal standard to ensure linearity.
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Protein concentration was determined by using the BCA assay (Pierce Chemical
Co., Rockford, IL). The tubes were snap-frozen in liquid nitrogen and stored at -80°C
until needed for analysis.
3.11 PREPARATION OF HYPOTHALAMIC NUCLEAR EXTRACTS
Nuclear extracts from hypothalami were prepared according to the method o f
Vaisse, et al. (1996) with modifications. The hypothalami were cleanly dissected and
frozen in liquid nitrogen. Frozen hypothalami were homogenized in 0.5 mL o f buffer A
[10 mM Hepes, pH 7.9; 10 mM KC1; 1.5 mM MgCU; I mM DTT; ImM Na3VC)4; I mM
EDTA; 1 mM EGTA; 10% glycerol; 0.5 mM PMSF; 10 mM NaF; 1 mM Benzamidine; 1
mM sodium pyrophosphate; 1pg/ml each o f leupeptin, aprotinin, pepstatin], five strokes
each, in a loose-fit and a tight-fit Dounce homogenizer, respectively. Homogenates were
centrifuged at 2,000 xg for 10 min at 4°C, and the supernatant (containing the cytosolic
extract) was carefully removed into a new tube. The pellet was resuspended in 4 volumes
o f buffer A and homogenized in a tight-fit Dounce homogenizer. The homogenate was
centrifuged as above and the supernatant was combined with the one obtained above. The
pellet, which contained nuclei, was resuspended in 2 volumes of buffer B [20 mM Hepes,
pH 7.9; 420 mM NaCl; 10 mM KC1; 20% glycerol; 1 mM DTT; 1 mM Na3V 0 4; 1 mM
EDTA; 1 mM EGTA; 0.5 mM PMSF; 10 mM NaF; 1 mM Benzamidine; 1 mM sodium
pyrophosphate; 1pg/ml each o f leupeptin, aprotinin, pepstatin], and the nuclear proteins
were extracted for 30 min on ice, with shaking. The tubes were centrifuged at 16,000 xg
for 10 min at 4°C and the supernatant (containing the nuclear proteins) was carefully
removed into a new tube and the pellet was discarded. The supernatant was diluted 1:1
with buffer C [20 mM Hepes, pH 7.9; 10 mM KC1; 20% glycerol; 1 mM DTT; I mM
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Na3V 0 4; 1 mM EDTA; 1 mM EGTA; 0.5 mM PMSF; 10 m M NaF; 1 mM Benzamidine;
1 mM sodium pyrophosphate; 1pg/ml each o f leupeptin, aprotinin, pepstatin], aliquoted
and snap-frozen in liquid nitrogen and then stored at —80°C. Protein concentrations were
determined by using the BCA reagent (Pierce Chemical Co., Rockford, IL). The nuclear
extract was used to analyze proteins by Western blotting and gel shift assays.
3.12 ELECTROPHORETIC MOBILITY SHIFT ASSAY (EMSA)
Electrophoretic Mobility Shift Assay (EMSA) or gel shift assays were performed
according to the method o f Vaisse, et al. (1996), with modifications o f Levy et al. (1989)
and Gronowski et al. (1995). The Stat-3 high affinity c-fos .S7.s--inducible element (m67SDE) probe was used to determine the binding capacity o f nuclear proteins in this study.
The pair o f m67-SIE oligonucleotide sequences used were m67-SIE sense, 5’CGCTCCATTTCCCGTAAATCAT-3’,

and

m67-SIE

antisense,

5’-

CGCTC ATGATTT ACGGGAAATG-3 ’.
The double-stranded DNA was generated by annealing equimolar concentrations
o f the oligonucleotides in annealing buffer [10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1
mM EDTA]. The mixture was heated to 95°C for 5 min and allowed to cool slowly at
room temperature for 2 hr. The annealed m67-SIE was diluted to 6 and 20 ng/pL with
nuclease-free water. For use in EMSA studies, 20 ng of m67-SIE DNA was end-labeled
using 10 pCi [y-32P]ATP and T4 polynucleotide kinase at 37°C for 30 min. The reaction
was stopped by addition o f sterile water and the probe was purified by using the Bio-Gel
30 spin-columns at 1,000 xg for 4 min. Radioactivity was counted and the probe was
diluted to 35,000 cpm/pL, which represents a final probe concentration of 0.06 ng/pL.
For competition assays in EMSA, a 100-fold excess o f cold m-67 (6 ng) was added in the
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reaction. All EMSA incubations were carried out at room temperature. One to 5 pg
hypothalamic nuclear extract was incubated with 2 pL o f I pg/pL poly(dI-dC)-poly(dIdC) (Pharmacia Biotech Inc., Piscataway, NJ), in EMSA buffer [20 mM Hepes, pH 7.9,
40 mM KC1, 10 mM MgCh, 10 mM NaCl, 0.2 mM EDTA, 0.1 mM EGTA, 0.5 mM
DTT, 1 pL o f 20 mg/ml BSA, and 4% Ficoll] in a final volume o f 24 pL. For nonspecific
binding, 2 pL of unrelated sheared E. coli B DNA was added to one tube, and for
antibody supershift, 3 pL o f Stat-3 was added. The mixture was incubated for 10 min and
the 32P-labeled m67-SIE (3 x 104 cpm) was added. The mixture was further incubated for
15 min, and thereafter 3 pL o f 10X gel retardation loading buffer [IX = Tris-HCl, pH
7.5; 0.4% glycerol; 0.002% bromophenol blue]. The samples were resolved on a pre-run
(100 V, 30 min) 4% native PAGE at 250 V for 1-2 hours in 0.5X TBE. The gel was fixed
in 10% acetic acid solution for 15 min and vacuum dried at 80°C for 1 hr. The dry gel
was exposed to the phosphoscreen overnight and the bands were analyzed using the
Phospholmager and quantified using the ImageQuant software (Molecular Dynamics
Inc., Sunnyvale, CA).
3.13 IMMUNOPRECIPITATION OF CYTOSOLIC AND NUCLEAR PROTEINS
Generally, 100 to 300 pg o f hypothalamic nuclear or cytosol extracts were used
for immunoprecipitation. Proteins were mixed with immunoprecipitation buffer [150 mM
NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5%
NP-40, fresh 0.2 mM NasVCU, fresh 0.2 mM PMSF] and 10 pL o f monoclonal or
polyclonal antibody (as indicated in the respective legends to figures on protein assays)
was added and incubated for 2 hr at 4°C with shaking at 120 rpm. Thereafter, 20 pL of
50% slurry Protein-A agarose (Pierce Chemical Co., Rockford, IL) was added and further
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incubated for 2 hr at 4°C, with agitation. The mixture was centrifuged at 16,000 xg for 4
min at 4°C. The beads were washed three times with immunoprecipitation buffer. The
beads were resuspended in an equal volume o f 2X Laemmli sample buffer and proteins
were eluted by boiling for 5 min. The tubes were centrifuge at 16,000 xg for 4 min and
the eluates were analyzed on 8 or 10% SDS-PAGE. After electrophoresis, the proteins
were transferred overnight with cold transfer buffer [25 mM Tris base, 192 mM Glycine,
15% methanol] onto PVDF nylon membranes (Boehringer-Mannheim, GmbH, Germany)
using the Bio-Rad Trans-blot apparatus (Bio-Rad Laboratories, Hercules, CA). Western
blotting was carried out using the Renaissance® chemiluminescence reagent plus method
(NEN Inc., Boston, MA). Briefly, membranes were blocked for I hr with 5% nonfat dry
milk in TBS-T [Tris-buffered saline with 0.05% Tween-20]. After blocking, the
membrane was washed with TBS-T three times for 10 min each wash. After washing, the
membrane was incubated for 1 hr with diluted primary antibody in 1% nonfat dry milk in
TBS-T. The membrane was washed as above and incubated for 1 hr with an appropriate
HRP-conjugated secondary antibody diluted 1:2000 in 1% nonfat dry milk in TBS-T. The
membrane was washed as above. Depending on the membrane size, equal volumes of
reagents A and B were mixed together and incubated for exactly 1 min with the
membrane. After 1 min, the reagent was discarded. The membrane was placed in a bag
and exposed to X ray film. After processing, the membrane was stripped using the
stripping buffer [62.5 mM Tris-HCl, 2% SDS, 100 mM P-mercaptoethanol], washed and
reprobed with other antibodies.
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3.14 RT-PCR FOR SOCS-3 AND STAT-3 mRNA EXPRESSION
Five [xg o f total RNA from individual hypothalami was reverse-transcribed by oligo(dT)
priming and Moloney murine leukemia virus (M-MLV) reverse transcriptase (Promega)
using oligo(dT)i5 -i8 . mRNA expression was determined by PCR using the following
primer

sequences:

5’-ACCAGCGCCACTTCTTCACA-3’

and

5’-

GTGGAGCATCATACTGGTCC-3’ to amplify a 450-bp DNA fragment o f SOCS-3
(GenBank AF075383, Bjorbaek et al. (1999)), 5’-AAGGACATCAGTGGCAAG-3’ and
5 ’-AC AGGCGGAC AGAAC AT AG-3 ’ to amplify a 715-bp DNA fragment o f STAT-3
(GenBank X91810) and 5’-GACAAAGTTCCAAAGACAGCAGAAAAC-3 ’ and 5’ACTTCAGTGAGAGCAGAGATTACAGGG-3’ were used to amplify a 528-bp DNA
fragment o f cyclophilin (GenBank M19533). PCR products were then cloned directly
into pCR2.1 T-A cloning system (Invitrogen, Carlsbad, CA), amplified and restriction
mapped as shown in Figures 3.6 and 3.8 for SOCS-3 and STAT-3, respectively. The
identity o f each cloned product was confirmed by sequencing using the ABI PRISM 373
Big Dye terminator sequencing kit, as shown in Figure 3.7 and 3.9 for SOCS-3 and
STAT-3, respectively. Quantitation o f mRNA expression was performed by quantitative
RT-PCR and ethidium bromide staining as described by Emilsson et al. (1999). The
intensities o f the bands were quantified using the Chemilmager™ 4000 (Alpha Innotech
Corp., San Leandro, CA). The bands were quantified relative to cyclophilin as an internal
standard.
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Figure 3.6. Restriction endonuclease digestion o f purified pSOCS-3 plasmid. The
amplified plasmid was undigested (lane 6), 250-bp insert excised with Kpnl (lane 1),
~460-bp SOCS-3 insert excised with EcoRl (lane 2), Hindlll-Xhol cut plasmid (lane 3),
HindEH-linearized plasmid (lane 4) and Xhol-linearized plasmid (lane 5). Lanes M are
100-bp/l-kb DNA ladders. Fragments were fractionated on a 1% agarose gel containing
ethidium bromide at 80 V for 1.5 hr. Arrow indicates the position of the SOCS-3 fragment
after EcoRl digestion.
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Figure 3.7. An electrophoretogram of pSOCS-3 plasmid DNA sequence obtained by sequencing using the ABI PRISM®
BigDye1Mterminator cycle sequencing ready reaction kit after purification of the PCR products. Samples were loaded onto a
36 cm gel containing 5% LongRanger gel, and run on an ABI PRISM® 373 automated DNA sequencer. A BLAST search
(v w .io. Iii.111111.11111 :!g \ , hi(i >i) identified nucleotides 10-80 as pC R2.1/T0P0 vector sequence and nucleotides 82-470 as rat
SOCS-3 gene sequence.
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Figure 3.8. Restriction endonuclease digestion of purified pSTAT-3 plasmid. The
amplified plasmid was undigested (lanes 3), digested with EcoRl (lanes 1, 4, 5) and Aval
(lane 2). The arrow indicates the 730-bp STAT-3 insert. Lane M is the 100-bp/l-kb DNA
ladder. Fragments were fractionated on a 1% agarose gel containing ethidium bromide at
80 V for 1.5 hr. Lanes 4 and 5 show EcoRl-digested STAT-3 fragment from large-scale
preparations.
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Figure 3.9. An electrophoretogram of pSTAT-3 plasmid DNA sequence obtained by sequencing using the ABI PRISM®
BigDye1Mterminator cycle sequencing ready reaction kit after purification of the PCR products. Samples were loaded onto a
36 cm gel containing 5% LongRanger gel, and run on an ABI PRISM® 373 automated DNA sequencer. A BLAST search
(u v. 'a 11*.hi.i) 1111.n 111. - hia-.i) identified nucleotides 60-120 as pCR2.1/TOPO vector sequence and nucleotides 121-390 as rat
Stat3 gene sequence.

CHAPTER FOUR
LEPTIN EFFECTS ON LIVER GENE EXPRESSION AND METABOLISM
4.1 INTRODUCTION
The liver is one o f the most complex organs in the body, carrying out a multitaide
of different processes. Metabolism o f glucose, fatty acids and protein occur in the liver.
The liver synthesizes and breaks down glucose by the processes of gluconeogenesis and
glycolysis, respectively. Glycogen is also synthesized and broken down in the liver by
processes o f glycogenesis and glycogenolysis. Hepatic protein synthesis is involved in
enzyme regulation and in the production o f other circulating factors. Among all thiese
functions, a change in liver glucoregulatory function is a characteristic response to
feeding, fasting, and to glucocorticoids. Liver glucose regulatory responses are m ediated
by the balance o f glucose uptake into the liver and the endogenous glucose release from
the liver into circulation. Glucose uptake into the liver is an insulin independent process
carried out by glucose transporters, Glut-1 and Glut-2 (Zierler, 1999). The balance
between glycolysis and gluconeogenesis and the ratio o f glycogenesis and glycogenolysis
determines the rate o f endogenous production o f glucose from the liver.
Gluconeogenesis is an energy-dependent process whereby lactate, pyruvate,
glycerol, and some amino acids are converted to glucose. The most important functiora o f
gluconeogenesis is the maintenance of blood glucose levels during times o f low food
supply and/or low glycogen stores. Hepatic gluconeogenesis and glycogenolysis are
alternative sources o f the glucose produced by the liver. Hepatic gluconeogenesis is
affected by many modulators, the most important o f which include insulin, glucagon,
glucocorticoids and catecholamines (Chu, et al., 1997). Insulin suppresses endogenous
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glucose output by inhibiting glucagon release from the pancreas (McCall, et al., 1998;
Sindelar, et al., 1997), and also directly inhibits gluconeogenesis and glycogenolysis
(Giacca, et al., 1997; Sindelar, et al., 1998).
Regulatory mechanisms o f enzymes involved in hepatic gluconeogenesis have
been extensively studied (Pilkis and Granner, 1992). Both transcriptional and posttranscriptional regulatory mechanisms are involved. A number o f hormones regulating
the expression o f genes that encode regulatory enzymes have been studied. Insulin
induces mRNAs that encode glycolytic enzymes and represses mRNAs that encode
gluconeogenic enzymes, whereas cAMP has opposite effects. Glucose also regulates the
expression o f these hepatic enzymes (Kahn, 1997; Rencurel and Girard, 1998). One o f
the extensively studied regulatory liver enzymes is phosphoewo/pyruvate carboxykinase
(PEPCK). PEPCK is the rate-limiting enzyme in gluconeogenesis and its activity is solely
determined by gene regulation, and not by allosteric effectors. PEPCK gene is regulated
by a variety o f dietary and hormonal signals, which result in an alteration o f the synthesis
o f the enzyme, both by transcription and by translation. Major factors that increase
PEPCK gene expression include cAMP, glucocorticoids, and thyroid hormone, whereas
insulin inhibits this process (Pilkis & Granner, 1992). Rose and Heath (1986) reported
that corticosterone or sympathetic activation stimulate PEPCK synthesis by increasing
glucagon and hepatic cAMP, despite the increase in portal insulin levels. Regulatory
elements that control PEPCK gene transcription in liver, kidney and adipose tissue have
been delineated, and many o f the transcription factors that bind to these elements have
been identified (Hanson & Reshef, 1997).
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Genetic studies in rodents have revealed leptin and its receptor as important
factors in the regulation of both appetite suppression and energy expenditure. Obesity had
been largely related to insulin resistance, and the discovery o f leptin has shed new insight
on the regulation o f body weight and energy metabolism. Evidence that leptin exerts
adipose-reducing effects in rodents was obtained from pair-feeding and Zucker rats
studies (Levin, et al., 1996; Unger, 1997). This suggested a significant metabolic
regulatory role for leptin, in addition to appetite suppression. Moreover, the expression of
the leptin receptors in peripheral tissues, such as liver, muscle and adipose tissue
(Ghilardi, et al., 1996; Luoh, et al., 1997; Cohen, et al., 1996), further supported this
metabolic role o f leptin. Based on these findings, it is possible that leptin interferes with
glucose metabolism by acting directly on the liver. In fact, leptin was reported to exert a
direct effect on glucose metabolism in skeletal muscle (Ceddia, et al., 1999) and isolated
adipocytes (Ceddia, etal., 1998).
In vitro studies with a human hepatic cell line, HepG2 cells, and the rat hepatoma
cell line, H4-Q-E, indicated that leptin causes attenuation o f several insulin-induced
effects (Cohen, et al., 1996). In contrast, Wang, et al. (1997), showed that in rat (H-35)
and human (HepG2) hepatoma cell lines expressing the long form o f the leptin receptor,
leptin did not cause any significant alteration in insulin effects. They therefore argued
that, in this instance, leptin will not contribute to the diabetic symptoms associated with
obesity.
In vivo studies by Rossetti and colleagues (1997) demonstrated that an acute
increase in plasma leptin enhances the inhibitory effect o f insulin on hepatic glucose
production, induces redistribution o f glucose fluxes within the liver and induces changes
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in the expression o f genes encoding hepatic enzymes that closely resemble those o f
fasting. It is evident that these studies focused on the effects of leptin on insulin actions
and hepatic glucose production, and generated conflicting results regarding the role o f
leptin in liver glucose metabolism. Recently, Nemecz, et al. (1999) reported that in the
presence o f leptin, adrenaline-stimulated hepatic glucose release was suppressed in
perfused livers. These studies performed in isolated perfused rat liver indicated that leptin
directly and acutely modulated hepatic glucose flux.
In the present study, I investigated whether leptin modulates expression o f the
PEPCK gene in rat hepatocytes. Using Northern blotting, the time course of expression o f
PEPCK mRNA in untreated hepatocytes, and in those treated with either leptin,
dexamethasone, or insulin was determined.
4.2 EXPERIMENTAL PROTOCOLS
Animals
Adult, eight-week-old male lean and obese Zucker rats and 10-week-old SpragueDawley rats were used in this study. They were housed individually in hanging wiremesh cages attached to an automated watering system in a room with a 12 hour light/dark
(7:00 AM to 7:00 PM) cycle at a temperature o f 22-23°C. All rats consumed nonpurified
chow diet (Rodent chow 5001, Purina Mills, St. Louis, MO, USA). All protocols used
were approved by the Pennington Biomedical Research Center Institutional Animal Care
and Use Committee (IACUC). Hepatocytes were prepared by the in situ collagenase
perfusion method as described in Chapter three.
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Experiment 4.1

Time course of PEPCK mRNA expression in hepatocytes from

Sprague Dawley rats
This experiment investigated the effects o f leptin, dexamethasone and insulin on
the expression o f PEPCK in hepatocytes obtained from Sprague Dawley rats. Two adult,
10 week old male Sprague Dawley rats were used per experiment. The rats were ad
libitum fed before use. Hepatocytes were prepared in the morning and plated before 12:00
noon. Cells were allowed to attach to the substratum for 4 hr, and thereafter incubated in
WE medium containing 5% fetal calf serum. The spent medium was changed the next
day and cells were incubated in serum-free medium supplemented with 10 mM glutamine
containing either 100 ng/ml leptin, 100 nM dexamethasone or 100 nM insulin. Cells were
treated for the times indicated in the figure legends. Total RNA was isolated as described
in Chapter three.
Experiment 4.2 The time course of PEPCK mRNA expression in hepatocytes from
lean and obese Zucker rats
This experiment investigated the effects o f leptin, dexamethasone and insulin on
the expression o f PEPCK in hepatocytes obtained from lean and obese Zucker rats. Two
lean and two obese 8-week-old Zucker rats were used per experiment. The rats were
either fed a d libitum or were food deprived a day before use. Hepatocytes were prepared
in the morning and plated before noon. Cells were allowed to attach to the substratum and
thereafter incubated in WE medium containing 5% fetal calf serum. The spent medium
was changed the next day and cells were incubated in serum-free medium supplemented
with 10 mM glutamine containing either 100 ng/ml leptin, 100 nM dexamethasone or 100
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nM insulin. Cells were treated for the times indicated in the figure legends. Total RNA
was isolated as described in Chapter three.
Experiment 4.3

Hormone concentration effect on PEPCK mRNA expression in

hepatocytes from lean and obese Zucker rats
This experiment determined the effects o f increasing concentrations o f leptin,
dexamethasone and insulin on the expression o f PEPCK mRNA in hepatocytes obtained
from lean and obese Zucker rats. Hepatocyte cells were handled as described above and
were incubated with increasing concentrations o f the hormones for 3 hr in serum-free
medium. After 3 hr treatment, spent medium was aspirated and cells were harvested by
lysis in solution D and RNA was extracted as described in Chapter three.
Experiment 4.4

The time course of glucose production from hepatocytes from

lean Zucker rats
This experiment determined the time course o f glucose production induced by
leptin, dexamethasone and insulin from hepatocytes isolated from either lean Zucker or
Sprague Dawley rats. Hepatocytes were isolated from lean Zucker rats and plated as
above. After adherence to the plate, cells were incubated in serum-free WE medium
containing 1ng/ml dexamethasone and 1 ng/ml insulin. After overnight incubation, spent
medium was aspirated and cells were treated with either leptin, dexamethasone or insulin
in 2 ml o f serum-free and glucose-, L-glutamine-, and sodium pyruvate-free DMEM. At
each time point, the medium was aspirated and frozen for use in glucose analysis studies.
Cells were harvested by washing with ice-cold PBS and total RNA was extracted as
described in Chapter three.

58

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4. 3

RESULTS

Experiment 4.1
This experiment was designed to investigate whether leptin affects the expression
o f PEPCK mRNA in hepatocytes. As shown in Figure 4.1, leptin induced the PEPCK
gene expression in Sprague Dawley rat hepatocytes after 3 hr incubation. Compared with
serum-free medium control, leptin at concentrations greater than 3 ng/ml increased the
levels o f PEPCK mRNA expression. Incubation o f hepatocytes with fetal bovine serum
(FBS) also increased the expression o f PEPCK mRNA compared to control. This data
showed that FBS may contain factors that can induce the expression o f PEPCK mRNA,
with leptin being one o f those factors.
Figure 4.2 shows the effects o f leptin, dexamethasone, or both on PEPCK mRNA
expression. Leptin at 30 and 100 ng/ml induced the expression of PEPCK mRNA
compared to serum-free control hepatocytes. Dexamethasone at 100 nM increased
PEPCK

mRNA

expression

compared

to control.

A

higher

concentration

of

dexamethasone (1 pM) was cytotoxic to cells and induced PEPCK mRNA levels lower
than at the 100 nM dose. The induction o f PEPCK mRNA was, however, still greater
than that o f the untreated control. Treatment of hepatocytes with a combination o f 30
ng/ml leptin and 100 nM dexamethasone showed a slight, but statistically not significant,
increase in PEPCK mRNA expression, which was reduced when the leptin concentration
was increased to 100 ng/ml. The cytotoxicity observed in 1 pM dexamethasone-treated
hepatocytes was reduced by co-treatment with leptin. This was accompanied by a
significant increase in PEPCK mRNA expression compared to untreated control and 1
pM dexamethasone-treated cells.
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Figure 4.1 Effects o f leptin concentrations on PEPCK gene expression in hepatocytes
treated with media alone, FBS or various concentrations of leptin. Hepatocytes from ad
libitum fed Sprague Dawley rats were incubated for 3 hr with different concentrations of
leptin. Total RNA was extracted and analyzed by Northern blot. (A) N orthern blot
analyses o f PEPCK and P-actin mRNA. (B) Histogram showing the quantification of
PEPCK mRNA using ImageQuant software. * p < 0.05 from zero leptun group (2
observations in triplicate per group).
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Figure 4.2 Effects o f leptin and dexamethasone on PEPCK mRNA expression in
hepatocyte from Sprague Dawley rats. Hepatocytes from a d libitum fed Sprague Dawley
rats were incubated for 3 hr with either leptin (30 and 100 ng/ml) or dexamethasone (0.1
and 1.0 pM) or the combinations o f leptin and dexamethasone. Total RNA was extracted
and analyzed by Northern blot. Relative expression o f PEPCK mRNA was determined by
Northern blot analysis and bands were quantified using the Phosphorlmager ImageQuant
software. Data expressed as mean ± SEM for samples in triplicates. * p < 0.05 compared
to control group and NS indicates not statistically significant.
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Experiment 4.2
This experiment was designed to determine the time course o f PEPCK gene
expression in hepatocytes from lean (Figure 4.3) and obese (Figure 4.4) Zucker rats
treated with leptin, dexamethasone and insulin. As shown in Figure 4.3, leptin treatment
o f hepatocytes from lean rats caused an increase in PEPCK mRNA expression at the 3 hr
time point and this was followed by a decline in mRNA expression. Dexamethasone did
not increase PEPCK gene expression until after 12 hours o f incubation, which is
consistent with the literature. Insulin, had no effect on the expression o f PEPCK mRNA.
The results of the time course o f PEPCK mRNA expression in hepatocytes from
obese Zucker rats are shown in Figure 4.4. In these cells, untreated obese Zucker rat
hepatocytes showed a rapid decrease in PEPCK mRNA expression. This decrease was
also evident in all other treatments, with leptin, dexamethasone and insulin. These
hepatocytes showed no response to treatment with any of the hormones.
The effect of leptin and dexamethasone on the production o f glucose from the
gluconeogenic substrates, pyruvate and glutamine, was also determined, as shown in
Figure 4.5. Hepatocytes from lean Zucker rats were incubated in serum-, glucose-, Lglutamine-, and sodium pyruvate-free DMEM medium supplemented with 10 mM
pyruvate and 10 mM glutamine. As shown in this figure, control cells produced on
average 10 mg/dL glucose in the medium, except after 24 hr where the levels o f glucose
in the medium rose to over 120 mg/dL. Leptin, on the other hand, progressively increased
the production o f glucose from 10 mg/dL to about 150 mg/dL after 24 hr in culture.
Dexamethasone only effected changes in gluconeogenic glucose after 24 hr in culture.
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Figure 4.3 Time course o f PEPCK gene expression in hepatocytes from lean Zucker rats
treated with leptin, dexamethasone and insulin. Hepatocytes were cultured for the
indicated times in serum-free medium containing either 100 ng/ml leptin, 100 nM insulin
or 100 nM dexamethasone (DEX). Relative expression of PEPCK mRNA was
determined by Northern blot analysis and bands were quantified using the
Phosphorlmager ImageQuant software. 0-actin mRNA shown is that of the leptin treated
samples. Data expressed as mean % of control at 0 hr ± SEM for samples in triplicates. *
p < 0.05 compared to control time value (n = 3 observations per group).
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Figure 4.4 Time course o f PEPCK gene expression in hepatocytes from obese Zucker
rats treated with leptin, dexamethasone and insulin. Hepatocytes were cultured for the
indicated times in serum-free medium containing either 100 ng/ml leptin, 100 nM insulin
or 100 nM dexamethasone (DEX). Relative expression o f PEPCK mRNA was
determined by Northern blot analysis (A) and bands were quantified using the
Phosphorlmager ImageQuant software (B). Three different blots for leptin
dexamethasone and insulin treatment, and P-actin shown is for insulin treatment. Data is
expressed as mean % o f control ± SEM for samples in triplicate.
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Figure 4.5 Effects o f leptin (100 ng/ml) and dexamethasone (100 nM) on glucose
production o f hepatocytes from lean Zucker rats. Hepatocytes were cultured for the
indicated times in serum-free DMEM medium supplemented with 10 mM glutamine and
10 mM pyruvate and treated with either 100 ng/ml leptin or 100 nM dexamethasone
(DEX). Glucose produced in the medium was assayed using the glucose kit from Sigma.
Data expressed as mean ± SEM for samples in triplicates. * p < 0.05 compared to control
values at the same time.
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Experiment 4.3
This experiment was undertaken to determine the effects o f leptin and
dexamethasone on the expression o f PEPCK mRNA in lean and obese Zucker rats after 3
hr in culture. In this study, as shown in Figure 4.6, PEPCK mRNA expression was ten
fold higher in hepatocytes from obese Zucker rats compared to those from the lean rats.
Treatment with 0.1 pM dexamethasone increased PEPCK gene expression. Again,
treatment with 1 pM dexamethasone decreased the expression o f PEPCK mRNA
compared to 0.1 pM dexamethasone treatment. Surprisingly, no effect o f PEPCK mRNA
expression was observed with leptin treatment o f hepatocytes from lean Zucker rats. In
hepatocytes from obese Zucker rats, dexamethasone and leptin treatment did not affect
the expression o f PEPCK mRNA.
4.4

DISCUSSION
The objective o f experiments described here was to investigate the direct effects

o f leptin, dexamethasone and insulin on the gene expression of the liver cytosolic form of
PEPCK and to determine whether changes in gene expression would account for the
changes in sensitivity to these hormones in both lean and obese Zucker rats. It has been
proposed that leptin may play a role in carbohydrate metabolism and insulin action (Flier,
1997; Cohen, et al., 1996; Kolaczynski, et al., 1996). Conversely, leptin treatment of
ob/ob mice decreased both plasma insulin and glucose concentrations, suggesting that
leptin may directly or indirectly improve in vivo insulin action (Pelleymounter, et al.,
1995; Weigle, et al., 1995; Schwartz, et al., 1996; Halaas, et al., 1995). Recent work in
cultured hepatocytes and human hepatoma cells indicated that leptin may regulate gene
expression o f a key gluconeogenic enzyme, phosphoewo/pyruvate carboxykinase and also
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Figure 4.6 Effects o f leptin and dexamethasone on PEPCK mRNA expression in
hepatocyte from lean (A) and obese (B) Zucker rats. Hepatocytes from ad libitum fed
lean and obese Zucker rats were incubated for 3 hr with either leptin (10 and 100 ng/m l)
or dexamethasone (0.1 and 1.0 pM). Total RNA was extracted and analyzed by N orthern
blot. Relative expression o f PEPCK mRNA was determined by Northern blot analysis
and bands were quantified using the Phosphorlmager ImageQuant software. D ata
expressed as mean ± SEM for samples in triplicates.
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antagonize insulin action (Cohen et al., 1996). In the studies described in this dissertation,
leptin was shown to increase the expression o f PEPCK mRNA in hepatocytes from
Sprague Dawley and lean Zucker rats, but not obese Zucker rats. The effect o f leptin was
neither synergistic nor additive when combined with dexamethasone, although leptin
seemed to have a protective effect against cytotoxicity induced by high dexamethasone
concentrations.
Leptin increased the expression o f PEPCK mRNA after 3 hr in culture o f
hepatocytes from lean Zucker rats, and this was accompanied by a steady increase in
glucose production from gluconeogenic substrates. In contrast, no effect o f either leptin,
dexamethasone or insulin was observed in the expression o f PEPCK mRNA from
hepatocytes isolated from obese Zucker rats. The amount o f glucose produced was
insignificant and below detection limits in hepatocytes from obese Zucker rats. This
could, o f course, be due to either the quick utilization o f glucose by these cells for
glycolytic purposes to supply energy to the cell or that no glucose was produced in the
presence o f gluconeogenic substrates, pyruvate and glutamine. The latter could be due to
the observed decrease in PEPCK mRNA levels, resulting in the shut off o f
gluconeogenesis. Alternatively, the high intracellular levels o f glucose in these cells may
repress the PEPCK mRNA and consequently inhibit gluconeogenesis. These observations
are consistent with the literature, where studies have shown that insulin resistance in
genetically obese Zucker rats affects peripheral tissues, such as liver, muscle and adipose
tissue (Czech, et al., 1978; Kemmer, et al., 1979; Terrettaz, et al., 1986). The
responsiveness to insulin o f basal gluconeogenesis from lactate was shown to be reduced
in hepatocytes from obese Zucker rats compared to their lean littermates (Sanchez-
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Gutierrez, et al., 1994; Sanchez-Gutierrez, et al., 1997). This data was consistent with the
reduction o f gluconeogenesis observed in studies reported herein.
Recent in vivo euglycemic hyperinsulinemic clamp studies have reported that
leptin, when administered intravenously for 6 hr, enhanced the inhibition o f hepatic
glucose production in response to insulin. Also, leptin induced redistribution of
intrahepatic glucose fluxes with a decrease in hepatic glucose production by inhibiting
glycogenolysis (Rossetti, et al., 1997). In another study, leptin by itself was not capable
of changing glucose production by the liver, but it markedly reduced the rate of
glucagon-stimulated hepatic glucose production (Ceddia, et al., 1999). These two studies,
in vivo and in vitro, respectively, showed that leptin is associated with a decrease in
hepatic glycogenolysis. In the presence o f gluconeogenic precursors, such as glycerol, Llactate, L-alanine and L-glutamine, leptin reduced glucose production by isolated
hepatocytes. This, however, was contradictory to the effect o f leptin on PEPCK mRNA
gene expression, where leptin was shown to increase PEPCK gene expression (Cohen, et
al., 1996; Rossetti, et al., 1997). These studies showed an increase in PEPCK mRNA
expression after intravenous leptin infusion in rats or after incubation o f human hepatoma
cells with leptin.
In our experiments, we used isolated rat hepatocytes and exposed them to
increasing leptin concentrations (0, 3, 10, 30 and 100 ng/ml) for 3 hr. Within this
incubation period, temporal changes in gene expression o f PEPCK were observed.
Initially, we used hepatocytes isolated from ad libitum fed rats, and could not observe any
gluconeogenic responses to leptin, dexamethasone and insulin. It was reported that
hepatocytes from a d libitum fed rats have increased glycolysis and glycogenolysis due to
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the increase in adenosine monophosphate (AMP) levels (Lopez, et al., 1988). AMP is a
known allosteric activator of phosphofructokinase and glycogen phosphorylase. In the
presence o f increased AMP concentrations, activation o f PEPCK and amino acid (Lglutamine)-induced gluconeogenesis could not be observed due to intensive glycolysis.
This situation,

therefore, altered the capability o f hepatocytes to

respond to

gluconeogenic precursors and to leptin dexamethasone and insulin.
When we made the switch to using overnight fasted rats, the effects o f these
hormones became evident. In the presence o f L-glutamine, the average glucose
production o f hepatocytes increased with time o f incubation with leptin. Dexamethasone
treatment only increased glucose production after 12 hr in culture, indicating the
dependence o f this mechanism on PEPCK gene expression. It has been reported that
PEPCK gene expression in hepatocytes treated with dexamethasone does not occur until
12 hours in culture. Our studies are, therefore, consistent with the late expression o f
PEPCK by dexamethasone and shows that leptin induces the expression much earlier.
From these studies, leptin was capable of altering the metabolic flux in hepatocytes from
overnight fasted rats by increasing not only the PEPCK gene expression, but also by
increasing glucose production from these cells.
Recently, it has been reported that 5 ng/ml leptin administered directly to perfused
livers o f ob/ob mice in vitro, caused an increase in glycogen synthesis, which was
accompanied by an increase in hepatic glycogen synthase activity (Cohen, et al., 1998).
This short term leptin treatment is consistent with leptin modulating pathways that
control hepatic glycogen synthesis in an insulin independent manner. In our studies under
fasting conditions, we assumed that glycogen stores had been depleted and that glycogen
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synthesis and breakdown was at a minimum. Therefore, addition of L-glutamine to the
medium could be used by hepatocytes as a source o f energy for the maintenance o f
hepatocyte metabolism. Also assuming limited glycogenolysis due to low levels o f
glycogen in fasted rats, leptin caused a direct effect on gluconeogenesis in isolated
hepatocytes by increasing PEPCK gene expression. The direct mechanism by which
leptin promotes gluconeogenesis in the liver remains to be determined.
Various peripheral tissues or organs have detectable levels o f mRNA encoding
the long (ObR-L) and short (ObR-S) leptin receptor isoforms. The abundance o f the long
isoform in peripheral tissues is minimal (Ghilardi, et al., 1996; Luoh, et al., 1997). It
remains to be investigated how leptin receptors are involved in the modulation o f leptin
effects in isolated hepatocytes, especially considering the known fact that the majority of
the transcripts in the liver encode the short isoforms o f the leptin receptor. In the current
studies, we could not identify any of the long isoform of the leptin receptor in the
hepatocytes. Only the short isoform of the leptin receptor was present. This observation is
consistent with the literature (Hoggard, et al., 1997; Ghilardi, et al., 1996). Zhao and
colleagues (2000), recently showed the presence o f various short isoforms o f ObR in
hepatocyte extracts and only the hypothalamic extracts contained both the long and short
ObR isoforms (Zhao, et al., 2000).
In vitro studies o f Cohen and colleagues (1996), using HepG2 and H4II hepatoma
cells, reported that leptin attenuated insulin-induced activities by altering the insulin
signaling pathway. For example, leptin treatment reduced the tyrosine phosphorylation o f
insulin receptor substrate (IRS)-I and decreased the association o f Grb2 with IRS-I.
Recently, Nemecz et al. (1999) showed that leptin or insulin inhibited hepatic glucose
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release using in vitro perfused livers. A combination of the two hormones had no further
inhibition. They speculated that leptin could exert its inhibitory effects via the same
signaling pathway as that o f insulin. Also, Walder et al. (1997) have demonstrated that
leptin inhibits insulin binding to its receptor in isolated adipocytes.
Recent studies have also shown that in cells expressing short forms o f ObR, JAK2
and IRS-1, leptin can induce tyrosine phosphorylation o f ERS-1 through the short form o f
the leptin receptor (Bjorbaek, et al., 1997). Also, leptin has been shown to activate PI3kinase in primary hepatocytes, myotubes (C 2 C 12 ) and pancreatic P-cells (Berti, et al.,
1997; Kellerer, et al., 1997).
In non-obese humans, plasma leptin values lie between 1 and 20 ng/ml, while
values up to 100 ng/ml exist in obese humans (Unger, et al., 1997). The leptin
concentrations (3-100 ng/ml) used in the studies reported here were within the
physiological range, inclusive o f obese and non-obese ranges. It can be concluded from
our data and results from short term in vivo leptin administration (Rossetti, et al., 1997)
that leptin regulates liver glucose production through PEPCK, by antagonizing the effect
o f insulin on PEPCK mRNA expression and thus activating the gluconeogenic pathway.
Also, our experience and data obtained with hepatocytes isolated from obese Zucker rats
show that these rats have an intrinsically defective response to short term leptin,
dexamethasone and insulin treatment under gluconeogenic conditions. This may arise
from the in vivo impairment o f the insulin-mediated reduction o f cAMP in these
hyperinsulinemic obese animals.
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CHAPTER FIVE
EFFECTS OF GLUCOCORTICOIDS ON GENE EXPRESSION IN LEAN AND
OBESE ZUCKER RATS
5.1

INTRODUCTION
The homozygous recessive trait found in Zucker fatty (fa/fa) rats is associated

with massive obesity, increased total body fat, increase in fat cell size and number,
increased levels o f serum insulin leading to gradual development of insulin resistance,
and an increase in lipoprotein lipase activity in adipose tissue (Bray & York, 1979).
Compared

to

lean

Iittermates,

the obese Zucker

rats

have

hyperinsulinemia,

hyperlipidemia, mild hyperglycemia and abnormal glucose tolerance. In vitro and in vivo
studies have demonstrated that insulin resistance in obese Zucker rats affects peripheral
tissues, such as liver, muscle and adipose tissue (Czech, et al., 1978; Crettaz, et al., 1980;
Terrettaz & Jeanrenaud, 1983; Terrettaz, et al., 1986). In the liver glucose output was not
blocked by the basal hyperinsulinemia, indicating insulin resistance (Terrettaz &
Jeanrenaud, 1983). In contrast, hepatic glycolysis in obese Zucker rats does not show
insulin resistance, as this metabolic pathway is continuously overstimulated by the
hyperinsulinemia present in these animals (Jeanrenaud, 1988).
Genetically obese rodents and women with abdominal obesity have slightly
elevated basal corticosterone/cortisol secretion during the diurnal trough (Walker, et al.,
1992; Pasquali, et al., 1993). Altered circadian rhythms have been described in the
Zucker rat (Prins, et al., 1986; Fukagawa, et al., 1992; Martin, et al., 1979; Murakami, et
al., 1995). These altered phases o f daily rhythms may also characterize obesity in humans
(Belisle, et al., 1988; Fricker, et al., 1990). The contribution o f the circadian rhythm to
the development and maintenance o f excessive weight gain and obesity is unknown.
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In

general,

glucocorticoids

increase

muscle

protein

breakdown

and

gluconeogenesis in stress and starvation to maintain the glucose supply for the brain
(Steele, 1975). The clinical syndrome o f glucocorticoid excess (Cushing's syndrome) is
associated with glucose intolerance, obesity and hypertension (Andrews & Walker,
1999). By opposing the actions o f insulin, glucocorticoids could contribute to insulin
resistance and obesity.
Adrenalectomy (ADX) was shown to slow the weight gain in both obese Zucker
rats and in their lean littermates, with the greater effect of ADX in the obese rats (Bray, et
al., 1992). ADX also produces a number o f profound effects on other animals with
recessive inherited obesity. In the ob/ob mouse, ADX reduced food intake (Saito & Bray,
1984), slowed down body weight gain (Bray, 1982; Yukimura & Bray, 1978b), increased
energy expenditure (Vander Tuig, et al., 1984), restored norepinephrine turnover to
normal in BAT and heart (Vander Tuig, et al., 1984), abolished insulin resistance in
muscle (Oshima, et al., 1984), lowers circulating insulin levels (Yukimura & Bray,
1978a) and normalized glucose tolerance (Bailey, et al., 1986; Solomon, et al., 1977).
Similar changes have been shown for the db/db mouse upon ADX (Bray, 1982). In the
obese Zucker (fa/fa) rat, ADX also produced decrease in weight gain, decreased food
intake and increased energy expenditure due to enhanced thermogenesis in BAT
(Yukimura, et al., 1978b; Marchington, et al.,

1983). ADX also changed the

characteristics o f the adipose tissue. The fat pad weights o f epididymal, inguinal and
retroperitoneal WAT were decreased by ADX. This decrease was associated with a
decrease in fat cell size in the epididymal and retroperitoneal fat pads, and a decrease in
the LPL activity o f WAT of obese Zucker rats and not the lean (Bray, et al., 1992). These
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studies suggested that ADX normalizes anomalies associated with genetic obesity, but
does not completely reverse the genetic defect o f the fatty Zucker rat (Bray, et al., 1989).
Increased ob mRNA expression has been reported for all forms o f obesity, namely
genetic, hypothalamic and dietary (Zhang, et al., 1994; Trayhurn, et al., 1995a; Maffei, et
al., 1995; Frederich, et al., 1995a; Funahashi, et al., 1995). This suggested that obesity
may be associated with increased expression o f the ob gene. However, ob/ob mice do not
produce normal leptin. Synthesis and release o f leptin is regulated by neuroendocrine,
endocrine and paracrine signals that impinge on the adipocyte. Fasting, 02- and B3 adrenergic receptor agonists, cAMP and thyroid hormones decrease the level o f ob
mRNA expression and leptin production (Trayhurn, et al., 1995a; Frederich, et al., 1995;
Hardie, et al., 1996; Ahima, et al., 1996; MacDougald, et al., 1995; Saladin, et al., 1995;
Fain, et al., 1997; Escobar-Morreale, et al., 1997; Valvaci, et al., 1997; Yoshida, et al.,
1997; Slieker, et al., 1996; Mantzoros, et al., 1996; Trayhurn, 1996). Glucocorticoids,
cytokines and insulin increase the ob mRNA expression (De Vos, et al., 1995; Slieker, et
al., 1996; Wabitsch, et al., 1996; Considine et al., 1997; Wabitsch, et al., 1996; Grunfeld,
et al., 1996; Sarraf, et al., 1997) and circulating protein levels (Malmstrom, et al., 1996).
Leptin signaling is mediated by the leptin receptor (OBR) (Tartaglia, et al., 1995;
Lee, et al., 1996; Chen, et al., 1996). In humans and rodents, two major isoforms o f OBR,
long and short, are detected, which differ in the intracellular domains that represent
products o f alternative splicing. Despite normal ligand binding activity, OBR-S has been
described as being incapable o f signaling (Ghilardi, et al., 1996; Baumann, et al., 1996).
It has, however, been recently shown that the short forms of OBR carry out limited
signaling function in peripheral tissues (Bjorbaek, et al., 1997; Murakami, et al., 1997;
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Yamashita, et al., 1998). For example, in human HepG2 cells and lean rat hepatocytes, it
has been shown that leptin enhances PEPCK mRNA levels (Cohen, et al., 1996; Chapter
3 o f this dissertation). These effects o f leptin were attributed to the action o f leptin on
OBR-S because OBR-L could not be detected in either study. In contrast, the OBR-L
isoform, which is primarily expressed in the hypothalamus, is considered to be the
signaling-competent receptor (Vaisse, et al., 1996; Ghilardi, et al., 1996; Baumann, et al.,
1996). The obese Zucker i f a/fa) rats carry a mutation (Gln269Pro) of the OBR in the
extracellular domain, whereas the db/db mouse has a mutation in the intracellular domain
due to splicing defect (Chua, et al., 1996a; Chua, et al., 1996b; Truett, et al., 1991). The
mutation in the Zucker rat has been shown to reduce leptin receptor affinity and
decreased signaling capacity o f the OBR (Crouse, et al., 1998, Yamashita, et al., 1998),
and the splicing defect in the db/db mouse produces receptors that are signaling
incompetent (Chua, et al., 1996b).
To gain insight into the effects of glucocorticoids on gene expression in the liver
and hypothalamus o f lean and obese Zucker rats, I studied 1) the effect o f adrenalectomy
on the liver PEPCK mRNA expression, 2) the effect o f adrenalectomy on the leptin
receptor mRNA expression in the hypothalamus and liver, and 3) the effect of
physiological changes of corticosterone and leptin on the leptin receptor mRNA
expression, in lean and obese Zucker rats. I assessed changes in serum hormone levels
and modulations o f the mRNA expressions, in an attempt to test the hypotheses that
glucocorticoid excess in obesity

1

) causes hyperglycemia due to dysregulation o f

PEPCK, and 2) leads to hyperleptinemia, which down-regulates the leptin receptor
mRNA expression, and leads to a reduced response to endogenous leptin.

76

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

5.2

MATERIALS AND METHODS

Animals
Age-matched, eight to ten-week-old male or female lean and obese Zucker rats,
were used in these studies. All protocols used were approved by the Pennington
Biomedical Research Center Institutional Animal Care and Use Committee (LACUC).
The animals were housed individually in shoe-box cages in a temperature-controlled
room with a 12-hour light/dark cycle. All rats consumed nonpurified chow diet (Rodent
Chow 5001, Purina Mills, St. Louis, MO, USA) ad libitum throughout the experiment,
and water or saline (where indicated) was provided in water bottles.
Experiment 5.1

Effects of adrenalectomy on liver PEPCK mRNA expression in

lean and obese Zucker rats
Age-matched lean and obese Zucker rats were bilaterally adrenalectomized via a
dorsal approach under isoflurane anesthesia. One group o f adrenalectomized rats were
subcutaneous implanted with 3 week-slow release 50 mg corticosterone pellets
(Innovative Research of America, Sarasota, FL). Adrenalectomized rats were provided
with 0.9% saline drinking water and allowed to recover for a week. Body weights were
monitored daily after adrenalectomy. After recovery, rats were killed by decapitation to
allow collection o f trunk blood and preparation of serum. Liver, epididymal adipose
tissues, hypothalamic and hippocampal tissues were dissected, weighed and snap-frozen
in liquid nitrogen and stored at -80°C until used for RNA extractions. Serum samples
were stored at -80°C before being used for hormone assays. Serum insulin and leptin
were measured using commercially available RIA kits (Linco, St. Charles, MO, USA)
based on rat standards according to the supplier’s instructions. Serum corticosterone was
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assayed using a commercial corticosterone RIA kit (ICN Pharmaceuticals, Costa Mesa,
CA). Total RNA was extracted from liver by the modified acid-phenol guanidiniumisothiocyanate and Northern analyses (PEPCK, P-actin) were performed as described in
general methods. The intensities o f the signals were analyzed relative to P-actin using the
Phospholmager (Molecular Dynamics, Sunnyvale, CA, USA) and quantified using
ImageQuant software.
Experiment 5.2

The effect of adrenalectomy on liver leptin receptor (OBR)

mRNA expression in lean and obese Zucker rats
Liver total RNA was obtained from Experiment 4.1. Semi-quantitative RT-PCR
and ribonuclease protection assays for OBR-S and P-actin were carried out as described
in the General Methods section. The intensities of the signals were analyzed relative to 3actin using the Phospholmager (Molecular Dynamics, Sunnyvale, CA, USA) and
quantified using ImageQuant software.
Experiment 5.3

The effect of adrenalectomy on hypothalamic OBR, NPY-Y1,

NPY-Y5 and CRH mRNA expression in lean and obese Zucker rats
This experiment investigated the effects o f adrenalectomy on the mRNA
expressions o f OBR and genes associated with regulation o f food intake, namely NPYY l and Y5 receptors, and CRH, in lean and obese Zucker rats. Total RNA was extracted
from hypothalami of lean and obese Zucker rats by the TRIzol method as described in the
general methods. RPAs for OBR, CRH, NPY-Yl, NPY-Y5 and P-actin were carried out
as described in general methods. The intensities of the signals were analyzed relative to
P-actin using the Phospholmager (Molecular Dynamics, Sunnyvale, CA) and quantified
using ImageQuant software.
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Experiment 5.4

The effect of corticosterone diurnal rhythm on liver and

hypothalamic OBR mRNA expressions in lean and obese Zucker rats
This experiment investigated the relationship o f diurnal changes in corticosterone
and leptin to the diurnal variation in the expression o f OBR in lean and obese Zucker rats.
Eight-week-old, weight-matched lean and obese Zucker rats were used in this
experiment. Rats were adapted to their living environment with a 12 hr light/dark cycle
(6:00 am-6:00 pm), and food and water was provided a d libitum. After adaptation, the
first group o f rats was sacrificed at 4:00 p.m., the second at 9:00 pm and the last group at
8:00 a.m. the next day. Trunk blood was collected for serum preparation. Liver,
epididymal adipose tissues, hypothalamic and hippocampal tissues were dissected,
weighed and snap-frozen in liquid nitrogen and stored at —80°C until used for RNA
extractions. Serum samples were stored at -80°C before being used for hormone assays.
Serum corticosterone, insulin and leptin were measured as described above. Total RNA
was extracted from liver by the TRIzol method as detailed in the general methods. RPAs
for OBR and P-actin were carried out as described in general methods, and OBR signal
intensities were analyzed relative to 3-actin using the Phospholmager (Molecular
Dynamics, Sunnyvale, CA, USA) and quantified using ImageQuant software.
Statistics
Analyses o f plasma corticosterone, leptin and insulin data as well as body and
tissue weights were performed using a two-way analysis o f variance (ANOVA). Analysis
of gene expression was done by Student’s t test.
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5.3

RESULTS

Experiment 5.1 Effects of adrenalectomy on liver PEPCK mRNA expression in lean
and obese Zucker rats
In all experiments, age-matched obese rats were significantly heavier than lean
rats. Changes in body and tissue weights and serum hormones caused by adrenalectomy
are summarized in Table 5.1. At the end o f the experiments, obese sham-operated rats
had significantly higher body weights compared to lean rats. The increase in body weight
was associated with an increase in mass of epididymal white adipose tissue and the liver.
Adrenalectomy attenuated the increase in body weight in obese rats, and this decline was
associated with decreased epididymal fat and liver weights compared with the shamoperated

rats.

Corticosterone

replacement

restored

the

obesity

syndrome

in

adrenalectomized rats, increasing the body weights parallel to those o f sham-operated
rats. Sham-operated obese Zucker rats had higher serum corticosterone, insulin and leptin
levels than the lean Zucker rats (Table 5.1). Adrenalectomy reduced the levels o f
corticosterone to low levels in both the lean and obese rats, and also decreased the levels
of circulating leptin and insulin in lean and obese. Corticosterone replacement in lean rats
increased the levels o f circulating corticosterone, leptin and insulin to the levels
approaching or comparable to those found in sham-operated rats, whereas in obese rats
the hormone levels remained below those of the sham-operated rats.
The results for the PEPCK mRNA expression in lean and obese Zucker rats of
various corticosterone status are shown in Figure 5.1. Sham-operated obese Zucker rats
had significantly higher levels of PEPCK mRNA expressed compared to sham-operated
lean rats. Adrenalectomy significantly reduced the PEPCK mRNA levels of obese Zucker
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Table 5.1. Body and epididymal WAT weights, and serum hormones o f adrenalectomized, adrenalectomized and steroid replaced, and
sham-operated lean (Fa/?) and obese (fa/fa) Zucker rats

LEAN ZU CK ER RAT________

OBESE ZU C K ER RAT
ADX+R

SHAM

245,9 ±17,2

271,3 ± 14.0

229.7 ±15.6

218.2 ±12.1

258,0 ± 17,6

297,2 ± 17 .4

282.1 ±16.9

12.3 + 4.3°

30.7 ± 4.3b

12,1 ±2.6°

25.9 ± 7.0b°

52.4 ± 6,9a

1.15 ± 0.13°

1.83 ±0.23°

1,88 ±0.19°

4.48 ± 0.35b

6.88 ± 0 .2 6 “

7.61 ± 0,43“

Corticosterone (ng/ml)

6,1 ± 2 .0 9 d

103,3 ± 8,76b

61.9 ±9.5°

Insulin (ng/ml)

1.3 + 0.19°

3.56 + 0.59°

3,11 ±0.45°

5.61 ±0.71°

17.43 ± 2 .9 9 b

26.15 ± 2.34“

Leptin (ng/ml)

0,96 ± 0,14d

2.2 ± 0.3d

2.95 ± 0,55d

17.2 ± 1,95°

29.5 ± 3,6b

39.3 ± 2.64*

ADX

ADX+R

SHAM

Initial Body weight (g)

196.7 ± 11,7

203.2 ± 13,7

187.6 ±9.5

Final body weight (g)

206,9 ± 12.7

215.5 ± 15.9

Body weight gain (g)

10.2 + 3.6°

Epididymal WAT (g)

ADX

6,9 ± 2,85d

108,2 ± 8 ,3 8 b

210.5 ± 18,59*

Values are means ± SEM. There were significant differences in body weight gain (F 5i67 = 9.78, P < 0.0001), epididymal WAT (Fs,46 =
93.05, P < 0.0001), serum corticosterone (F5>g6= 65,79, P < 0,0001), serum insulin (F 5ig6 = 34,71, P < 0,0001), and serum leptin (Fs.se =
57.01, P < 0,0001) levels between lean and obese Zucker rats. Significant difference between groups is indicated by the differences in
letter symbols, with P < 0,05,

rats compared with sham-operated obese rats. In contrast, adrenalectomy had no
significant effect on the PEPCK mRNA levels o f lean rats compared with the shamoperated lean rats. Corticosterone replacement o f obese adrenalectomized rats did not
return the PEPCK mRNA levels to that o f sham-operated rats. Corticosterone
replacement did not have any effect on PEPCK mRNA expression in adrenalectomized
and steroid replaced lean rats.
Experiment 5.2 The effect of adrenalectomy on liver leptin receptor (OBR) mRNA
expression in lean and obese Zucker rats
In this experiment we determined the effects o f adrenalectomy on the expression
o f liver OBR mRNA in lean and obese Zucker rats. The expression o f liver OBR mRNA
was examined by semi-quantitative RT-PCR and by RPA. The OBR-S mRNA expression
and quantification by RT-PCR are shown in Figure 5.2. Adrenalectomy significantly
increased OBR-S mRNA level in livers o f obese Zucker rats compared with shamoperated obese rats. Corticosterone treatment of obese adrenalectomized rats decreased
the levels o f OBR-S mRNA to that comparable to sham-operated obese rats. In contrast,
adrenalectomy and corticosterone replacement had no significant effects on the OBR-S
mRNA expression in livers o f lean Zucker rats. Similar observations were obtained in a
separate experiment using RPA to measure OBR-S (Figure 5.3). Again, a statistically
significant increase in OBR-S mRNA expression was obtained in adrenalectomized obese
Zucker rats compared to sham-operated obese rats. Adrenalectomy did not have any
effect on the OBR-S mRNA expression from lean Zucker rats. However, corticosterone
replacement did not show any effect on OBR-S mRNA expression in either the lean or
obese rats in this experiment.
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Experiment 5.3
This experiment was designed to determine the effects o f ADX on the expression
o f OBR-L mRNAs in the hypothalamus o f lean and obese Zucker rats. The OBR mRNA
expression was examined by semi-quantitative RT-PCR and RPA. Figure 5.4 shows the
effect o f ADX on OBR-L mRNA expression in lean and obese Zucker rats. ADX caused
a significant increase in OBR-L mRNA expression in obese Zucker rats compared to
sham-operated rats. ADX did not have any effect on the OBR-L mRNA expression in
lean rats compared to sham-operated rats. The effect o f corticosterone replacement was
not evaluated in this study.
Figure 5.5 shows the effects o f ADX on OBR mRNA expression in the
hypothalamus o f lean and obese Zucker rats as determined by RPA. Unexpectedly, ADX
did not have any significant effect on the expression o f either the long and short isoforms
o f OBR in lean and obese Zucker rats. W e also determined the effect o f ADX on the
expression o f NPY receptors and CRH mRNA levels. Figure 5.6 shows the RPA
autoradiograms for NPY-Y1, NPY-Y5, CRH and P-actin for lean (A) and obese Zucker
rats. In all experimental groups, the NPY-Y1, NPY-Y5 receptors and CRH were
significantly higher in lean Zucker rats compared to obese Zucker rats. ADX did not have
any effects on the mRNA levels o f NPY-Y1, NPY-Y5 receptors and CRH.
Experiment 5.4
This experiment was designed to determine the effects o f basal physiological
changes in corticosterone during the diurnal rhythm, on the expression o f hypothalamic
OBR-S and OBR-L mRNAs in lean and obese Zucker rats. Figure 5.7 shows the changes
in basal levels o f corticosterone and leptin in lean and obese Zucker rats. In lean rats,
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Figure 5.1. Effects of adrenalectomy on liver PEPCK mRNA expression in lean and
obese Zucker rats. (A) A representative Northern blot of PEPCK and 3-actin mRNA. (B)
Histogram showing the quantification o f PEPCK mRNA relative to 3-actin. Total liver
RNA (40 pg/lane) was analyzed by Northern blotting. Relative expression o f PEPCK
mRNA was determined by hybridization with 3 2 P-Iabeled PEPCK and 3-actin cDNAs.
Lanes 1,3,13,15 = lean-ADX, lanes 2,4,14,16 = obese-ADX, lanes 5,7,17,19 = leanADX+R, lanes 6,8,18,20 = obese-ADX+R, lanes 9,11,21,23 = lean-sham, and lanes
10,1222,24 = obese-sham. Bands were quantified using the ImageQuant software. Data
are expressed as means ± SEM. This figure represents typical data obtained from 5
separate experiments. * p < 0.05 compared to lean sham-operated rats, ** p < 0.005
compared to sham-operated obese rats.
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Figure 5.2. Effects o f adrenalectomy on liver OBR-S mRNA expression in lean and
obese Zucker rats. (A) A representative semi-quantitative RT-PCR for OBR-S and 3"
actin mRNA. Lanes 1, 5, 9 = lean-sham, lanes 2, 6 , 10 = Iean-ADX, lanes 3, 7, 1 1 =
obese-sham and lanes 4, 8 , 12 = obese-ADX. (B) Histogram showing the quantification
o f OBR-S mRNA relative to 3-actin. Total RNA was extracted and analyzed by RT-PCR.
10 pg of total RNA was reverse transcribed and amplified by PCR in the presence o f [a3 2 P]dCTP (10 pCi was used for whole experiment). cDNA (5 pL) was mixed with
sequencing stop solution and fractionated on a sequencing gel. The gel was dried and
exposed to phosphoscreen. Expression of OBR-S mRNA was determined relative to 3"
actin. Bands were quantified using the ImageQuant software. Data is expressed as means
± SEM for 3 rats in each group. * p < 0.05 compared to obese sham-operated rats.
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Figure 5.3. Ribonuclease protection assay to determine the effect o f ADX on liver leptin
receptor mRNA expression. Total RNA was extracted from livers o f ADX, ADX+R and
sham-operated lean (A) and obese (B) Zucker rats. RNA was hybridized with 32P-labeled
antisense probes for OBR, GR and (3-actin and processed as described in the general
methods. Representative RPA autoradiograms for short leptin receptor isoforms, and
histograms showing the quantification of the OBR-S mRNAs. The arrow shows the 270bp protected fragment for OBR-S, and the * arrow shows GR protected fragment. P is
undigested probe for OBR (top band) and GR (bottom band). Data are presented as
means ± SEM. * p < 0.05 compared to obese sham-operated rats.
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Figure 5.4. Effects o f adrenalectomy on hypothalamic OBR-L mRNA expression in lean
and obese Zucker rats. (A) A representative semi-quantitative RT-PCR for OBR and 3actin mRNA. Lanes 1, 5, 9 = lean-sham, lanes 2, 6, 10 = lean-ADX, lanes 3, 7, 11 =
obese-sham and lanes 4, 8, 12 = obese-ADX. (B) Histogram showing the quantification
of OBR-L mRNA relative to 3-actin. Total RNA was extracted and analyzed by RTPCR. 10 pg o f total RNA was reverse transcribed and amplified by PCR in the presence
of [<x-32P]dCTP (10 pCi was used for whole experiment). cDNA (5 pL) was mixed with
sequencing stop solution and fractionated on a sequencing gel. The gel was dried and
exposed to phosphoscreen. Expression of OBR-L mRNA was determined relative to 3actin. Bands were quantified using the ImageQuant software. Data is expressed as means
± SEM for samples in triplicate. * p < 0.05 compared to obese sham-operated rats.
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corticosterone were high 2 hr before lights off and slightly, but significantly (p < 0.05),
decreased after feeding. The levels o f corticosterone further decreased significantly (p <
0.005) the following morning [Figure 5.7 (A)]. The levels o f corticosterone was also
elevated in obese rats before dark-onset. After feeding, the corticosterone levels
decreased significantly (p < 0.05). The levels o f corticosterone in the obese rats did not
decrease any further in the morning compared to the lean rats. Serum leptin levels in lean
rats showed some rhythm [Figure 5.7 (B)]. Leptin levels in these rats were lower before
dark-onset and significantly (p < 0.005) increased after feeding. In the morning, leptin
levels were significantly (p < 0.005) reduced compared to those observed after feeding.
In contrast, no leptin rhythm was observed in obese rats, even though there was a change
in corticosterone levels in these rats. Figures 5.8 and 5.9 indicates the effect o f leptin and
corticosterone rhythms on the liver and hypothalamic OBR-S and hypothalamic OBR-L
mRNA expressions in lean and obese Zucker rats. There were no significant effects of
leptin or corticosterone rhythms on OBR mRNA expression.
5.4

DISCUSSION
This study was undertaken to investigate the role o f glucocorticoids on the

regulation o f gene expression of PEPCK and OBR mRNAs in lean and obese Zucker rats.
Data presented in this dissertation provide evidence for a role o f glucocorticoids in
modulating PEPCK and OBR mRNA, particularly in obese animals. Adrenalectomy
reduced circulating serum corticosterone, insulin and leptin levels in both lean and obese
rats. The decrease in serum hormones was accompanied by an increase in the
hypothalamic OBR-L and OBR-S mRNA, and liver OBR-S mRNA in obese Zucker rats.
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Figure 5.5. Ribonuclease protection assay to determine the effect o f ADX on leptin
receptor mRNA expression. Total RNA was extracted from individual hypothalami o f
ADX, ADX+R and sham-operated lean and obese Zucker rats. RNA was hybridized with
P-labeled antisense probes for OBR and 3-actin and processed as described in the
general methods. A) A representative RPA autoradiogram for leptin receptor isoforms,
and B) histograms showing the quantification o f the OBR-L and OBR-S mRNAs, where
the open-bars are lean and dark-bars are obese samples. Data are presented as means ±
SEM. There were no statistically significant differences between all groups.
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Figure 5.6. Ribonuclease protection assay to determine the effects o f adrenalectomy on
NPY receptors mRNA expression in the hypothalamus o f lean and obese Zucker rats.
Total RNA was extracted from individual hypothalami of ADX, ADX+R and shamoperated lean and obese Zucker rats. RNA was hybridized with 32P-Iabeled antisense
probes for NPY-Y1, NPY-Y5, CRH and P-actin and processed as described in the
general methods. Representative RPA autoradiograms for NPY-Y1, NPY-Y5, CRH, and
P-actin in lean (A) and obese (B) Zucker rats.
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Figure 5.6. (cont.). Histograms showing the quantification of the NPY-Y1, NPY-Y5 and
CRH mRNA relative to P-actin, where the open-bars are lean and dark-bars are obese
samples. Data are presented as means ± SEM. There were no statistically significant
differences caused by ADX between all groups.
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The increase in the mRNA expressions was concomitant with the correction o f the
hyperleptinemia by adrenalectomy in obese Zucker rats.
An increase in hepatic gluconeogenesis is believed to be an important factor
responsible for the fasting hyperglycemia detected in patients with NIDDM (Valera, et
al., 1994). The presence o f mild hyperglycemia has been reported in obese Zucker rats
compared to lean rats, and this was more pronounced in males than in females (Triscari,
et al., 1979; observation in this study). This hyperglycemia was associated with elevated
liver and kidney PEPCK activity and kidney glucose production in obese compared to
lean rats. Furthermore, total liver glycogen levels and rates o f glycogen synthesis were
increased significantly in obese compared to lean rats. The authors concluded that the
mild hyperglycemia present in obese Zucker rats was not associated with delayed
disappearance o f intravenously administered glucose, but could be due to the increased
production o f glucose by whole kidney and liver (Triscari, et al., 1979).
Recently, Friedman and colleagues (1997), using transgenic mice expressing the
intact PEPCK(460)-C-reactive protein transgene, showed that these mice were obese,
hyperinsulinemic, and developed fasting hyperglycemia with age. Levels o f CRP reporter
gene expression were increased 2-fold despite severe hyperinsulinemia compared with
non-diabetic non-obese transgenic mice, and treatment o f obese diabetic db/db transgenic
mice with the glucocorticoid receptor blocker RU 486 decreased plasma glucose by 50%
and reduced PEPCK, GLUT2, gIucose-6-phosphatase, tyrosine aminotransferase and
CRP reporter gene expression to levels similar to those o f non-obese normoglycemic
transgenic mice. These results showed that -460 bp o f 5'-flanking sequence is sufficient
to mediate the induction o f PEPCK gene transcription in genetically obese db/db mice
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Figure 5.7. Serum corticosterone and leptin rhythms in lean and obese Zucker rats.
Serum was obtained from lean and obese Zucker rats killed by decapitation at 4:00 pm
(open bars), 9:00 pm (slashed bars) and 8:00 am (black bars). Corticosterone (A) and
leptin (B) were measured by RIA kits. The insert is an enlargement o f the serum leptin
levels in lean Zucker rats to indicate the rhythm in leptin. Data is expressed as mean ±
SEM.

93

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

c
z
OS
e
«e
I
es

z

OS

£

CZI5

PS

0a
O

□ 4:00 PM
HI 8:00 PM
■ 9:00 AM

0.10

0.09
0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0.00

Lean

Obese

Figure 5.8. The effect o f leptin and corticosterone rhythms on liver OBR-S mRNA
expression. Livers were dissected from lean and obese Zucker rats killed by decapitation.
Histogram showing the quantification of OBR-S mRNA relative to P-actin. Total RNA
was extracted and analyzed by RPA. 40 gg o f total RNA was hybridized to 32P-labelled
antisense ObR403 probe. Expression of OBR-S mRNA was determined relative to Pactin. Bands were quantified using the ImageQuant software. Data is expressed as means
± SEM for samples in triplicate.
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Figure 5.9. The effect o f leptin and corticosterone rhythms on hypothalamic OBR-S and
OBR-L mRNA expression. Hypothalami were dissected from lean and obese Zucker rats
killed by decapitation. Histograms showing the quantification of OBR-S and OBR-L
mRNA relative to 3-actin. Total RNA was extracted and analyzed by RPA. 40 pig o f total
RNA was hybridized to 32P-labelled antisense ObR403 probe. Expressions o f OBR-S and
OBR-L mRNA were determined relative to P-actin. Bands were quantified using the
ImageQuant software. Data is expressed as means ± SEM for samples in triplicate.
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during the development of hyperglycemia, demonstrating that the mechanism underlying
increased expression o f gluconeogenic enzymes in the db/db mouse requires the action o f
glucocorticoids (Friedman, et al., 1997). Sharma and Patnaik (1983, 1984) have shown
that the activity o f PEPCK is highest in livers o f adult rats and that adrenalectomy
decreases significantly the activity o f PEPCK of livers o f rats o f all the ages.
Administration o f hydrocortisone to adrenalectomized rats increased the activity o f
PEPCK in the liver o f young and adult rats but not in the old rats. Our studies indicate a
significant induction o f liver PEPCK mRNA in obese Zucker rats, and that this increase
can be reduced by adrenalectomy. PEPCK mRNA transcription is negatively regulated by
insulin. The obese Zucker rat is hyperinsulinemic, but this high endogenous insulin
concentration cannot inhibit PEPCK gene transcription. Rosella and colleagues (1995)
recently described an overexpressed, non-insulin-responsive gluconeogenic PEPCK. This
leads us to speculate that obese Zucker rats express this type o f PEPCK mRNA, which is
mainly under regulation by glucocorticoids. Data presented in this study is consistent
with previous reports which showed an increased ob gene expression and leptin levels in
adipose tissue from obese Zucker rats compared to lean littermates (Murakami & Shima,
1995). Maffei and colleagues (1995) reported a 50-fold increase in circulating leptin in
obese Zucker rats, which was quantitatively comparable to our results. They also showed
that an increased expression o f the ob gene is common to other animal genetic obesity
models and diet-induced obesity (Maffei, et al., 1995).
The beneficial effects o f adrenalectomy, such as decreases in food intake, body
weight gain, plasma insulin, triglycerides, fat cell size and LPL activity, have been shown
to be reversed by the replacement o f corticosterone (Castonguay, et al., 1986; Freedman,
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et al., 1986; Bray & York, 1979). However, the mechanisms by which the loss of
glucocorticoids prevents the phenotypic expression o f obesity in the obese Zucker rat are
still unknown. This study provides data consistent with the possibility that expression of
the leptin receptor is regulated by glucocorticoids, whereby glucocorticoids increase
leptin gene expression and protein levels which then causes downregulation o f OBR-L
and OBR-S. This suggests that corticosterone, directly or indirectly, is an important
factor in the expression o f obesity in fa /fa rats. It is possible that glucocorticoid hormones
have a direct effect to regulate transcription o f the OBR gene. Indirectly, corticosterone
increases ob gene expression and secretion, and this increase in leptin may lead to
downregulation o f the leptin receptor isoforms. Alternatively, it is also possible that
glucocorticoids modulate other genes, the products o f which regulate leptin receptor or
leptin gene expression. Obese (fa/fa) Zucker rats carry a mutation (Gln269Pro) on the
cytokine-binding domain o f the leptin receptor (Chua, et al., 1996), and this mutation has
been shown to reduce leptin receptor signaling (Chen, et al., 1996). As adrenalectomy
prevented further weight gain in fa /fa rats, it suggests that the effects o f adrenal steroids
are independent o f the changes observed in the levels of the mutated receptor. The
increase in leptin expression in fa /fa rats could result from a number o f mechanisms. It
could reflect the absence o f an appropriate leptin feedback onto the mutated leptin
receptor. Alternatively, it is possible that increased hyperinsulinemia may stimulate
increased synthesis and secretion of leptin in obese Zucker rats. This was recently
supported by the observation that ob gene expression was not increased in preweaning
obese rats, whereas it increased with increase in insulin after weaning and in adult
animals (Cusin, et al., 1995). In contrast, basal leptin was not further increased by
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hyperleptinemia in obese rats despite the higher plasma insulin concentration reached in
obese animals (Pagano, et al., 1997). This could indicate a possible alternative
mechanism whereby the ob gene is not under the control o f insulin in obese fci/fa rats, but
under the control o f glucocorticoids. Our data supports the latter mechanism, which is
further supported by the observation that fasting, which reduces plasma insulin and
increases glucocorticoids both in lean and obese Zucker rats, inhibits ob gene expression
only in lean rats (Cusin, et al., 1995). This indicates that increase in already high
glucocorticoids in obese rats during fasting increased ob gene expression.
It is still unclear whether hyperleptinemia in obesity results from the increased
size of the white adipose tissue, or if other hormonal, metabolic and neuroendocrine
factors may also play a role. Our results suggest that glucocorticoids are important
regulators of leptin and leptin receptor mRNA expression, because adrenalectomy was
effective in decreasing the former and increasing the latter. This reciprocal modulation of
the ligand and its receptor could suggest that the receptor is down-regulated in the
presence o f circulating high ligand, in this case with leptin down regulating the receptor
in the presence o f high glucocorticoids. This also indicates that, in the absence of
glucocorticoids, leptin secretion by white adipose tissue is reduced. This could reflect a
direct effect of the absence o f adrenal glucocorticoids on leptin gene expression or it
could be due to decreased fat pad size induced by removal of adrenal glucocorticoids.
However, the effect o f insulin on our system cannot be entirely discounted, even though a
role of insulin in influencing leptin concentration in humans does not support this. The
size of the white adipose tissue was shown to be a relevant determinant o f circulating
leptin (Considine, et al., 1996). Our results also indicate that glucocorticoids do influence
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leptin secretion by adipose tissue, since leptin secretion was increased by the replacement
with corticosterone in adrenalectomized rats.
NPY is the most potent orexigenic agent known, and icv administration thereof
causes hyperphagia, hyperinsulinemia and obesity. However, the mechanism by which
NPY causes obesity development remains to be defined. Much research is now focused
on which NPY receptor might mediate the potent NPY induced feeding response. Several
pieces of evidence pointed to NPY-Y1 and NPY-Y5 receptor subtypes to be the
candidates for this action. Glucocorticoids play an important role in energy balance, as
excessive corticosterone promotes obesity and increase N PY synthesis and NPY-Y1
receptor expression in the ARC. ADX reduces hyperphagia and body weight in obese
Zucker rats, and prevents obesity induced by central icv NPY infusion. Larsen et al.
(1994) reported that ADX does not alter NPY-Y1 mRNA expression in the ARC. Our
data is consistent with this observation, because ADX did not influence the mRNA levels
o f NPY-Y1 and NPY-Y5. In contrast, Wisialowski and colleagues (2000) recently
showed that ADX decreases NPY-Y1 and NPY-Y5 receptor mRNA in the VMH. It is
possible that significant localized changes in NPY receptor expression within nuclei
occur, but overall there seems to be no changes in these receptor mRNAs in our studies
o f the whole hypothalamus. However, these observations could imply that NPY receptors
are modulated by glucocorticoids. It is also possible that glucocorticoids act by regulating
the levels of CRH, which has been shown to decrease food intake and inhibit NPY
synthesis and release. The decrease in NPY expression in ADX rats was proposed to be a
result of increased CRH activity as well as decreased corticosterone levels. In this study,
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however, no changes in CRH mRNA were observed, but we cannot rule out changes
occurring within the PVN, the site o f glucocorticoid effects on CRH.
Glucocorticoids, at physiological concentrations, stimulate leptin secretion by
enhancing the pre-translational machinery in human visceral fat. This effect was more
pronounced in obese subjects due to a greater responsiveness o f the ob gene and could
contribute to the metabolic abnormalities associated with central obesity by paracrine or
endocrine actions o f hyperleptinemia on adipocytes and liver (Halleux, et al., 1998).
Unlike dexamethasone, insulin had no direct stimulatory effect on ob gene expression
and leptin secretion, and even prevented the positive response to dexamethasone by a
cAMP-independent mechanism that remained functional despite insulin resistance
(Halleux, et al., 1998). A similar argument can be presented in this study, where insulin,
per se, may not have any effect on the expression and secretion o f leptin, but that the
observed effects were exclusively under the influence o f glucocorticoids.
The existence o f abnormal regulation of the HPA axis in genetically obese Zucker
rats has been reported (Guillaume-Gentil, et al., 1990). Previous data have shown
increased morning plasma corticosterone in obese animals (White, et al., 1988). Some
results have described the absence of a circadian rhythm o f the corticosterone in obese
rats (Martin, et al., 1978; Gibson & Krieger, 1981). In the present study, basal
measurement

of corticosterone

and

leptin

were

determined.

Morning

serum

corticosterone levels o f obese Zucker rats are significantly higher than those o f their lean
littermates. Afternoon corticosterone levels are significantly higher than the morning
levels in lean rats, and this level is decreased 3 hr after meal time. In contrast,
corticosterone levels in obese rats decreased after meal time, but did not decrease to
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lower levels in the moming. This data could be in keeping with the preservation o f a
“partial” circadian rhythm o f corticosterone in the obese rats, even though the trough will
not be as deep as it could be in the lean rats. This data supports that o f Yukimura and
colleagues (1978). This data is also in keeping with the study that showed an increased
daily urinary corticosterone output in obese Zucker rats in comparison to lean Iittermates
(Cunningham, et al., 1986). Furthermore, our results may indicate that there is an
increased activity o f the HPA axis in the obese Zucker rats compared to the lean rats. In
contrast to the partial diurnal rhythm o f corticosterone in obese Zucker rats, no leptin
rhythm was observed in these rats. Lean Zucker rats showed a rhythm where leptin was
reduced before dark-onset, increased 2 hr after a meal and decreased during the lights on.
This rhythm could be a functional regulator o f the leptin receptor in lean rats, with the
receptor decreasing during high leptin and increasing during the low levels. This,
however, would be a lost function in obese Zucker rats that are hyperleptinemic and have
no rhythm o f the circulating leptin. This effect could induce down-regulation o f the leptin
receptor, which may in turn be responsible for potential leptin resistance. Even though we
observed leptin rhythm in lean Zucker rats, no rhythm of OBR was seen in these rats.
This could suggest that leptin does not regulate OBR or that the time o f sampling for
OBR was inappropriate because we did not allow a lag time from leptin measurements.
The presence of glucocorticoids is necessary for the development and
maintenance o f obesity (Fletcher, 1986), and the administration o f corticosterone to
normal rodents causes hyperinsulinemia (Diamant & Shafrir, 1975) and increased fat
deposition and hyperphagia (Bray, et al., 1990), Furthermore, adrenalectomy of
underweight rats blunted hyperphagic response associated with free access to food, and
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this defect was normalized by central administration o f glucocorticoids (Green, et al.,
1992). These observations suggested that hypercorticosteronemia observed in the obese
rat contributes to several aspects o f its metabolic abnormalities (Jeanrenaud, et al., 1985).
This is validated by reports that administration o f cortisol to normal humans produced
insulin resistance (Rizza, et al., 1982), a similar feature o f Zucker rats (Jeanrenaud, et al.,
1985). The increased HPA activity o f the obese Zucker rats has been shown to be
associated with an abnormal (increased) regulation o f CRF release (Bestetti, et al., 1990).
Adrenalectomy may therefore, help restore the hypothalamic CRF content and normalize
abnormalities o f obesity via restoration of the autonomic nervous system (RohnerJeanrenaud, et al., 1989).
While we could demonstrate effects o f adrenalectomy on the levels o f OBR
mRNA in obese rats, the lack of difference in OBR mRNA between lean and obese rats
and the lack o f a diurnal variation in OBR mRNA suggest that corticosterone does not
regulate OBR at physiological concentrations. However, the dramatic effect o f
adrenalectomy might be interpreted to suggest that there is a permissive requirement for
glucocorticoids for the downregulation o f the leptin receptor.
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CHAPTER SIX
EFFECTS OF ADRENALECTOMY ON THE LEPTIN RECEPTOR
SIGNALING SYSTEM
6.1

INTRODUCTION
Adrenalectomy prevents the development o f all forms o f rodent obesity, including

those that have a defect in the leptin signaling pathway. The mechanism through which
this response is mediated remains unclear, but is related primarily to the removal of
adrenal glucocorticoids because glucocorticoid replacement o f adrenalectomized animals
restores fat deposition and obesity (Bray, et al., 1990a; Bray, et al., 1990b; Saito & Bray,
1984; Bruce, et al., 1982; Freedman, et al., 1986). Also, blockage o f type II GR with the
antagonist RU486, inhibits development o f obesity induced by the overactivity o f the GR
receptor (Langley & York, 1990; Okada, et al., 1990). Leptin, a hormone secreted by the
adipose tissue, plays an important role in the regulation o f energy balance, providing a
signal to the central nervous system on the levels o f triglyceride stores (Halaas, et al.
1995; Friedman & Halaas, 1998; Friedman, 1999). Glucocorticoids and insulin stimulate
leptin gene expression in the adipose tissue and leptin protein secretion into the
circulation (De Vos, et al., 1995; Slieker, et al., 1996; Wabitsch, et al., 1996; Malmstrom,
et al., 1996). Administration o f glucocorticoids increases food intake in rodents,
overriding the effect o f increased endogenous leptin expression and secretion. These
contrasting effects o f glucocorticoids may suggest that glucocorticoids either reduce
sensitivity to leptin or oppose leptin action through independent pathways. Indeed, an
increase in response to leptin has been described in adrenalectomized rats by Zakrzewska
and colleagues (1997). Corticotropin-releasing hormone (CRH), which suppresses food
intake, is negatively regulated by glucocorticoids. However, CRH deficiency after ADX
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did not affect food intake and body weight, indicating that factors other than or in
addition to CRH are important in mediating food intake responses after ADX (Jacobson,
1999).
The effects o f leptin are impaired when receptors o f neurotransmitters implicated
in feeding, namely GLP-1, MC-4, and NPY, are either knocked out or blocked by
specific antagonists (Marsh, et al., 1999; Hollopeter, et al., 1998b; Scrocchi, et al., 1997;
Goldstone, et al., 1997). These observations led to the conclusion that leptin’s actions to
inhibit food intake may not be direct, but mediated or modified by the action o f other
neurotransmitters. Figure 6.1 shows some of the suggested possible pathways that leptin
uses to regulate feeding. Evidence supporting an interaction between leptin and NPY
came from studies showing that the NPY mRNA expression in the ARC is increased in
animal models with leptin signaling abnormalities (Schwartz, et al., 1996a). Peripheral
injection o f leptin to fasted rats and ob/ob mice normalized the overexpression of NPY in
these situations (Stephens, et al., 1995; Schwartz, et al., 1996a; Wang, et al., 1997;
Schwartz, et al., 1996b). More evidence for the interaction between leptin and NPY was
shown by the presence o f leptin receptors on NPY neurons (Hakansson, et al., 1996;
Baskin, et al., 1999a; Baskin, et al., 1999b). NPY, which is modulated by leptin and
glucocorticoids, is an important mediator of leptin’s action in the CNS (RohnerJeanrenaud, et al., 1996), since recombinant leptin inhibits, and glucocorticoids enhance,
hypothalamic NPY gene expression and secretion (Stephens, et al., 1995; Schwartz, et al.,
1996).
Neurons o f the ARC also synthesize POMC, which is enzymatically cleaved into
melanocyte stimulating hormones (a, 3, and y) and P-endorphin. a-M SH has been shown
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to affect food intake by activating post-synaptic receptors, especially the melanocortin-4
(MC-4) receptor subtype (Zemel & Shi H, 2000; York, 1999; Kask, et al., 1998).
Targeted disruption o f this receptor subtype causes obesity (Huszar, et al. 1997). POMC
neurons in the ARC express leptin receptor mRNA, suggesting that leptin may bind to
neurons in this brain region to influence the production o f melanocortins (Cheung, et al.,
1997). Injection o f leptin to fasted animals and ob/ob mice increased POMC mRNA
expression, but this effect was not observed in db/db mice which lack the capacity for
leptin signaling (Mizuno, et al., 1998; Schwartz, et al., 1996b).

LEPTIN

OREXIN
CRH
Urocortin

POMC

Y l, Y5
Receptors

CART

MCH

a-MSH

CRH-2
Receptor
Median
Eminence

MC-4
Receptor

ACTH
Glucocorticoids

FOOD INTAKE

Adipocytes

Figure 6.1. Possible pathways downstream of leptin receptor to control feeding.
Corticotropin releasing hormone (CRH), pro-opiomelanocortin (POMC) and cocaineamphetamine related transcript (CART) decrease food intake, whereas neuropeptide Y
(NPY), orexin, melanin-concentrating hormone (MCH) and agouti-related protein
(AGRP) increase food intake. Agouti-related protein (AGRP) is increased by leptin and
competes with a-M SH for the MC-4 receptor to decrease food intake.
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CRH is released in the median eminence, where it induces ACTH release from the
anterior pituitary via the hypothalamic pituitary portal circulation. In addition to its
ability to activate the HPA axis, CRH also regulates food intake and energy balance
(Arase, et al., 1989). Loss of the negative feedback from glucocorticoids to the brain
following ADX acts to increase CRH mRNA and content in the PVN (Jacobson, et al.,
1990).
The Ieptin receptor (OBR) is a single membrane-spanning receptor that is similar
to the class I cytokine receptor family (Tartaglia, et al., 1995). The majority of the
transcripts in most tissues are those encoding the short forms o f the receptor (Ghilardi, et
al., 1996), and the transcript that encodes the long form is less abundant except in the
hypothalamus. Within the hypothalamus, the long OBR isoform is expressed in regions
that are thought to control food intake and body weight, namely, the arcuate nuclei
(ARC), ventromedial nuclei (VMN) and paraventricular nuclei (PVN) (Mercer, et al.,
1996). The functions of the long and short intracellular domains o f the leptin receptor are
currently being defined. The short isoforms play a major role in transporting leptin from
the blood into the brain or out of the brain into the cerebrospinal fluid (CSF) for clearance
(Cumin, et al., 1996; Cumin, et al., 1997; Esler, et al., 1998). The long OB-R isoform
provides intracellular signaling by acting through the JAK-STAT pathway as illustrated
in Figure 2.5, particularly the STAT-3 protein in the hypothalamus (Vaisse, et al., 1996).
The JAK proteins are associated with the receptor intracellular domain, where they
phosphorylate tyrosine residues of the receptor upon ligand binding. The phosphorylated
receptor then provides the docking site for ST AT proteins, which are also tyrosine
phosphorylated upon binding the phosphorylated receptor. The activated ST AT proteins
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then dimerize and translocate to the nucleus to stimulate gene transcription (Darnell, et
al., 1994; Darnell, 1996; Darnell, 1997).
Recently, a family o f cytokine-induced cytokine signaling inhibitors has been
described. It includes eight members, namely the cytokine-inducible SH2 proteins (CIS)
and suppressor o f cytokine signaling (SOCS) 1 to 7 (Hilton, et al., 1998). Structurally, the
SOCS proteins are composed of an N-terminal region o f variable length and amino acid
composition, a central SH2 domain, and a previously unrecognized C-terminal motif
called the SOCS box. By using the SOCS box amino acid sequence consensus, 16 other
proteins that contain this motif were identified. These proteins fall into five classes based
on the protein motifs found N-terminal o f the SOCS box. In addition to four new SOCS
proteins (SOCS-4 to SOCS-7) containing an SH2 domain and a SOCS box, three new
families o f proteins that contain either WD-40 repeats (WSB-1 and -2), SPRY domains
(SSB-1 to -3) or ankyrin repeats (ASB-1 to -3) N-terminal o f the SOCS box were
identified (Hilton, et al., 1998).
The expression of SOCS proteins is induced by various cytokines, and once
expressed, SOCS proteins down-regulate JAK/STAT pathways and hence modulate the
biological response. Peripheral administration o f leptin to ob/ob, but not db/db mice,
rapidly induced SOCS-3 mRNA in hypothalamus (Bjorbaek, et al., 1998; Emilsson, et al.,
1999). This leptin-dependent increase o f SOCS-3 mRNA was seen in areas o f the
hypothalamus expressing high levels o f the long form OBR. Furthermore, SOCS-3 was
shown to block leptin-induced signal transduction in mammalian cell lines. The
expression o f SOCS-3 mRNA in the ARC and DMN is increased in agouti mice, an
obesity model o f leptin-resistance. This indicated that SOCS-3 is a leptin-inducible
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inhibitor o f leptin signaling, and suggested SOCS-3 to be a potential mediator o f leptin
resistance in obesity (Bjorbaek, et al., 1998). Furthermore, Auemhammer and colleagues
(1998), showed an inhibition of LIF-stimuIated STAT-3 phosphorylation in SOCS-3
overexpressing AtT-20 cells, and concluded that SOCS-3 inhibits the JAK-STAT
pathway.
Adrenalectomy has been shown to increase sensitivity to leptin (Zakrzewska, et
al., 1997). We hypothesize that this leptin sensitivity upon adrenalectomy could be
through several mechanisms, including direct action on expression o f the leptin receptor,
changes in activation o f the JAK/STAT pathway or expression o f the suppressors of
cytokine signaling or through direct effects on the neuropeptide genes that modulate the
effects of leptin on energy balance. To determine if glucocorticoids impair the activity of
the leptin receptor signaling pathway, we studied the effects o f adrenalectomy and
corticosterone replacement on components o f the

leptin receptor signaling pathway,

including the hypothalamic leptin receptors, SOCS-3, STAT-3 and NPY.
6.2

EXPERIMENTAL PROTOCOLS

Animals
Ten-week-old male Sprague Dawley rats were purchased from Harlan Sprague
Dawley, Inc. (Indianapolis, IN). They were housed individually in hanging wire-mesh
cages attached to an automated watering system in a room with a 12 hour light/dark (7:00
AM to 7:00 PM) cycle at a temperature o f 22-23°C. All rats consumed nonpurified chow
diet (Rodent chow 5001, Purina Mills, St. Louis, MO, USA). Food was available ad
libitum throughout the experiment. All protocols used in these studies were reviewed and
approved by the Pennington Center’s Institutional Animal Care and Use Committee.
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Intracerebroventricular (icv) Cannulation
Rats weighing 270-300 g were anesthetized by intraperitoneal (ip) injection with
0.125ml anesthesia per lOOg body weight [anesthesia = mixture o f Ketamine (80mg/ml);
Ace Promazine (1.6mg/ml) and Xylazine (5mg/ml)]. They were stereotaxically implanted
with a stainless steel guide cannula (25 gauge, 14-mm long) into the third cerebral
ventricle. The coordinates were: 2.8 mm posterior to bregma, 0.0 mm lateral to
midsagittal, and 8.1 mm ventral to the dura according to the brain atlas o f Paxinos and
Watson (1982). Cannulas were secured in place with anchor screws and dental acrylic
and occluded with 30-gauge wire stylet. The injector (31-gauge) was projected 0.5 mm
longer beyond the tip o f the guide cannula. Body weights were monitored daily during
the 7 days recovery period.
Ad renalecto my
Seven days after recovery from cannula placement surgery, rats were bilaterally
adrenalectomized via a dorsal approach under isoflurane anesthesia. One group o f
adrenalectomized rats were subcutaneous implanted with 3 weeks-release 100 mg
corticosterone pellets (Innovative Research o f America, Sarasota, FL). Adrenalectomized
rats were provided with 0.9% saline drinking water and allowed to recover for 7 days
before leptin treatment. Body weights were monitored daily after adrenalectomy.
In vivo experiments
Intracerebroventricular microinfusions (2.0 pi leptin/rat) in unrestrained rats were
at the rate o f lpl/min using an infusion pump (Harvard Apparatus, South Natick, MA).
Each animal was infused between 3:00 and 3:30 pm (4 hours before dark onset). Rats
received either vehicle (sterile physiological saline, 2 pl/rat) or 2.5 gg/rat recombinant
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leptin (R&D Systems, Inc., Minneapolis, MN) dissolved in 2 \xL saline vehicle. Twentyfour (24) h food intake and body weight were monitored. After 24 hours, rats were given
second icv injections o f saline or 2.5 pg leptin. Two hours later, rats were killed by
decapitation. Trunk blood was collected for the determination of plasma hormones.
Hypothalami, epididymal fat pads and livers were dissected out, weighed and snap-frozen
in liquid nitrogen and stored at -80°C until used for total RNA and protein analyses. The
dose o f leptin chosen for these studies was based on our lab’s previous studies that
determined the concentration-dependence o f leptin effects on food intake (Lin, et al.,
1999). The time selected for tissue sampling (2 h after icv administration and 2 h before
dark onset) was also based on the food intake profiles exhibited by rats receiving leptin.
RNA analysis
Total RNA was extracted from hypothalamus and liver tissues by the modified
guanidinium-isothiocyanate method (Chomczynski and Sacchi, 1987) using TRIzol
reagent (Life Technologies, GIBCO BRL, Gaithesburg, MD), with modifications as
described in the General Methods section. RPA (OBR, P-actin), semi-quantitative RTPCR (SOCS-3, STAT-3, cyclophilin) and Northern (NPY, P-actin) analyses were carried
out as described in the General Methods section. The intensities of the signals were
analyzed relative to appropriate internal standard using the Phospholmager (Molecular
Dynamics, Sunnyvale, CA) and quantified using ImageQuant software.
Protein analysis
Total lysates, nuclear and cytosolic fractions were prepared from hypothalami
according to the method o f Vaisse, et al. (1996) as described in the General Methods
section. Nuclear STAT-3 protein was immunoprecipitated with anti-STAT-3 antibody
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(Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and sequentially immunoblotted with
anti-phosphotyrosine

(pY20), and anti-STAT-3 polyclonal antibody (Santa Cruz

Biotechnology,

Santa Cruz,CA).

Inc.,

SOCS-3

and

SHPTP-2

proteins

were

immunoprecipitated and immunoblotted from the cytosolic fraction using their respective
antibodies purchased
Phosphorylation

from Santa Cruz Biotechnology,

o f SHPTP-2

was

determined

by

Inc (Santa Cruz, CA).

immunoblotting

with anti-

phosphotyrosine (clone 4G10) antibody (Upstate Biotechnology, Lake Placid, NY).
Electrophoretic mobility shift assay
DNA binding studies were performed using the c-fos 5 /5 -inducible element (m67SIE) which specifically binds STAT-3 protein dimers, as described in the General
Methods section. Nuclear extracts were incubated with radiolabeled double-stranded
probe and the products were fractionated on a 5% nondenaturing PAGE. The intensities
of the bands were analyzed using the Phospholmager (Molecular Dynamics, Sunnyvale,
CA) and quantified using ImageQuant software.
Serum assays
Plasma corticosterone, insulin and leptin were measured with radioimmunoassay
(RIA) kits (Linco Research, Inc., St. Charles, MO) based on rat standards according to
the supplier’s instructions. Nonesterified fatty acids (NEFAs) from serum were quantified
using a colorimetric in vitro enzymatic assay according to the manufacturer’s
specifications (Wako Pure Chemical Industries Ltd., Richmond, VA). The blood glucose
levels were measured with a blood glucose meter (Glucometer Elite, Bayer Corp.,
Elkhart, IN).
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Statistics
Data are presented as means ± SEM. Statistical analysis were performed using the
Student’s t test, and two-way analysis of variance (ANOVA). Post hoc analysis was
performed using the Duncan multiple range test method at p < 0.05.
6.3

RESULTS
Adrenalectomy attenuates the development o f obesity and leptin reduces food

intake and body fat in rodents. To test the hypothesis that adrenalectomy increases the
sensitivity to leptin, we adrenalectomized and steroid-replaced rats with corticosterone
pellets and injected them icv with either saline vehicle or 2.5 pg leptin. Figure 6.2 shows
the effects o f adrenalectomy and leptin treatment on food intake. In saline treated rats,
ADX reduced 24-h food intake by 35% in ADX rats compared to sham-operated rats.
Leptin treatment of sham-operated rats significantly decreased 24-h food intake by 43%
compared to saline treated rats. Corticosterone replacement o f saline-treated ADX rats
returned the food intake to the level equivalent to that o f sham-operated rats, indicating
an inhibition o f ADX-induced decrease in food intake. Treatment o f ADX rats with leptin
significantly decreased food intake by 73% compared to saline treated ADX rats. When
corticosterone replaced rats were treated with leptin, leptin significantly decreased food
intake, however corticosterone reduced the sensitivity of leptin-induced decrease in food
intake by 50% compared with leptin treated ADX rats. Table 6.1 shows the data obtained
on body and tissue weights, serum hormones, glucose and NEFAs. ADX significantly
reduced the epididymal fat pad weight compared to sham-operated rats. Leptin treatment
of ADX rats decreased epididymal fat pad weight by 32% compared to ADX-saline rats,
however this decrease was not significant.
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Figure 6.2. Effects o f adrenalectomy and leptin treatment on the 24-hr food intake.
Sprague-Dawley rats received an injection o f 2 pL saline vehicle or 2.5 pg leptin in 2 pL
icv before dark-onset, and food intake was measured after 24-hr. Results are expressed as
means ± SEM. Significant differences between groups are indicated by the differences in
letter symbols. ANOVA showed that there is significant differences in food intake (Fs,42
= 22.92, p =0.0001).

Corticosterone-replacement in ADX rats attenuated leptin- induced fat pad weight loss,
and permitted weight gain to the level o f saline-treated corticosterone-replaced ADX rats.
As with the slight body weight change, corticosterone-replaced ADX rats had similar
epididymal fat pad weights regardless o f leptin treatment. In sham-operated rats,
however, leptin treatment significantly reduced the weight o f the liver compared to
saline. Furthermore, leptin treatment consistently caused a decrease in the liver weights in
all groups, but the decreases were not significant.
To determine the effects o f ADX and leptin treatment on serum hormones,
changes in serum insulin, corticosterone, leptin, glucose and NEFA levels in ADX,
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Table 6.1. Body weight, liver and epididymal WAT weights and serum hormone levels o f adrenalectomized, adrenalectomized and
steroid replaced, and sham-operated lean Sprague Dawley rats

ADX
Saline

ADX+R
LeDtin

Saline

SHAM
Leptin

Saline

Leptin

Initial Body weight (g)

277.6 ±25,5

3 1 6 ,2 ± 4 ,4

244.7 ± 11.6

241.1 ± 13.1

289.5 ± 18.9

311.2 ± 11,4

Final body weight (g)

275.2 + 24.1

295,1 ± 3 .4

239.1 ±10.8

225.9 ± 10.3

296.8 ± 18.8

302.7 ± 11.2

-15.2 ± 3,0C

7,4 ± 1.6“

-8.5 ± 0.7b,c

-21,1 ± l,2b,c

-5.6 ± l . l b,c

2.42 ± 0 .18a,b

1.64 ± 0.21b

2.03 ± 0 .1 6b

1,73 ± 0 .2 lb

2,96 ± 0,37a

2,25 ± 0.22a,b

Liver (g)

9,95 ± 0.76a,b

8.81 ± 0 .9 5 b’c

9.56 ± 0.38a,b,c

7.95 ± 0.48c

10.68 ± 0 .5 4 a

8,57 ± 0.27b,c

Corticosterone (ng/ml)

18.7 ± 18.7d

29,2 ± 19.4c,d 304.4 ± 37.6°

350,3 ± 66.6°

568.2 ± 58.2b

704.3 ± 40.5a

Insulin (ng/ml)

0.56 ± 0.18b

0.63 ± 0,22b

0.95 ± 0.17a,b

1,82 ± 0.4a

0.93 ± 0.37a,b

Leptin (ng/ml)

0.55 ± 0.18c

1.53 ± 0.8l b>c

0.42 ± 0.1 l c

Glucose (mg/dL)

114 ± 14,8h

NEFAs (mmol/L)

0.26 ± 0.04a,b

Body weight gain (g)

-2.5 ± l,6a,b

Epididymal WAT (g)

130.6 ± 5 ,3 a’b
0,31 ± 0.05a'b

129.8 ± 3 .3 a,b
0.21 ±0,03b

1.01 ±0.1 l a,b
3.6 ± 1.53a,b
125.8 ± 3 .8 b
0 .3 0 ± 0 ,0 3 a,b

1,27 ± 0,35b’°
139,4 ± 2 .4 a,b
0,30 ± 0.03a,b

4.91 ± l,55a
141,8 ± 4 .6 a
0.38 ± 0,04“

Values are means ± SEM, Significant difference between groups is indicated by the differences in letter symbols, with P < 0,05, The
were 6-8 animals in each experimental group, ANOVA showed significant differences in body weight change (F 5i42 = 6,16, p = 0,002),
epididymal WAT (Fs.^z = 3,84, p = 0.005), liver (Fj>42 = 3.84, p = 0.02), corticosterone (F5i42 = 21.17, p = 0,0001), leptin levels ( F ^ =
4.03, p = 0,01), and glucose (F5i42 = 2,56, p = 0,01), but not in insulin (Fs,42 = 2.37, p = 0.07), and NEFAs (Fsi42 = 2,37, p = 0,06),

steroid-replaced and sham-operated rats were measured (Table 6.1). In sham-operated
rats, leptin treatment reduced plasma insulin levels by almost 50% compared to saline
treated sham-operated rats. ADX significantly reduced plasma insulin levels compared to
sham-operated rats. However, leptin treatment o f ADX rats had no further effects on
serum insulin. Corticosterone-replacement showed a tendency to increase plasma insulin
levels, even though they did not increase to the level o f sham-operated rats. In ADX and
replaced rats, plasma corticosterone levels were equivalent regardless o f leptin treatment.
ADX rats had very low corticosterone levels. Sham-operated and ADX-rep laced rats had
higher levels o f corticosterone, which were also equivalent regardless o f leptin treatment.
Replacement o f ADX rats with corticosterone increased serum corticosterone to levels
that were approximately 50% of those seen in the sham-operated rats. Plasma leptin
levels varied not only as a result o f leptin infusion, but also in association with
corticosterone depletion and replacement. ADX significantly reduced the levels o f
plasma leptin. However, replacement with corticosterone did not elevate plasma leptin
levels in saline treated rats. Plasma leptin was increased in ADX rats infused with leptin
and replacement with corticosterone also showed an increase in plasma leptin levels. The
increment in leptin levels in leptin-treated rats was far greater in sham-operated rats
compared to ADX rats, with the replaced rats showing intermediate levels.
To determine the effects of ADX and leptin treatment on the hypothalamic leptin
receptor levels, we used a ribonuclease protection assay to measure mRNA expression
for the leptin receptor isoforms in ADX, steroid-replaced and sham-operated rats (Figure
6.3). ADX significantly increased ObR-L mRNA levels compared to sham-operated rats
(0.104 ± 0.02 vs 0.051 ± 0.009, p < 0.05). Corticosterone replacement o f ADX rats did
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not have an effect on the ObR-L mRNA expression compared to ADX rats. Leptin
treatment had no effect on the levels o f ObR-L mRNA in any experimental groups. ADX
significantly increased ObR-S mRNA levels compared to sham-ADX rats (0.078 ± 0.012
vs 0.047 ± 0.008, p < 0.05). Corticosterone replacement did not alter these ADX-induced
increases in ObR-L and ObR-S mRNA levels. In sham-operated rats, leptin treatment did
not have an effect on the ObR-S mRNA expression compared to saline treated rats (0.048
± 0.008 vs 0.038 ± 0.003, p > 0.05). Leptin treatment had no effect on the levels o f ObRS mRNA in any experimental groups.
To assess the effects of ADX and leptin treatment on hypothalamic STAT-3
mRNA levels, semi-quantitative RT-PCR was used to measure STAT-3 mRNA
expression (Figure 6.4). The hypothalamic STAT-3 mRNA levels were increased
following ADX compared to sham-operated rats (1.30 ± 0.05 vs 0.78 ± 0.10, p < 0.001).
Glucocorticoid-replacement of ADX-saline treated rats reduced the levels o f STAT-3
mRNA (0.99 ± 0.08 vs 1.30 ± 0.05, p< 0.05). Leptin treatment o f ADX rats had no
further effect on the STAT-3 mRNA expression compared to saline treatment (1.28 ±
0.05 vs 1.30 ± 0.05). Leptin treatment o f sham-operated rats reduced STAT-3 mRNA
expression compared to saline treated rats (0.56 ± 0.05 vs 0.78 ± 0.08, p< 0.05).
To assess the effects of ADX and leptin treatment on hypothalamic STAT-3 total
protein levels, immunoprecipitation and Western blotting was used to measure STAT-3
protein levels in whole hypothalamic lysates (Figure 6.5). ADX increased the levels o f
total STAT-3 protein levels compared to sham-operated rats. Leptin treatment o f ADX
rats increased the levels of STAT-3 compared to saline treated rats. In steroid-replaced
ADX rats, the levels o f STAT-3 protein were variable, but replacement with
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corticosterone caused a decrease in STAT-3 protein in 75% o f the replaced samples.
Unlike the effects o f leptin on the STAT-3 mRNA levels, leptin treatment had no effect
on the levels o f STAT-3 protein in sham-operated rats. This discrepancy may be due to
differences in the times o f sampling for the mRNA and protein, where the rate of
transcription would have been different between these groups at the time o f sampling.
We then investigated whether the increase in STAT-3 protein levels due to ADX
was associated with increased STAT-3 activity. Therefore, nuclear protein extracts were
immunoprecipitated with STAT-3 polyclonal antibody to measure phosphorylation of
STAT-3

protein

(Figure

6.6).

Leptin

treatment

increased

STAT-3

protein

phosphorylation in the hypothalamus o f sham-operated rats compared to saline-treated
rats. ADX induced constitutive STAT-3 protein tyrosine phosphorylation compared to
sham-operated saline-treated rats. Leptin treatment of ADX rats further increased nuclear
STAT-3 protein phosphorylation compared to leptin-treated sham operated rats. Steroid
replacement o f adrenalectomized

rats returned

the

levels

o f STAT-3

protein

phosphorylation to that o f sham-operated saline treated rats. However, leptin effects on
STAT-3 protein phosphorylation were abolished. In order to make sure that equal levels
o f protein were loaded on the gel and that efficiency o f transfer was optimum,
membranes were stripped and re-blotted with the STAT-3 polyclonal antibody. Western
blotting with STAT-3 antibody verified that the tyrosine phosphorylated 92-kDa protein
was STAT-3 and that each lane contained the same amounts of the STAT-3 protein. This,
therefore, showed that ADX and leptin treatment induced phosphorylation o f STAT-3,
which is then translocated to the nucleus to affect transcription o f STAT-3-dependent
genes.

117

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

SHAM
L ep tin

B

©

0.00

0.00

ADX

ADX+R

SHAM

ADX

ADX+R

SHAM

Figure 6.3. Ribonuclease protection assay to determine the effect of ADX and leptin
treatment on leptin receptor mRNA expression. Total RNA was extracted from individual
hypothalami o f rats treated icv with either saline vehicle or 2.5 pig leptin. RNA was
hybridized with 32P-labeled antisense probes for ObR and 3-actin and processed as
described in the general methods. A) A representative RPA for leptin receptor isoforms,
and B) histograms showing the quantification of the ObR-L and ObR-S mRNAs, where
the open-bars are saline-treated and dark-bars are leptin-treated samples. M is century
RNA molecular markers. Data are presented as means ± SEM. * p < 0.05 compared to
sham-operated rats.
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Figure 6.4. Effects o f ADX and leptin treatment on the hypothalamic STAT-3 mRNA
expression. Total RNA was extracted from hypothalami of ADX, ADX-steroid replaced
and sham-operated rats. RNA was reverse transcribed and PCR amplified using STAT-3
specific primers. PCR products were fractionated in a 1.5% agarose gel for 2 hr. A) A
representative agarose gel showing the 715-bp STAT-3 PCR product and cyclophilin as
internal standard, and B) histogram showing the quantification o f the STAT-3 mRNA.
Open-bars are saline-treated and dark-bars are leptin-treated samples. Data are presented
as means ± SEM for two independent observations. * p < 0.05, ** p < 0.001 and p <
0.0001 compared between indicated groups.
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Figure 6.5. Effects o f ADX and leptin treatment on hypothalamic STAT-3 protein levels.
Total STAT-3 protein levels were analyzed by immunoprecipitating STAT-3 from
hypothalamic lysates o f rats treated with either saline vehicle or 2.5 pg leptin using
STAT-3 antibody, followed by Western blotting and analysis with STAT-3 antibody. A)
Immunoblot of STAT-3. B) Densitometric values o f the immunoblot. Open-bars are
saline-treated and dark-bars are leptin-treated samples. Data are presented as means +
SEM. * p < 0.05 compared to sham-operated rats.
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F igure 6.6. Effects of ADX and leptin treatment on tyrosine phosphorylation o f STAT-3
protein. Tyrosine phosphorylation o f STAT-3 was analyzed by immunoprecipitating
STAT-3 from hypothalamic nuclear extracts obtained from ADX, ADX-rep laced and
sham-operated rats treated with either saline vehicle or 2.5 pg leptin using STAT-3
antibody, followed by Western blotting and analysis with antiphosphotyrosine (pY20)
antibody. The membranes were stripped and reprobed with STAT-3 antibody. A)
Immunoblot o f phosphotyrosine and STAT-3. B) Densitometric values o f the
immunoblot. Open-bars are saline-treated and dark-bars are leptin-treated samples. Data
are means ± SEM. * p < 0.05 compared between indicated groups.
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Nuclear extracts were also used to examine the effects o f ADX and leptin
treatment on STAT-3 DNA binding activity on the sis-inducible element (SIE) from a cfo s promoter (m67-SIE) by using gel shift assays (Figure 6.7). The DNA-protein
complex was inhibited by an excess o f unlabeled m67-SIE oligonucleotide. Supershift
analysis showed that the complexes bound to the m67-SIE in response to ADX and leptin
treatment were composed o f STAT-3. Leptin treatment o f sham operated rats enhanced
the activation o f STAT-3 compared to saline treated rats. STAT-3 phosphorylation was
already enhanced in ADX rats compared to sham-operated saline treated rats, which
suggests constitutive DNA binding activity. This STAT-3 DNA binding activity was not
further upregulated by leptin treatment, but rather decreased. Corticosterone replacement
o f ADX rats did not effect DNA binding activity, but again leptin treatment reduced
DNA binding activity.
SOCS proteins represent a family o f negative regulators o f cytokine signaling that
switch off the cytokine signal by binding to the SH2 domain o f JAK proteins, thereby
inhibiting the activation of STAT proteins. This family consists o f eight known members,
namely, the cytokine-inducible SH2 proteins (CIS) and the suppressor o f cytokine
signaling 1 to 7 (SOCS-1-7). Recently, peripheral administration o f leptin to ob/ob mice
was shown to rapidly induce SOCS-3 mRNA in the hypothalamus, but this effect was
absent in db/db mice (Bjorbaek, et al., 1998; Emilsson, et al., 1999). The effects o f ADX
and leptin treatment on SOCS-3 mRNA expression (Figure 6.8) and protein levels
(Figure 6.9) were examined by using semi-quantitative RT-PCR and Western blot
analysis o f immunoprecipitated SOCS-3, respectively. Leptin treatment o f sham-operated

122

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1 2 3 4 5

ADX
_ _ +

ADX-R
+

- ■■&

+

SHAM

+ ._

+

+

L e p tin

Mi-*SM -Mb <&*

F ree p ro b e

ADX

AD X+ R

SHAM

Figure 6.7. Effects of ADX and leptin treatment on the DNA binding activity o f STAT-3
protein. Nuclear extracts were incubated with 32P-labeled m67-SIE and fractionated on a
5% nondenaturing PAGE. A) A representative EMSA gel, and B) densitometric
quantification of the STAT-3-DNA complex. Open bars are saline treated and dark bars
are leptin treated samples. Lane 1 = DNA only, Lane 2 = DNA and unrelated DNA, lane
3 = competition with 100-fold molar excess o f cold m67-SIE, lane 4 and 5 = STAT-3
antibody competition. Data are presented as means ± SEM. * p < 0.05 and ** p < 0.005
compared to indicated groups.

123

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

rats had no effect on SOCS-3 mRNA expression, but increased SOCS-3 protein levels.
ADX decreased the SOCS-3 mRNA expression and protein levels compared to shamoperated rats. Glucocorticoid-replacement o f ADX rats returned the levels o f SOCS-3
mRNA and protein to that o f sham-operated rats. Leptin treatment o f ADX or ADXreplaced rats had no significant effects on SOCS-3 mRNA, but increased protein levels.
Activation o f OBR-L by leptin treatment has recently been shown to induce
tyrosine phosphorylation o f the SH2-containing phosphotyrosine phosphatase 2 (SH
PTP-2 or SHP-2) and its recruitment to the cytoplasmic domain o f OBR-L (Carpenter, et
al., 1998). SHP-2 has also been shown to negatively regulate STAT3-mediated gene
induction after activation o f OBR-L (Carpenter, et al., 1998). Therefore, the effects o f
ADX and leptin treatment on the protein levels and phosphorylation o f SHP-2 were
examined (Figure 6.10). ADX had no effect on the levels and phosphorylation o f SHP-2
protein in all experimental groups. However, leptin treatment showed some increase in
tyrosine phosphorylation o f SHP-2 protein
NPY, a potent stimulator of food intake that is down-regulated by leptin and
glucocorticoids, mediates leptin’s action in the CNS (Rohner-Jeanrenaud, et al., 1996).
The effects o f ADX and leptin treatment on the expression of hypothalamic NPY mRNA
were determined by using Northern blot analysis (Figure 6.11), adrenalectomy
significantly reduced NPY mRNA levels and this effect was reversed by corticosterone
replacement.

Leptin

treatment

of

sham-operated

and

corticosterone

replaced

adrenalectomized rats also significantly reduced NPY mRNA expression compared to
saline-infused controls. However, no further decrease in NPY mRNA expression was
observed in ADX rats treated with leptin.
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Figure 6.8. Effects o f ADX and leptin treatment on the hypothalamic SOCS-3 mRNA
expression. RNA was reverse transcribed and PCR amplified using SOCS-3 specific
primers. PCR products were fractionated in a 1.5% agarose gel for 2 hr. A) A
representative agarose gel showing the 450-bp SOCS-3 PCR product and cyclophilin as
internal standard, and B) histogram showing the quantification o f the SOCS-3 mRNA.
Open-bars are saline-treated and dark-bars are leptin-treated samples. Data are presented
as means ± SEM for two independent observations. * p < 0.05 and ** p < 0.001 between
indicated groups.
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Figure 6.9. Effects o f ADX and leptin treatment on SOCS-3 protein levels. SOCS-3
protein levels were analyzed by immunoprecipitating SOCS-3 from hypothalamic cytosol
extracts obtained from ADX, ADX-replaced and sham-operated rats treated with either
saline vehicle or 2.5 jig leptin using SOCS-3 antibody (gift o f Dr. Jeffrey Flier, Harvard
Medical School, Boston, MA), followed by Western blotting and analysis with SOCS-3
antibody (Santa Cruz Biotechnology, Inc.). A) A representative immunoblot of SOCS-3
protein, and B) densitometric quantification of the immunoblot. Open-bars are salinetreated and dark-bars are leptin-treated samples. Data are presented as mean ± SD. * p <
0.05 and ** p < 0.005 compared between indicated groups.
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Figure 6.10. Effects of ADX and leptin treatment on SH-PTP2 protein phosphorylation
and levels. Tyrosine phosphorylation o f SH-PTP2 was analyzed by immunoprecipitating
SH-PTP2 from hypothalamic cytosol extracts obtained from ADX, ADX-replaced and
sham-operated rats treated with either saline vehicle or 2.5 pg leptin using SH-PTP2
antibody, followed by Western blotting and analysis with antiphosphotyrosine (4G10)
antibody. The membranes were stripped and reprobed with SH-PTP2 antibody. A)
Representative immunoblots o f phosphotyrosine and SH-PTP2 protein, and B)
densitometric quantification o f the immunoblots. Open-bars are saline-treated and darkbars are leptin-treated samples. Data are presented as mean ± SEM. No statistical
significance was found between the groups.
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Figure 6.11. Effects o f ADX and leptin treatment on NPY gene expression. A)
representative Northern blots o f NPY and P-actin mRNA. (B) Histogram showing the
quantification o f NPY mRNA relative to P-actin. Total hypothalamic RNA (20 pg/lane)
was analyzed by Northern blotting. Relative expression o f NPY mRNA was determined
by hybridization with 32P-labeled NPY and P-actin cDNAs. Bands were quantified using
the ImageQuant software. Data are expressed as means ± SEM. * p < 0.05 compared to
indicated groups.
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6.4

DISCUSSION
The key findings of this study were: 1) that the feeding response to leptin is

sensitive to adrenal glucocorticoids, their absence enhancing the anorectic response to
leptin; 2) that mRNA expression o f the leptin receptor isoforms is increased by
adrenalectomy; 3) that adrenalectomy increased STAT-3 mRNA expression and total
protein levels; 4) that leptin treatment of sham-operated rats induced phosphorylation o f
STAT-3, and adrenalectomy induced constitutive phosphorylation o f STAT-3 protein; 5)
that adrenalectomy and leptin treatment induced STAT-3 DNA binding activity, but there
was no synergy between adrenalectomy and leptin treatment; 6) that adrenalectomy
decreased the expression of SOCS-3 mRNA and protein levels, whereas leptin treatment
increased SOCS-3 protein levels; and 7) that the increased sensitivity to leptin upon
adrenalectomy is not due to further changes in NPY mRNA expression.
Our original observations that adrenalectomy increases the expression o f both the
long-form and short-form leptin receptors in the hypothalamus of obese Zucker rats
suggested that adrenal glucocorticoids might modulate their effect on leptin response
through modulation of leptin receptor activity (Madiehe, et al., 1999). Leptin affects food
intake and body weight by actions on the receptors in the hypothalamus, and
adrenalectomy has been shown to reduce food intake and stop the development o f
obesity. Our study is consistent with the published data (Zakrzewska, et al., 1997) which
showed that adrenalectomized rats have increased sensitivity to leptin treatment. The
mechanism by which adrenalectomy increases leptin sensitivity was the subject o f this
study. We hypothesized that glucocorticoids modulate the leptin receptor expression and
activity in the hypothalamus. To identify the components o f the leptin signal transduction
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pathway modulated by glucocorticoids, we investigated the effects o f adrenalectomy on
either gene expression, protein phosphorylation, or DNA binding activity o f several
candidate proteins, which included leptin receptor, STAT-3, SOCS-3, SHP-2 and NPY.
In this dissertation, we show that adrenalectomy caused an increase in the levels
o f mRNA for the long and short forms of the receptor. This was associated with a
reduction in circulating leptin levels, which may suggest that the change in receptor
expression may help to enhance the effects of leptin on food intake when leptin is
administered directly into the brain. The data could also be interpreted as reflecting that
leptin can modulate the expression of its own receptors, with receptor gene expression
increasing when leptin levels decrease. However, if this is the case it appears to be a
delayed response in the absence o f glucocorticoids,

since acute treatment o f

adrenalectomized rats with leptin, did not reduce the levels o f either ObR-L or ObR-S
mRNA. The increase in leptin receptor population in the hypothalamus may lead to
increased receptor activity and thereby cause pronounced effects o f leptin action.
Leptin receptors have been identified in NPY/AGRP- and POMC/CARTcontaining neurons of the ventromedial and ventrolateral ARC, respectively (Elias, et al,
1998; Hakansson & Meister, 1998), and in MCH- and orexin-containing neurons o f the
lateral hypothalamus (Elias, et al., 1998; Elmquist, et al., 1997; Elmquist, et al., 1998).
This suggested that these messengers are mediators o f the actions o f leptin in the
hypothalamus. Recent functional studies showed that NPY, AGRP, POMC-derived
peptides, CART, MCH and orexins are all important regulators o f food intake (Sahu,
1998; Marsh, et al., 1999; Hollopeter, et al., 1998b; Scrocchi, et al., 1997; Goldstone, et
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al., 1997). The exact mechanism by which leptin activates these targets is relatively
unknown.
Leptin has been shown to control insulin secretion from pancreatic (3-cells
(Kieffer, et al., 1997; Ookuma, et al., 1998; Poitout, et al., 1998; Pallett, et al., 1997).
Furthermore, central administration o f leptin inhibits insulin secretion and increases
insulin sensitivity o f peripheral tissues directly (Kamohara, et al., 1997; Cusin, et al.,
1998; Minokoshi, et al., 1999; Haque, et al., 1999). Leptin receptors were identified on
pancreatic |3-cells (Kieffer, et al., 1996; Islam, et al., 1997; Emilsson, et al., 1997), and it
was later showed that Ieptin-mediated inhibition of insulin secretion was by activation o f
ATP-sensitive K+ channels (Kieffer, et al., 1997). Seufert and colleagues (1999), showed
that leptin inhibited transcription o f the preproinsulin by altering transcription factor
binding to sequences upstream from the elements that confer glucose responsivity to the
rat insulin I gene promoter. Therefore, leptin exerts inhibitory effects on both insulin
secretion and insulin gene expression in pancreatic (3-cells. In this study, leptin decreased
insulin levels in sham-operated rats, but not in ADX rats. This may suggest that leptin
effects on insulin secretion may require circulating glucocorticoids.
Leptin regulates food intake and body weight via interactions with hypothalamic
neuronal circuits expressing leptin receptors. The long isoform o f ObR acts through the
JAK-STAT pathway o f signal transduction. Recent evidence suggests that STAT-3
transcription factor mediates leptin’s action in the hypothalamus (Vaisse, et al., 1996;
Rosenblum, et al., 1996; Baumann, et al., 1996; McCowen, et al., 1998; Hakansson &
Meister, 1998). In our study, immunoblotting analysis o f hypothalamic nuclear extracts
with pY20 antibody demonstrated leptin-induced STAT-3 phosphorylation and DNA
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binding activity, consistent with the literature (Vaisse, et al., 1996; McCowen, et al.,
1998). ADX induced a similar, but constitutive phosphorylation o f STAT-3 and DNA
binding activity. This constitutive phosphorylation o f STAT-3, but not the DNA binding
activity, was increased by leptin treatment. It was rather puzzling that constitutive STAT3 tyrosine phosphorylation after ADX and leptin treatment did not translate into increased
DNA binding. This finding might be explained if the excess phosphorylated STAT-3 was
bound by PIAS3, a recently described protein inhibitor of activated STAT-3 (Chung, et
al., 1997). PIAS3 blocks the DNA binding activity o f STAT-3, thus inhibiting STAT-3
mediated gene activation. We did not study other ST AT proteins, especially STAT-1,
because McCowen and colleagues (1998) showed that leptin did not increase the
phosphorylation o f STAT-l and STAT-5, despite abundant expression o f these signaling
molecules in the hypothalamus.
Cytokines are secreted proteins that regulate important cellular responses, with
well defined key events in cytokine signal transduction. Cytokines induce receptor
dimerization, leading to activation of members of the JAK family o f cytoplasmic tyrosine
kinases. In turn, members of the STAT family o f transcription factors are recruited and
phosphorylated, dimerize and increase the transcription of genes with STAT recognition
sites in their promoters. These cellular responses to cytokines are tightly controlled, but
little is known about how cytokine signal transduction is switched off. Few molecules
have now been identified which are able to switch these signals off. The suppressors of
cytokine signaling (SOCS) proteins are a new family o f negative regulators o f cytokine
signal transduction. The expression of SOCS proteins is induced by cytokines, including
leptin (Bjorbaek, et al., 1998). Once expressed, SOCS down-regulate JAK/STAT
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pathways and hence modulate the biological response. The leptin-dependent increase o f
SOCS-3 mRNA was seen in areas of the hypothalamus expressing high levels o f the long
form OB-R (Bjorbaek et al., 1998; Emilsson, et al., 1999). Furthermore, SOCS-3 was
shown to block leptin-induced signal transduction in mammalian cell lines, suggesting
that SOCS-3 is a leptin-inducible inhibitor o f leptin signaling, and suggested SOCS-3 to
be a potential mediator o f leptin resistance in obesity (Bjorbaek, et al., 1998). In our
study, leptin treatment o f sham-operated rats increased SOCS-3 protein levels in the
hypothalamus, which is consistent with the literature (Bjorbaek, et al., 1998; Emilsson, et
al., 1999). In contrast, adrenalectomy decreased SOCS-3 mRNA expression and SOCS-3
protein levels. This decrease in SOCS-3 potentially provides a mechanism by which
leptin resistance could be alleviated.
In support o f this proposal for downregulation o f SOCS-3 after adrenalectomy,
we searched the rat SOCS-3 (GenBank AJ249240) upstream region and identified a
putative glucocorticoid response element (GRE) with a 393-agaaccaggca-^f03 bases
sequence.

This confirms the possibility that

SOCS-3

can be upregulated

by

glucocorticoids. This upstream region also contains two putative STAT-3 binding
elements that have been characterized (Auernhammer, et al., 1999), and showed to
regulate SOCS-3 expression induced by LDF. Our studies show that, in the absence o f
glucocorticoids, leptin activation of STAT-3 led to a moderate increase in SOCS-3
protein levels, whereas sham-operated rats showed a much greater stimulation o f SOCS-3
after leptin treatment. This could suggest that STAT-3 activation and glucocorticoids act
in a concerted manner to regulate SOCS-3.
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In trying to establish the mechanism of regulation o f SOCS-3 expression by leptin
and the mechanism by which SOCS-3 inhibits leptin action, Bjorbaek, et al. (1999) stably
transfected CHO cells with the long form o f the leptin receptor. In these cells, leptin
induced transient expression o f endogenous SOCS-3 mRNA and protein. Leptin
signaling was blocked by pretreatment of cells with leptin, which correlated with
increased SOCS-3 expression. Forced expression o f SOCS-3 in OBR-L transfected COS
cells resulted in inhibition o f leptin-induced tyrosine phosphorylation of JAK2, providing
further evidence that SOCS-3 is a leptin-regulated inhibitor o f leptin signaling in vivo
(Bjorbaek, et al., 1999).
Activation o f OBR-L has been reported to induce the tyrosine phosphorylation o f
the tyrosine phosphatase SH2-containing phosphatase 2 (SH-PTP2 or SHP-2) and that
SHP-2 binds to OBR. Mutation o f Tyr986 to Phe o f OBR-L was shown to abrogate SHP2 phosphorylation and binding to the receptor, but this mutation led to dramatically
increased gene induction mediated by STAT3. Carpenter and colleagues (1998) indicated
that SHP-2 is a negative regulator o f STAT3-mediated gene induction after activation o f
OBR, raising the possibility that blocking the interaction o f SHP-2 with OBR could
overcome leptin resistance and boost leptin's weight-reducing effects in obese individuals
(Carpenter, et al., 1998). In our study, adrenalectomy did not have any effect on SHP-2
protein phosphorylation and levels. This suggests that, upon activation o f OBR-L by
ADX, SHP-2 is inactivated and its interaction with the leptin receptor is reduced. This
would lead to increased STAT-3 protein activation, consistent with the notion that
inhibition o f SHP-2 phosphorylation will lead to increased leptin action through STAT-3.
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Li and Friedman (1999) cotransfected OBR-L, JAK2 and SHP-2 into 293T cells
to study the mechanism by which SHP-2 inhibits leptin induced STAT-3 activation. They
showed that leptin treatment resulted in direct binding o f SHP-2 to OBR-L and that the
bound SHP-2 is itself tyrosine phosphorylated after leptin treatment. In the absence o f
SHP-2 phosphorylation, the level o f JAK2 phosphorylation was increased. Tyrosine
phosphorylation of the OBR-L and STAT3 were not affected by phosphorylation o f SHP2, suggesting that activation o f SHP-2 by the leptin receptor results in a decreased
phosphorylation of JAK2 and may act to attenuate leptin signal transduction (Li and
Friedman, 1999). This could explain, at least in part, how ADX induced increased STAT3 phosphorylation compared to sham-operated rats. During adrenalectomy, no increased
phosphorylation of the SHP-2 was observed, indicating that ADX does not modulate
tyrosine phosphorylation o f SHP-2. Leptin treatment increased SHP-2 tyrosine
phosphorylation, and ADX caused the constitutive phosphorylation of STAT-3. The latter
could be the driving force in the failure o f SHP-2 to attenuate leptin signaling.
Initially, among several mediators o f leptin action within the hypothalamus, NP Y
was the most compelling (Erickson et al., 1996). Several properties suggested that it
might be an essential conduit for the leptin signal. Injection o f NPY centrally evokes
virtually all o f the features o f leptin deficiency, including hyperphagia, decreased BAT
thermogenesis, and hyperinsulinemic insulin resistance. Repetitive injection causes
obesity. Arcuate nucleus NPY is increased by starvation and is elevated in the ob/ob
mouse, both o f which are restored to normal by leptin treatment. Recently, leptin
receptors were found in cells o f the ARC containing NPY mRNA or POMC mRNA
(Mercer, et al., 1996; Meister, 2000). Following leptin administration, NPY cells in the
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ARC did not express Fos but expressed SOCS-3 mRNA. In contrast, leptin induced both
Fos and SOCS-3 expression in POMC neurons, many o f which also innervated the LHA.
These findings suggested that leptin directly and differentially engages NPY and POMC
neurons that project to the LHA, linking circulating leptin and neurons that regulate
feeding behavior and body weight homeostasis (Thornton, et al., 1997; Elias, et al.,
1999). Recent studies have shown that a-MSH, produced from POMC precursors,
decreases food intake (Brown, et al., 1998). In the arcuate nucleus, which also expresses
NPY, approximately 30% of the POMC neurons express the mRNA for the leptin
receptor long form, and arcuate POMC mRNA expression is regulated positively by
leptin (Thornton, et al., 1997; Mercer, et al., 1996). Thus, one can envision a loop in
which rising leptin drives the increase in arcuate POMC expression, which then projects
a-M SH containing axons to cell bodies elsewhere in the hypothalamus, causing
decreased food intake. Both ADX and leptin administration directly into the brain
decrease NPY gene expression and release. Treatment o f ADX rats, which already have
low NPY levels, with leptin can further decrease orexigenic neuropeptides (NPY and
AGRP) and increase anorexigenic ones (POMC and CART) by acting directly on the
leptin receptors found in these neurons.
Leptin is reported to have effects in peripheral tissues that are independent o f its
central effects on food intake and body weight. ADX causes a decrease in white adipose
tissue depots and size (Edens, et al., 1999), whereas corticosterone replacement increases
white adipose tissue weight gain. Leptin treatment, probably through sympathetic
stimulation o f white adipose tissue, causes fat loss which is modulated by the inhibitory
effect of corticosterone on sympathetic outflow. This increased sympathetic outflow to
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these depots may further be increased by ADX, and therefore have an increased
sensitivity to leptin in the absence o f glucocorticoids. Furthermore, leptin has been shown
to decrease lipid synthesis (Edens, et al., 1999). ADX could enhance the adipocyte
response to leptin on lipid synthesis and fat mobilization. Moreover, Sarmiento and
colleagues (1997) showed that the peripheral effects o f leptin include increased
thermogenesis and lipid oxidation in brown fat coupled with increased lipolysis and
decreased fat synthesis in white and brown fat, which lead to a rapid reduction in the
body weight and adiposity o f mice (Sarmiento, et al., 1997). It is, therefore, conceivable
that the sensitivity to leptin after ADX, could be due to the combined inhibitory effects o f
leptin on WAT leptin production and the disappearance of WAT, as induced by both
ADX and leptin, but it may also be a consequence of the energy imbalance th at is
induced by leptin in the absence o f glucocorticoids.
The induction o f SOCS genes, by STAT elements present in the SOCS promoter,
has so far been restricted to activators o f the cytokine receptor family, such as LIF, EL-6,
interferon y, GH and leptin. Although STAT activation is the hallmark o f cytokine action,
they can be activated by other agents, such as angiotensin n, EGF and PDGF. Recent
evidence, therefore, indicates that STAT proteins can be activated by a variety o f receptor
and non-receptor protein-tyrosine kinases (Ihle,

1996). Unlike cytokine-induced

activation o f STATs, where JAKs are known to play a pivotal role in phosphorylating
STATs, the mechanism for receptor protein-tyrosine kinase-mediated activation o f
STATs remains elusive. Insulin modulates cellular metabolism by modifying the activity
and intracellular localization of several proteins, and by modulating transcription
(O’Brien & Granner, 1996). Recently, insulin has been shown to induce tyrosine
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phosphorylation and DNA binding activity o f STAT-5B in a perfused rat liver (Chen, et
al., 1997), showing its involvement in the regulation o f transcription by STAT factors.
Moreover, insulin via its receptor with intrinsic tyrosine kinase activity has now
been shown to specifically induce SOCS-3 mRNA expression and protein translocation
from the cytoplasm to the cell membrane in 3T3-L1 adipocytes (Emanuelli, et al., 2000).
This expression o f SOCS-3 was potentiated by STAT-5B activation, but the authors did
not rule out the possibility that STAT-3 o r other transcription factors stimulated by
insulin might play a role in this mechanism. Caldenhoven and colleagues (1996) showed
that insulin induced SOCS-3 expression in COS-7 cells that were not transfected with
STAT-5B, indicating that the induction could result from low levels o f endogenous
STAT-3 found in these cells. SOCS proteins generally inhibit cytokine signaling through
inhibition o f JAK kinase, but insulin receptor kinase has been shown to activate STAT5B independent o f JAK (Chen, et al., 1997). Emanuelli and colleagues (2000), therefore,
proposed that inhibition o f STAT-5B occurs through competition between SOCS-3 and
STAT-5B for binding to the insulin receptor, and not through inhibition o f JAK kinase.
This is quite intriguing for two reasons. First, not only leptin- and CNTF-treatments
induce SOCS-3, but insulin does as well, and all three o f these molecules are recognized
as satiety factors (Woods, et al., 1998). This insulin effect, however, could provide an
explanation for the paradox of increased levels o f SOCS-3 in leptin-deficient ob/ob mice,
which are hyperinsulinemic. It remains to be evaluated how insulin mediates its effects
on SOCS-3 expression in vivo. Second, leptin and CNTF control feeding behavior and
inhibit insulin release from pancreatic P-cells (Harvey, et al., 1997; Kieffer, et al., 1997;
Gloaguen, et al., 1997). Therefore, if insulin induces SOCS-3 expression in vivo, leptin-

138

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

or CNTF-induced inhibition o f insulin release should cause a decrease in SOCS-3
expression. But, this is not the case. On the other hand, insulin stimulates the production
o f leptin. It is therefore, conceivable that insulin administration in these studies increased
the endogenous levels o f leptin, which in turn increased the expression o f SOCS-3.
Alternatively, one can foresee a situation under hyperinsulinemic conditions, in which
insulin induces the expression of SOCS-3 which can then negatively regulate the
cytokine signal transduction of leptin. In order for leptin to overcome the inhibitory
effects o f SOCS-3, more and more endogenous leptin is released, and this consequently
leads to leptin resistance.
In studies described in this dissertation, leptin treatment of sham-operated rats
caused a decrease in serum insulin levels, but an increase in SOCS-3 mRNA expression
as well as an increase in SOCS-3 protein levels. Furthermore, leptin treatment o f ADX
rats significantly increased SOCS-3 protein levels despite the low levels o f insulin in
these animals. Chavez and colleagues (1997) showed that ADX also increased sensitivity
to central insulin administration, similar to that observed with leptin treatment o f ADX
rats in studies described in this dissertation and those o f Zakrzewska and colleagues
(1997). Whether the insulin sensitivity o f ADX rats is due to increased STAT activation
remains to be investigated. The three studies suggest that the absence of glucocorticoids
increases the brain’s sensitivity to leptin and insulin, and that these hormones act to lower
food intake and body weight through a glucocorticoid-sensitive mechanism, making
glucocorticoids the more important in the regulation o f obesity.
Central administration of NPY causes hyperphagia, hyperinsulinemia, and
obesity, a response that is prevented by prior adrenalectomy in rats (Stanley, et al. 1989).
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NPY-induced food intake was similar in ADX and control rats after acute icv injection of
NPY. Injection o f NPY caused a significant increase in plasma insulin in control rats, but
this effect was absent in ADX rats in which basal plasma insulin levels were also lower
than controls. This suggested that glucocorticoids are necessary for acute NPY-mediated
insulin release which are absent in ADX rats. Again, it stands to reason that NPY-induced
insulin release leads to increase in leptin gene expression and secretion which may
increase the expression of SOCS-3 to inhibit cytokine signaling, but not insulin itself
inducing the expression of SOCS-3.
In contrast to the work of Emanuelli and colleagues (2000), treatment o f rat
hepatoma cells with insulin attenuated the IL-6 stimulation o f acute phase protein genes
(Campos, et al., 1996). This decrease in IL-6 stimulation by insulin was accompanied by
insulin dose-dependent reduction in STAT-3 gene transcription, mRNA accumulation,
protein concentration, and IL-6-inducible DNA binding activity. Insulin mediated a
similar reduction in the mRNA encoding the EL-6 receptor alpha subunit and EL-6
binding activity. These effects o f insulin contribute to the strongly suppressed
transcriptional induction of the EL-6-responsive acute phase plasma protein genes
(Campos, et al., 1996).
Using the insulin-like growth factor I receptor (IGF-IR) in vitro and in vivo to
assess the role o f JAKs in the process of STAT activation, Zong and collegues (2000)
found that STAT-3, but not STAT-5, was activated in response to IGF-I in 293T cells
cotransfected

with

IGF-IR and

STAT

expression

vectors.

Moreover,

tyrosine

phosphorylation o f STAT-3, JAK1, and JAK2 was increased upon IGF-I stimulation of
endogenous IGF-IR in 293T cells transfected with the respective STAT or JAK
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expression vector. Endogenous STAT-3 was tyrosine-phosphorylated upon IGF-I
stimulation in the muscle cell line C2C12 as well as in various embryonic and adult
mouse organs, which supported the observation in 293T cells. They also showed that
SOCS-1 and SOCS-3 proteins inhibited the IGF-I-induced STAT-3 activation. This
inhibition o f STAT-3 activation by SOCS was overcome by overexpression o f native
JAK1 and JAK2 indicating that IGF-I/IGF-IR mediated activation o f STAT3 in vitro and
in vivo and that JAKs are essential for the process o f activation (Zong, et al., 2000).
Kim and colleagues (2000) studied the leptin signal transduction directly in
insulin-sensitive tissues in vivo to examine the ability o f iv leptin to acutely stimulate
phosphorylation o f STAT-3, STAT-1, and MAPK. Both leptin and insulin stimulated
tyrosine phosphorylation o f STAT-3 and STAT-1 in adipose tissue, but leptin increased
STAT-3 phosphorylation in liver and muscle. Both hormones also increased MAPK
phosphorylation, but leptin was less effective than insulin at stimulating IRS pathways.
They also showed that leptin stimulated STAT-3 phosphorylation in fat and that these
effects appear to be direct. Furthermore, leptin activated STAT-3 and MAPK in adipose
tissue ex vivo and in 3T3-L1 adipocytes. This activation of STAT-3 by leptin is in
contrast to the effects o f insulin on SOCS-3 expression described by Emanuelli and
colleagues (2000). It would be interesting to determine whether the activation o f STAT-3
in 3T3-L1 adipocytes is associated with SOCS-3 expression and whether SOCS-3 affects
the DNA binding activity o f the activated STAT-3. In their studies, Kim et al., (2000)
showed that leptin rapidly activates signaling pathways directly at the level o f insulin
sensitive tissues presumably through the long-form leptin receptor, and this pathway
overlaps with, but is distinct from, that engaged by insulin.
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Figure 6.12. A proposed model of the effects of ADX and leptin treatment on the leptin receptor signaling system. In a sham-operated
rat treated with leptin (A), leptin activates OBR-L and JAK, which phosphorylates STAT-3. STAT-3 dimerizes and translocates to the
nucleus to influence transcription o f STAT-3-dependent genes, like SOCS-3. Glucocorticoids (GC) bind to glucocorticoid receptor
(GR) and causes translocation of GR, which binds to GRE regions to influence transcription. Leptin activation o f STAT-3 in the
presence of GC, leads to high levels of SOCS-3 gene expression and protein. SOCS-3 then binds to JAK to inhibit leptin-induced
signaling. In an ADX rat treated with leptin (B), the GR cannot be translocated in the absence o f GC, ADX induces constitutive
activation of STAT-3. Leptin activates OBR-L and JAK, which phosphorylates STAT-3. Activated STAT-3 translocates to the nucleus
and bind to STAT-3 dependent genes to influence transcription. In the absence o f GC, STAT-3 induces low transcription o f SOCS-3
and protein. SOCS-3 protein cannot inhibit JAK, and this leads to constitutive activation o f STAT-3, which may influence expression of
neuropeptide genes involved in food intake. In ADX rats treated with leptin, decrease in STAT-3 DNA binding could be due to
inhibition by PIAS-3.

Another interesting observation is one in which leptin activates STAT-3
signalling mechanism in pancreatic islets and in a rat model of the pancreatic 3-cell,
RINm5F. Activation o f STAT-3 in RINm5F and isolated rat islets by leptin induced
DNA binding in a manner consistent with STAT3 activation. Conditions that mimic
increased metabolic activity resulted in attenuation o f leptin-mediated STAT DNA
binding but had no significant effect on STAT-3 tyrosine phosphorylation in RINm5F
cells (Morton, et al., 1999).
In conclusion, we have showed that ADX induces increased leptin receptor
mRNA expression, a constitutive STAT-3 activation, and increases sensitivity to leptin
by activating the JAK-STAT signaling pathway through activation o f STAT-3 and
reducing the cytokine inhibitor, SOCS-3. Our studies are consistent with those o f Solano
and Jacobson (1999), who recently showed that ADX-induced sensitivity to leptin is not
due to further decrease in NPY. Reduced DNA binding o f phosphorylated STAT-3,
observed in the stimulation of STAT-3 phosphorylation by leptin treatment o f ADX rats,
is consistent with the work of Scarpace and colleagues (2000), where leptin treatment of
old rats increased the levels o f phosphorylated STAT-3 but had no effect on STAT-3
DNA binding activity compared to young rats. Rothwell et al. (1984) report that ADX o f
older rats produced characteristics similar to those o f young rats becomes fascinating. It
will be interesting, therefore, to compare the effects o f ADX on the STAT-3 activation
between young and old rats, for a possible involvement o f this pathway in aging. The
study of the involvement o f glucocorticoids in leptin-induced SOCS-3 expression will
certainly provide useful information for the understanding o f the circuitry o f various
signaling networks involved in the development o f obesity caused by glucocorticoids.
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CHAPTER SEVEN
DIFFERENTIAL EXPRESSION OF LEPTIN RECEPTOR IN HIGH- AND LOWFAT FED OSBORNE-MENDEL AND S5B/P1 RATS*
7.1 INTRODUCTION
The susceptibility o f different rat strains to become obese when exposed to dietary
manipulations has been previously reported (Schemmel, et al., 1970; Shier & Schemmel,
1975). Osbome-Mendel (OM) rats become obese when fed a high-fat (HF) diet, but the
S5B/P1 rat is highly resistant to the development o f obesity when fed the same diet (Fisler
& Bray, 1990). These two rat strains show differing preferences for dietary fat when
given a choice o f macronutrient sources, with OM rats consuming more calories from fat
than carbohydrate, whereas the opposite is true for S5B/PI rats (Okada, et al., 1992).
Furthermore, a variety o f physiological differences have been described in these two rat
strains. The OM rat is more insulin resistant compared to the S5B/P1 rat (Buchanan, et
al., 1992) and has an attenuated activity of the fatty acid sensitive K+ channel in their
taste buds (Gilbertson, et al., 1998). In addition, numerous differences in their response to
feeding modulators have been reported (Singer, et al., 1997; Nagase, et al., 1996; Arase,
et al., 1988; Okada, et al., 1992). These have suggested the involvement o f hypothalamic
areas in the sensitivity o f OM rats for the HF diet induced obesity. Lin, et al., (1996),
while investigating the feeding response to various orexigenic agents, showed a
differential feeding response of OM and S5B/P1 rats to galanin, neuropeptide Y (NPY),
enterostatin and P-casomorphin-(i-7 ) but a similar inhibitory response to corticotropin
releasing hormone (CRH). Enterostatin, galanin and P-casomorphin have been implicated

* Published work. Reprinted with permission from Obesity Research.
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in regulation o f fat intake (Smith, et al., 1997; Leibowitz, et al., 1998; Lin, et al., 1998).
Differences in the levels of NPY, NPY Y1 and Y5 receptor mRNAs between OM and
S5B/P1 rats have also been described (Schaffhauser, et al., 1999) and may be related to
the susceptibility of OM rats to develop obesity when fed a HF diet.
Leptin is a protein released from adipose tissue that enables the brain to adjust
energy intake and thermogenesis in relation to the size o f energy reserves (Zhang, et al.,
1994; Tritos & Mantzoros, 1997; Considine & Caro, 1997; Caro, et al., 1996; Collins, et
al., 1996). The action o f leptin on food intake and weight loss is mediated by interaction
o f the hormone with its hypothalamic receptor (Chua, et al., 1996). The responsiveness o f
the hypothalamus to the inhibitory effects o f leptin on food intake and body weight is
influenced by multiple factors, including deficiency of either leptin (Campfield, et al.,
1996) or leptin receptor (OBR) (Baskin, et al., 1998). OBR-L mRNA in the
hypothalamus is sensitive to genetic and physiological interventions that change
circulating leptin levels indicating that overexpression o f OBR-L in the hypothalamus
may contribute to increased leptin sensitivity. It has also been shown that rats made obese
by feeding a high-calorie diet override the normal satiety effects o f leptin (Widdowson, et
al., 1997). When they are returned to a normal laboratory diet, they reduce their calorie
intake, possibly as a result o f a restoration of the satiety effects o f endogenous leptin
(Widdowson, et al., 1997). Also, the hypophagic response to exogenous leptin is
impaired in these rats, indicative o f a resistance to the satiety signal. Other studies
suggest that HF diet changes the sensitivity to leptin by evoking a sustained increase in
circulating leptin (Frederich, et al., 1995). Therefore, despite increased leptin levels,
animals fed a high-fat diet became obese without decreasing their caloric intake
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(Frederick, et al., 1995). Leptin resistance may be caused by a variety o f factors including
changes in leptin transport into the brain, altered receptor population or sensitivity,
changes in the JAK-STAT signaling pathway or induction o f a cytokine inhibitory
protein SOCS-3 (Widdowson, et al., 1997).
The present study provides evidence that OM and S5B/P1 rats differentially
express leptin receptor mRNA encoding the long form of the receptor and suggest that
diet-induced hyperleptinemia does not down regulate expression of the receptor gene.
7.2 EXPERIMENTAL PROTOCOLS
Animals
Osbome-Mendel (OM) and S5B/P1 rats were obtained from the breeding colonies
at the Pennington Biomedical Research Center. All protocols used in these studies were
reviewed and approved by the Institutional Animal Care and Use Committee.
D iet

The high-fat (HF) diet contained 56% o f energy from fat and the low-fat (LF) diet
15%. The specific composition of the diets has been previously described (Okada, et al.,
1992). The protein content of both diets was identical at 24% of total energy.
In vivo studies
Forty age-matched male, eleven-week old, OM and S5B/P1 rats were used in this
study. They were housed individually in hanging wire-mesh cages attached to an
automated watering system in a temperature-controlled room with a 12-hour light/dark
cycle. All rats consumed nonpurified chow diet (Rodent Chow 5001, Purina Mills, St.
Louis, MO, USA) until the beginning of the experiment. Food was available a d libitum
throughout the experiment. After ten days adaptation to a reversed light/dark cycle, 20
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OM and 20 S5B/PI rats were provided with either the HF or the LF diet for 14 days. Food
intake and body weight were monitored daily, and diet was replaced daily. Two hours
before dark onset, rats were killed by decapitation to allow collection o f trunk blood and
preparation o f serum. Hypothalamic tissue was dissected and frozen in liquid nitrogen
prior to RNA extraction. Serum samples were stored at -80°C before being used for
hormone assay.
Ex vivo studies
Isolation o f total RNA. Total RNA was extracted from hypothalamic tissue by

the modified guanidinium-isothiocyanate method (Chomczynski & Sacchi, 1987) using
TRIzol Reagent (Gibco BRL, Gaithesburg, MD, USA), as described in the General
Methods section.
cDNA probes. cDNA riboprobe for the rat leptin receptor was generated from
the BamHl-linearized pZObR403 plasmid as described in the General Methods section,
according to Ghilardi, et al. (1996). In vitro transcription was performed with the
MAXIscript kit (Ambion, Austin, TX, USA) using T3 RNA polymerase and [a-32P]UTP,
800 Ci/mmol (29.6 TGBq/mmol) (NEN, Boston, MA, USA). As an internal standard, a
160-bp rat 0-actin riboprobe was synthesized using a cDNA template purchased from
Ambion (Austin, TX, USA). Transcripts were gel purified in a 5% sequencing gel and
eluted using the probe elution buffer. The ObR probe is used to detect both the short and
long forms of the receptor mRNAs by using the principle that RNAse A/Tl will digest all
single-stranded unprotected fragments. Therefore, the long form mRNA will yield a 403bp protected fragment and the short form mRNA will produce a 270-bp protected
fragment from the same probe.
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Serum hormone assays. Serum insulin and leptin were measured with double
antibody radioimmunoassay (RIA) kits (Linco, St. Charles, MO, USA) based on rat
standards according to the supplier’s instructions.

Serum corticosterone was assayed

using a commercial radioimmunoassay (ICN Pharmaceuticals, Costa Mesa, CA ).
Preparation o f total protein lysate. The frozen hypothalamic tissues were
homogenized in 0.25 ml o f ice-cold lysis buffer [50 mM Hepes, pH 7.9; 10% glycerol; 1
mM EDTA; 1 mM sodium pyrophosphate; 1 mM sodium fluoride; 1 mM sodium
vanadate; 1 mM Phenylmethylsulfonyl fluoride (PMSF); 1 pg/ml each o f aprotinin,
leupeptin, and pepstatin] using the motor-driven Polytron PTA 20S operated at maximum
speed for 30 s. Nonidet P-40 (NP-40) and Triton X-100 were each added to a final
concentration o f 1%. The homogenates were incubated on ice for 15 min with shaking.
After centrifugation, the supernatant was carefully removed into a new tube and the
debris discarded. The protein concentration was determined by the BCA assay (Pierce).
The protein samples were aliquoted into 100 gg/20pl and were snap-frozen in liquid
nitrogen and stored at —80°C. The procedure was carried out on ice and dithiothreitol
(DTT) and sodium vanadate were added in the beginning and at the end o f the
experiment.
Western blotting. An equal volume of sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) sample buffer was added to the protein samples (100
|ig/20pL), and the proteins were heated to 100°C for 5 min. Proteins were separated by
SDS-PAGE and transferred to PVDF membranes (Boehringer Mannheim) with a TransBlot transfer cell (Bio-Rad Laboratories, Richmond, CA) in TG buffer [48 mM Tris, 39
mM Glycine] and 20% methanol. Membranes were blocked for 1 h with 5% nonfat dry
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milk in TBS-T [10 mM Tris, pH 8.0 and 150 mM NaCl with 0.05% Tween-20],
incubated with ObR13 A primary antibody (Alpha Diagnostics, Inc.) in 1% BSA in TBST for 2 h, washed three times for 15 min with TBS-T, and incubated with secondary
antibody for 1 h in 1% nonfat dry milk in TBS-T. After washing three times for 20 min
each time in TBS-T, antibody binding was visualized using an ECL (Renaissance)
detection system. Before reuse, membranes were stripped, blocked and reprobed
according to the manufacturer’s instructions. Membranes were reprobed with anti-ObR
(K-20) antibody (Santa Cruz Biotechnology, Co.).
Statistics
Analyses o f hypothalamic gene expression, plasma corticosterone, leptin and
insulin data as well as tissue weights were performed using a three-way analysis o f
variance (ANOVA) with the factors o f strain, diet and age. Individual comparisons
between means were made using Bonferroni’s post-hoc analysis.
7.3 RESULTS
Age-matched OM and S5B/PI rats were maintained either on a HF or LF diet for
14 days. As is characteristic o f OM rats on a high fat diet, they became significantly
obese, attaining body weight of 392.2 ± 6.1 g compared to 355.7 ± 9.93 o f OM rats on
the LF diet (Table 7.1). This amounts to 20% increase in body weight from the beginning
o f the study. S5B/P1 rats showed a slight increase in body weight on a high fat diet (285.5
± 8.64 versus 261.2 ± 9.41 g). Both strains showed only marginal increases in body
weights on the LF diet. The effect o f dietary fat on serum hormone levels is also shown in
Table 7.1. OM rats had increased levels o f insulin (2.76 ± 0.40 and 2.04 ± 0.22 ng/ml,
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Table 7.1. The effect of diet on body weight and serum leptin and insulin.

Strain
Diet

§

S5B/P1____________________________ Osborne-Mendel_________
___________ LF________________ HF________________ LF_______________ HF

Initial Body weight (g)

269.3 ±7,07

261.2 ±9.41

334.418.43H

326.9 ±6.01H

Final Body weight (g)

267.7 + 7,58

285.5 ±8.64*

355,7 ±9,93H

392,2±6.10*H

Leptin (ng/ml)

4,84 ±0,82

4.55 ±0.51

6.20 ±0.63

9.43 ± 1.32*H

Insulin (ng/ml)

0.60 ±0,06

0,64 ±0,06

2.04±0.22H

2.76 ± 0,40 H

Animals (10 in each group) were exposed to HF and LF diets for 14 days, This table indicates the final body weights at the
time of sacrifice. Data are presented as means ± SEM, (n = 10/group) * p < 0,05 compared to LF group, H p < 0.05 compared
to equivalent S5B/P1 group.

for HF and LF groups respectively) compared to S5B/PI rats on the same diets (0.64 ±
0.05 and 0.60 ± 0.06 ng/ml respectively). The serum insulin levels in OM rats on HF diet
were elevated approximately 5-fold over those o f their S5B/PI counterparts. Diet did not
have any effect on the levels o f insulin in either OM or S5B/P1 rats.
Serum leptin levels in OM rats fed the HF diet were elevated 2-fold over those o f
their S5B/P1 counterparts. OM and S5B/P1 rats had comparable leptin levels after
maintenance on the LF diet (6.20 ± 0.63 and 4.81 ± 0.82 ng/ml, respectively).
Furthermore, OM rats on a HF diet had higher leptin levels than those on a LF diet (9.43
± 1.32 compared to 6.20 ± 0.63, respectively).
Using a Ribonuclease Protection Assay, we found that neither diet nor strain had
any significant effect on the expression of either the short form or the long form o f the
leptin receptor mRNA in the hypothalamus. However, the OM rats on both diets had an
increase in the long form o f the leptin receptor mRNA compared to S5B/P1 rats (Figure
7.1). Western blots of total protein lysates from the hypothalami are shown in Figure 7.2.
The levels o f OBR-S were reduced by over 50% in both OM and S5B/P1 rats fed the HF
diet but there was no intrastrain difference. Likewise, the levels of OBR-L were
decreased in rats fed the HF diet in both OM and S5B/P1 rats.
7.4 DISCUSSION
The main findings o f this study were; 1) that leptin levels are increased by feeding
high fat diets; 2) that leptin levels o f OM rats were greater than those of S5B/P1 rats fed
the same diet; 3) that there were no differences in the levels o f the mRNA for the short
form o f the leptin receptor (OBR-S mRNA) in the hypothalamus between OM and
S5B/P1 rats or with dietary fat; 4) that the level o f mRNA for the long form o f the
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OMHF

----- ObR riboprobe

Figure 7.1. A representative RPA autoradiogram o f leptin receptor gene expression in OM and S5B/P1 rats fed HF and LF diets. Total
hypothalamic RNA was hybridized with an antisense riboprobe for leptin receptor as described in the Methods. Arrows indicate the
positions of the long form protected fragment (403-bp) and the short-form protected fragment (270-bp), Insert: Yeast controls for the
leptin receptor probe. Lane M is the century marker, lanes 1 and 2 are leptin receptor probe controls in the presence and absence ot
RNase A/RNase T1 enzymes, respectively.
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Figure 7.1 B. Histograms of leptin receptor gene expression in OM and S5B/P1 rats fed
HF and LF diets. The histogram shows the relative expression of leptin receptor (short
form and long form) to (3-actin mRNA in OM (filled bars) and S5B/P1 (empty bars) rats
fed the HF and LF diets. Data are presented as means ± SEM (n = 6-8). * indicates p <
0.005 compared to S5B/P1 group on the same diet.
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Figure 7.2. Comparison of the short isoform leptin receptor protein levels in OM and
S5B/PI rats fed HF and LF diets. Total hypothalamic protein lysates were prepared as
described in the general methods section. Samples prepared from individual rat
hypothalami were analyzed by Western blotting with the short form specific (ObR K-20,
Santa Cruz Biotechnology Co.) leptin receptor antibodies. M is protein molecular marker.
The histograms show the relative optical densities o f short form leptin receptor to actin
protein in OM (filled bars) and S5B/P1 (empty bars) rats fed the HF and LF diets. Data
are means ± SEM. * p < 0.05 compared to LF diet.
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Figure 7.3. Comparison o f the long isoform leptin receptor protein levels in OM and
S5B/P1 rats fed HF and LF diets. Total hypothalamic protein lysates were prepared as
described in the general methods section. Samples prepared from individual rat
hypothalami were analyzed by Western blotting with the long form specific (ObR13A,
Alpha Diagnostics, Inc.) leptin receptor antibodies. M is protein molecular marker. The
histograms show the relative optical densities o f long form leptin receptor to actin
protein in OM (filled bars) and S5B/P1 (empty bars) rats fed the HF and LF diets. Data
are means ± SEM. * p < 0.05 compared to LF diet.
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receptor (OBR-L) was increased in the hypothalamus o f OM rats compared to S5B/PI
rats, but was not affected by dietary fat; 5) that the protein levels o f OBR-L and OBR-S
were decreased in rats fed HF diets.
While obesity in mutant rodents has been associated with decreased leptin
production (ob/ob mouse) (Zhang, et al., 1994) or absence o f a functional receptor (db/db
mouse and fa /fa rat) (Considine & Caro, 1997; Chua, et al., 1996), these abnormalities
are rare in humans (Clement, et al., 1996). Like human obesity, nonmutant obese animals
typically show elevated plasma leptin levels and increased expression o f leptin mRNA in
the adipose tissue (Lin, et al., 1998; Guerre-Millo, 1997) suggesting leptin resistance. By
manipulating nutritional variables in different inbred strains, several animal models of
diet-induced obesity have been developed (Schemmel, et al., 1970). In our model of
dietary obesity, Osbome-Mendel (OM) and S5B/P1 rats differ in their sensitivity to
develop obesity when fed a high fat (HF) diet, OM rats become obese, whereas S5B/P1
rats remain thin (Bray, et al., 1990a; Bray, et al., 1990b). Such models provide the
opportunity to evaluate the interaction o f diet and genetic background on the
development o f obesity.
The discovery o f leptin has elucidated a feedback loop in the hormonal control of
energy balance and body fat.

Murine mutations that lack an intact ob gene or its

receptors become obese (Zhang, et al., 1994; Considine & Caro, 1997; Chua, et al.,
1996). In this study, the role of leptin and its receptor in high fat diet-induced obesity was
investigated. We confirmed our previous result showing hyperleptinemia in OM rats in
response to HF feeding for two weeks. However, we did not observe any increase in
serum leptin levels in S5B/P1 rats fed the HF diet in this study. Previously (Lin, et al.,
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1998) we reported that S5B/P1 rats responded to the introduction o f a HF diet by an
increase in leptin gene transcription and serum leptin levels after 2 days, but the
magnitude of the responses was greatly decreased at 7 days and serum leptin levels were
not affected by diet after 5 weeks. Thus the absence o f a HF diet induced increase in
serum leptin reported in this study may reflect the length of exposure (14 days) to the
diet. Previous studies reporting the hyperleptinemia in obese humans and other animals
seem to contradict the ability of leptin to increase energy expenditure and reduce food
intake (Bray & York, 1997). Further, the differential leptin response to a high fat diet that
we observed here in OM and S5B/P1 rats suggests that sensitivity to a HF diet, rather than
resistance, is associated with an increase in leptin secretion. This contrasts to studies in
mice in which dietary fat-induced obesity was associated with an attenuated increase in
plasma leptin (Ahren, et al., 1997). Ob gene expression and leptin production by the
adipose cells are under the control of various hormonal and metabolic factors. High-fat
feeding increases ob gene and plasma leptin, and induces a state o f leptin resistance (Lin,
et al., 1998; Ahren, et al., 1997; Van Heek, et al., 1997). Two hormones, insulin and
corticosterone, increase leptin production in rodent and human adipose cells (Barr, et al.,
1997; Slieker, et al., 1996; Dagogo-Jack, et al., 1996; MacDougald, et al., 1995;
Malmstrom, et al., 1996). In contrast, the activity of the sympathetic nervous system
exerts an opposite effect, mainly through activation of the adipose ph-adrenergic
receptors (Guerre-Millo, 1997; Lu, et al., 1998). Insulin has been postulated to be
necessary stimulus for leptin release, and our data suggest that this is the case.
Hyperleptinemia developed in HF-fed OM rats in parallel with their increase in insulin
secretion, whereas S5B/P1 rats, which did not have increased leptin levels, did not
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increase insulin levels when fed the HF diet. Devaskar, et al (1997), have shown that
leptin mRNA and peptide levels are higher during consumption of a high fat milk diet.
They suggested that high levels of leptin with increasing food intake and body weight
gain signify hypothalamic leptin receptor resistance during the immediate postnatal
period. Our laboratory has previously shown that a high fat diet significantly increased
leptin mRNA and serum leptin levels (Lin, et al., 1998). However, when leptin was
administered centrally, a similar dose-dependent reduction in energy intake was observed
in response to leptin in both OM and S5B/PI rats. These responses were independent o f
the diet. These studies suggested that the acute susceptibility of OM rats to HF dietinduced obesity was not related to either a loss o f central sensitivity to leptin or a failure
to enhance leptin production (Lin, et al., 1998). Similar conclusions were made from a
study o f HF induced obesity mice (Van Heek, et al., 1997) in which obesity was induced
in two strains o f mice, C57BL/6 and AKR, by exposure to HF diet. Serum leptin
increased in proportion to body weight. C57BL/6 mice on the HF diet developed leptin
resistance, whereas those on LF diet retained their leptin sensitivity. Intriguingly, both
groups became resistant to peripherally administered leptin after long term exposure, but
retained sensitivity to centrally administered leptin (Van Heek, et al., 1997).
To date there is little information on the regulation o f the leptin receptor. Both
nutritional status and estradiol (E2) treatments affect OBR mRNA expression (Bennett, et
al., 1998). Food deprivation increased the abundance o f OBR-L transcripts in the
thalamus despite a decrease in total OBR and OBR-S in this area. Fasting has also been
shown to up-regulate ObR mRNA expression in the Arcuate nucleus o f C57 BL/6 lean
(+/+) but not obese (ob/ob) mice (Lin & Huang, 1997). Obese Zucker rats also show
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different expression to lean rats with an increased expression o f OBR-L transcripts in all
brain areas analyzed and a decrease in total OBR gene expression.
Changes in the balance between OBR-L and OBR-S forms of the receptor,
observed in these studies could alter tissue sensitivity to leptin. In the current study, we
did not identify any changes in the total hypothalamic levels o f mRNA for either OBR-S
or OBR-L with dietary fat, but there was a significantly elevated level of OBR-L mRNA
in hypothalamus o f OM compared to S5B/P1 rats. In contrast, OBR-S mRNA levels were
similar in both strains. The increase in OBR-L mRNA in hypothalamus of OM rats was
evident despite the increase in circulating leptin and insulin in this strain.

However,

W estern blot analyses showed that mRNA expression levels were not an

index o f

receptor protein levels. Indeed, OBR-L protein levels were reduced in rats fed HF diets
suggesting that posttranscriptional events are important for the control o f receptor
activity. This result is somewhat surprising since we have previously shown that there is
no difference in the dose-response curve to central leptin in OM and S5B/P1 rats fed a HF
diet. The possible explanation for this may be that these receptor protein changes are not
uniformly spread across all hypothalamic sites and that the changes in the nuclei that
regulate

feeding

behavior

are

less

dramatic.

In

situ

hybridization

and

immunohistochemical approaches will be needed to investigate this possibility.
The uptake o f leptin in the choroid plexus appears to be saturable (Banks, et al.,
1996; Karonen, et al., 1998). The possibility exists that the high fat feeding may influence
the transport and, in so doing, the availability o f leptin, to the centers important in
regulation of food intake and energy expenditure. Leptin may gain access to the brain via
receptor-mediated transport through the blood-brain barrier (BBB), and the BBB leptin
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receptor (OBR) may regulate the availability o f circulating leptin to brain cells. Boado et
al (1998) showed that the OBR-S is the principal leptin receptor expressed at the BBB
and that this BBB OBR isoform is up-regulated by a high fat diet. We were unable to
confirm this in the current study in which we assayed total hypothalamic OBR-S mRNA
levels. Further, we showed that OBR-S protein levels were significantly reduced by HF
feeding in both rat strains suggesting that leptin transport across the BBB would be
reduced by HF feeding. This is consistent with a recent report that leptin transport is
decreased in mice that become fat (Banks, et al., 1999). Again the differential responses
of mRNA and protein levels for OBR-S suggest regulation at a posttranscriptional level.
However, despite this reduction in OBR-S, S5B/P1 rats fed a HF diet do not become
obese suggesting that mechanisms other than leptin transport and leptin receptor numbers
may be important to their response.
Insulin and leptin are thought to regulate feeding behavior through their abilities
to regulate transcription of several neuropeptide genes including neuropeptide Y (Baskin,
et al., 1999). We have recently shown that OM rats fed a high fat diet have elevated
hypothalamic NPY mRNA levels (Schaffhauser, et a., 1999), suggestive o f both leptin
and insulin resistance since both these hormones normally decrease neuropeptide Y. As
NPY activity in the PVN promotes hyperinsulinemia and hypercorticism (RohnerJeanrenaud & Jeanrenaud, 1997), the elevated levels o f insulin and glucocorticoids would
in turn enhance leptin synthesis and secretion (Barr, et al., 1997). The majority o f
genetically obese rodents have similar endocrine profiles in which the hyperleptinemia is
associated with hyperinsulinemia and hypercorticosteronemia (Bray, et al., 1990a; Bray,
et al., 1990b; Rohner-Jeanrenaud & Jeanrenaud, 1997). Our data is, therefore, consistent
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with the hypothesis, that insulin promotes the observed hyperleptinemia observed in OM
rats compared to S5B/P1 rats and the increase in leptin associated with feeding a high fat
diet.

The apparent resistance to endogenous leptin in OM rats is reflected in the

increased hypothalamic NPY levels (Schaffhauser, et al., 1999). Likewise, the anorectic
response to intra-cerebroventricular insulin is lost when rats are fed a HF diet implying a
fat-induced central insulin resistance (Arase, et al., 1988).
The results o f this current study confirm that obesity associated with consumption
o f a high fat diet is characterized by hyperleptinemia. Despite the high levels o f the longform o f the leptin receptor mRNA in the hypothalamus of obese OM rats and the normal
levels o f the short form receptor mRNA, changes in the protein levels o f both receptors
would lead to impaired leptin transport across the BBB and impaired leptin signaling.
These protein changes would be expected to promote obesity and contribute to the leptin
resistance that is seen in HF fed rats.
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CHAPTER EIGHT
SUMMARY AND RESEARCH DIRECTIONS
Adrenal glucocorticoids play a significant role in the control o f substrate supply to
tissues. They protect the body fat stores by counter-regulating the effects o f lipolytic
agents (Remesar, et al., 1997), and also enhance the induction o f lipogenic enzymes by
insulin (Wurdeman, et al., 1978). The obese often show enhanced sensitivity to
glucocorticoids (Tokuyama & Himms-Hagen, 1989. Humans and rodents maintain high
circulating levels o f cortisol and corticosterone, respectively, due to alterations in the
activity o f the HPA axis (Rosmond & Bjorntorp, 2000). The effects o f circulating
glucocorticoids are mediated through the adipose tissue, the main target for lipid storage
induced by insulin (Wurdeman, et al., 1978). Glucocorticoids also regulate the expression
and production o f leptin from the white adipose tissue, therefore regulating the
expression o f its counter-regulatory hormone. Adrenalectomy prevents fat accretion of
the already obese rat and stops weight gain and obesity development in all forms of
obesity (Bray, et al., 1990a; Bray, et al., 1990b). After adrenalectomy, a situation exists in
which all the counter-regulatory mechanisms that depend on glucocorticoids are
removed. For example, the integrity o f fat stores is no longer protected, because ADX
affects energy balance.
Leptin, whose expression and production are controlled by glucocorticoids,
modulates food intake (Weigle, et al., 1995; Rentsch, et al., 1995; Campfield, et al.,
1995), body weight (Halaas, et al., 1995; Pelleymounter, et al., 1995; De Vos, et al.,
1995) and energy expenditure (Mistry, et al., 1997; Haynes, et al., 1997; Scarpace, et al.,
1997; Himms-Hagen, 1997) through its action in the hypothalamus. It also modulates
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insulin release and function (Cohen, et al., 1996; Walder, et al., 1997) and thermogenesis
(Hwa, et al., 1996). Some o f these effects o f leptin are analogous to those produced by
adrenalectomy.

For example,

leptin treatment

and

ADX

both

increase

BAT

thermogenesis, decrease food intake and body weight, increase energy expenditure, and
lower circulating levels o f insulin. Furthermore, Jeanrenaud’s group showed that
adrenalectomy increases sensitivity to leptin (Zakrzewska, et al., 1997). Therefore, the
present studies investigated the molecular bases o f this sensitivity to leptin by studying
the effects o f adrenalectomy and leptin treatment on the leptin signal transduction
pathway, to determine whether glucocorticoids are implicated in the reduced response to
leptin in obesity.
In this research project, we studied leptin receptor expression and activity in the
hypothalamus and liver after adrenalectomy. To confirm that ADX increases sensitivity
to leptin when given icv, we measured food intake, serum hormones, gene expression and
protein levels and activities of candidates in the leptin receptor signaling pathway in the
hypothalamus. Since inhibition o f food intake by leptin is thought to be caused, in part at
least, by inhibition o f NPY, its mRNA expression in the hypothalamus was also
measured. The results demonstrate that leptin treatment o f adrenalectomized rats caused a
large decrease in food intake and body weight, consistent with data o f Zakrzewska and
colleagues (1997). The possibility existed that the reduced food intake and body weight
in leptin-treated ADX rats may be due to activation or inhibition o f central food intake
related genes or neurotransmitters. We hypothesized, that removal o f adrenal
glucocorticoids may potentiate leptin effects by modulating the leptin receptor signaling
pathway, with positive effects on genes that are negatively regulated by glucocorticoids,
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and vice versa. The results from experiments described in this dissertation show that
ADX

increased

ObR

mRNA

expression,

constitutively

enhanced

STAT-3

phosphorylation and DNA binding, decreased the cytokine inhibitory SOCS-3 mRNA
and protein levels. Leptin treatment of ADX produced superior effects on food intake and
body weight because leptin effects could not be counteracted by glucocorticoids. The
deregulating effects o f leptin treatment in ADX rats were more evident in the lowering of
insulin levels, and central administration o f leptin has been shown to inhibit insulin
secretion and increase insulin sensitivity of peripheral tissues directly (Kamohara, et al.,
1997; Cusin, et al., 1998; Minokoshi, et al., 1999; Haque, et al., 1999). The results
presented here strongly support the hypothesis that glucocorticoids play a key role in the
modulation o f leptin-induced imbalance o f energy intake and expenditure. The
mobilization o f fat reserves, elicited by leptin treatment, is probably hampered by
glucocorticoids.
Furthermore, leptin receptors are expressed in the arcuate POMC neurons
(Cheung, et al., 1997), and the anorectic effects of leptin can be blocked by central MC4R antagonist (Satoh, et al., 1998). The neuropeptides, NPY, 3-endorphin, AGRP, orexin,
galanin and melanin concentrating hormone, all increase food intake and reduce
sympathetic activity. In contrast, peptides including CCK, CRH, enterostatin, leptin,
CART and a-M SH reduce food intake and increase sympathetic activity. The
melanocortin receptor system may be particularly important in modulating food intake,
because a transgenic mouse which does not express melanocortin-4 receptors is
massively overweight (Marsh, et al., 1999). Adrenal glucocorticoids are important in
obesity since ADX prevents the development o f all forms o f obesity. It will therefore be
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interesting to study, by immunohistochemistry, the effects o f leptin and ADX on the
expression o f some o f these central neuropeptides. The increased sensitivity to leptin on
food intake, fat stores and energy expenditure may be related to changes in these
neuropeptides, but, NPY was recently showed not to be influenced by a combination o f
leptin and ADX (Solano & Jacobson, 1999). AGRP was recently shown to be suppressed
by leptin, but was not regulated by ADX (Li, et al., 2000).
The reciprocal relationship between food intake and sympathetic activity is
robust, and suggests that 3 -receptors in the periphery and brain may be involved in the
control o f feeding (Bray, 2000). Haque and colleagues (1999) examined the interaction o f
the effects o f hypothalamic leptin and insulin administered peripherally. They reported
that leptin in the hypothalamus enhances glucose uptake in certain peripheral tissues
through mediation of a P-adrenergic mechanism for the sympathetic nerves innervating
the tissues and that central leptin and peripheral insulin have a synergistic role in
augmenting tissue glucose uptake (Haque, et al., 1999). Furthermore, exercise was shown
to decrease leptin mRNA expression, an action attributed to activation o f the P3 adrenergic receptor, because this decrease was blocked by pretreatment with P3 adrenergic receptor antagonist, SR.-59230A (Bramlett, et al., 1999). Whether the
activation o f

33

-adrenergic receptors (receptor numbers) or the increase in its gene

expression account for the increased sympathetic activity remains to be determined.
Therefore, P3 -receptor stimulation, like ADX, down-regulates adipose tissue leptin
mRNA in vivo and increase sympathetic activity. It will be interesting to see whether the
combination o f a chronic

33

-receptor stimulation with C L 316,243 agonist and icv leptin

could show a similar response to that shown in this dissertation.
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We have also showed that peripheral leptin resistance was induced in OM rats fed
HF diet (Lin, et al., 1998), and also that HF diet down-regulates the hypothalamic leptin
receptor protein in OM and S5B/P1 rats (Madiehe, et al., 2000). Recently, Bjorbaek and
colleagues (1998) showed that leptin resistance was accompanied by increase in SOCS-3,
which was named a potential marker for leptin resistance. Because leptin induce SOCS-3
mRNA and protein expression, it is imperative to expand this study to determine whether
HF feeding induced-leptin receptor down-regulation was associated with SOCS-3
expression. It will also be interesting to determine the potential differences in the leptin
receptor signaling between OM and S5B/P1 rats due to their distinct differences in
sensitivity to HF diet-induced obesity.
The identification o f other genes that could be involved in the induction of leptin
resistance remains a lucrative endeavor, because it offers endless opportunities toward
understanding how diet-induced obesity is manifested and how certain genes within dietsensitive and diet-resistant individual may be influenced by a conducive environment.
This study reveals a need in future research to identify potential molecules that could
alleviate the decrease in leptin receptor protein, or those that could influence other genes
that are regulated by leptin to reduce adiposity. Our data shows consistency with the
literature, and further suggests a need to address key issues associated with leptin
resistance, as these will be useful in developing drugs toward the treatment o f human
obesity. The identity o f neuropeptides and pathways required for development o f obesity
need to be mapped out and various interactions be resolved. An understanding of the
participants and their functions will expand the knowledge that could potentially be used
in treatment of obesity and/or diabetes.
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Future research should continue to focus on the interaction o f glucocorticoids, leptin and
insulin, the major players in obesity thus far, to offer a clear connection between
glucocorticoids, leptin and insulin in the development o f obesity. A variety o f questions
to guide and focus future research arise from this study: 1) In what ways could we
activate the leptin receptor or inhibit SOCS-3 expression under conditions o f high
corticosterone levels? Glucocorticoid receptor antagonists have been shown to decrease
body weight. 2) Can GR antagonists activate leptin receptor activity or down-regulate
cytokine signaling inhibitors (e.g. SOCS-3)? The analysis o f SOCS knockout mice
showed that SOCS proteins have physiological role in regulating responsiveness because
the SOCS knockout mice die before weaning due to liver degeneration and lymphoid
deficiency (Starr, et al., 1998). Alternatively, mutations that may lead to the loss o f SOCS
activity could give rise to increased cytokine responsiveness, which may contribute to the
development o f diabetes. Therefore, small molecule effectors which modify SOCS
function may potentially be useful therapeutic agents for the treatment o f certain diseases,
including obesity. (Starr & Hilton, 1998). 3) Are there any other unknown potentially
novel systems involved in the development of obesity that are regulated by high
glucocorticoid levels, and what interactions do they have with other known systems? In
searching for answers to these questions, we can both develop a better understanding of
how obesity is manifested and also take the necessary steps toward treatment of obesity.
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